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A b s tr a c t
Overactive bladder (OAB) is a common condition of the lower urinary tract (LUT) that is 
characterised by urinary urgency, with or without incontinence, accompanied by frequency and 
nocturia as a result of involuntary urinary bladder contractions. OAB affects millions of people 
worldwide and has a significant impact on quality of life. A significant amount of research has 
been undertaken, and is still on-going, investigating the underlying mechanisms of bladder 
dysfunction and the development of new therapeutic agents for the treatment of LUT conditions.
It is now clear that the simplistic ideology of the bladder acting as a passive reservoir is far more 
complicated, and involves complex mechanisms between the different components of the 
bladder wall.
The recently emerging role of the bladder urothelium and sub-urothelium in regulating bladder 
functions has laid the foundation for a hypothesis supporting a mechanosensory basis for OAB. 
The urothelium expresses several different types of receptors and ion channels, and upon 
stimulation releases mediators such as ATP, nitric oxide and acetylcholine. These mediators 
act on receptors in the urothelium and in the underlying nerves and muscle to mediate bladder 
activity, and although these mechanisms are still not completely understood there is evidence to 
suggest that in pathological conditions, these pathways may be altered. The aim of this project 
was to investigate the mechanisms, structures and transmitters involved in these mechano­
sensory pathways in the bladder wall using in vitro pharmacology, histology, 
immunohistochemistry and mediator assays
Spontaneous phasic contractions (PCs) developed in tissue strips isolated from the dome, body 
and trigone regions of the pig bladder, and the amplitude and frequency of these PCs was 
measured. Functional and structural differences were observed between the different bladder 
regions, particularly in the trigone versus the dome and body. Removal of the mucosa 
significantly increased the development time of PCs in the dome and body but not in the trigone. 
Mucosa removal also significantly decreased the frequency of contractions in the dome and 
body but not in the trigone. Since increased PCs of the bladder are associated with OAB, the 
mechanisms regulating these contractions were explored. Phasic contractions amplitude could 
be increased by low concentrations of the muscarinic receptor agonist carbamylcholine 
(carbachol - CCh), and functional differences were observed in the trigone compared to the 
dome and body regions. The muscarinic receptor subtype involved in mediating the effect of 
CCh was also investigated, but from the results obtained it was not possible to determine which 
subtype was responsible.
Research into the role of interstitial cells (ICC) in the bladder has grown in the past decade 
since this specialised class of cells was discovered in the urinary bladder. It is postulated that 
these cells may be involved as mediators of mechanosensory function in the bladder. The 
expression of c-Kit, a tyrosine kinase receptor, on ICC allowed for the functional role of these 
cells in PCs of the bladder to be investigated, and to attempt to determine their localization in 
the different bladder layers using immunohistochemistry. Imatinib, a tyrosine kinase receptor 
inhibitor, had no effect on the amplitude or frequency of PCs in tissue strips from the different 
bladder regions, suggesting that c-Kit positive ICC may not be involved in PCs in the pig 
bladder. A population of cells staining positive for vimentin, but lacking specific c-Kit staining, 
was identified but cannot be conclusively identified as ICC.
Investigation and measurement of ATP release using a luciferase assay kit in response to 
stretch was also performed in the dome and body regions of the bladder. ATP release was 
found to increase with stretch. The presence of a heterogeneous population of cells in the 
bladder including detrusor smooth muscle cells, urothelial cells and ICC makes it difficult to 
determine the exact source of ATP, although literature suggests the urothelium to be the 
dominant source.
In summary, the data presented in this thesis support a role for the urothelium and 
suburothelium the complex physiological processes of the pig urinary bladder. Further 
research is required into the integrated physiology of the bladder wall, and this may contribute 
to the discovery of new targets for pharmacological agents to treat lower urinary tract conditions.
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CHAPTER 1
GENERAL INTRODUCTION
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In t r o d u c t io n
The urinary system is composed of a pair of kidneys which form urine, ureters that 
carry the urine from the kidneys to the bladder, the urinary bladder which stores the 
urine and periodically eliminates it, and the urethra through which the urine is excreted. 
The main functions of the urinary system are elimination of waste products from the 
blood, elimination of these waste products into the environment and homeostatic 
regulation of blood plasma volume and solute concentration (Martini and Nath 2009). 
The kidneys filter on average 125ml of plasma per min of which 124ml/min is 
reabsorbed and 1ml/min is excreted as urine. Thus of the 180L of plasma filtered in 
day, 1.5L of urine is formed (Sherwood 2008) with the urinary bladder vital to the 
urinary system as the major player in the storage and elimination of the toxic wastes 
excreted into the urine.
1.1 U r in a r y  T r a c t  A n a t o m y
1.1 .1  Th e  U r e t e r s
The ureters are a pair of muscular tubes that extend inferiorly and medially from the 
renal pelvis to the bladder base and are firmly attached to the posterior abdominal wall 
(Martini and Nath 2009). The walls of the ureters are composed of 3 layers - the inner 
mucosa made up of transitional epithelium, a middle layer of both circular and 
longitudinal smooth muscle and an outer connective tissue layer. The ureters function 
under low pressure to transport urine from the kidneys to the bladder and this occurs 
via intrinsic peristaltic contractions. The urine drains into the bladder at the vesico- 
ureteric junction which, if correctly functioning, allows for unidirectional flow of urine 
and contains a mechanism to prevent retrograde flow of urine back into the ureters 
from the bladder. This protects the ureters from bladder infections and the high 
pressure encountered in the bladder during voiding (Chappie 2011).
1 .1 .2  Th e  U r in a r y  B l a d d e r
The urinary bladder is a hollow, muscular organ located in the pelvic cavity and is 
primarily involved in the collection, storage and emptying of urine (Andersson and 
Arner 2004). The bladder is anchored by the middle and lateral umbilical ligaments 
towards the umbilicus, while the anterior, posterior and inferior surfaces of the bladder 
are anchored to the pelvic and pubic bones by tough ligamentous bands (Martini and 
Nath 2009). Depending on its state of distension, its size varies and it can hold 
anywhere between 400ml-1000ml of urine (Chu and Dmochowski 2006). The bladder 
can be anatomically divided into three sections: - the bladder dome which forms the top
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of the bladder, the bladder body which is located above the ureteral orifices and the 
bladder base comprised of the trigone, anterior bladder wall, urethral-vesical junction 
and deep detrusor (Andersson and Arner 2004). (Figure 1.1) The bladder wall, is 
composed of several layers of cells namely the urothelium, sub-urothelium, detrusor 
muscle and adventitia or serosa.
1.1 .3 THE BLADDER WALL LAYERS
The urothelium is the transitional epithelial lining of the urinary tract and extends from 
the renal pelvis to the urethra. It is composed of 3 layers of cells - a basal layer 
comprised of small cells attached to the basement membrane, an intermediate layer of 
moderately sized cells and an apical superficial layer of hexagonal "umbrella" cells 
(Apodaca et al., 2003). The umbrella cells are characterised by rigid membrane 
plaques composed of uroplakin membrane proteins that have an important role in the 
maintenance of urothelial permeability and physical integrity (Riedel et al., 2005). 
These umbrella cells maintain the urothelial barrier against small molecules such as 
water, urea and protons via tight junction complexes composed of specialised 
membrane lipids. They are organised into heterodimers interconnected with extensive 
junctional complexes (Birder 2005). The basal cells are involved in the continuous 
regeneration of worn out or damaged urothelial cells.
The bladder urothelium was traditionally seen as passive protective barrier between the 
urinary tract and its contents. This simplistic view has changed over the years with 
emerging evidence of the highly specialized functions of the urothelium. Besides its 
protective function, the urothelium has been shown to be a responsive structure 
capable of detecting chemical, mechanical and thermal stimuli, and expresses a 
number of receptors such as purine receptors (Ferguson et al., 1997; Burnstock 2001; 
Birder et al., 2003; Chopra et al., 2008), acetylcholine receptors (Chess-Williams 2002; 
Beckel et al., 2006; Kullmann et al., 2008), adrenoceptors (Birder et al., 2002) and 
adenosine receptors (Yu et al., 2006). The urothelium also expresses several different 
ion channels including amiloride and mechanosensitive sodium channels (Carattino et 
al., 2008) and TRP channels (TRPV1, TRPV2, TRPV4, TRPM8) (Birder et al., 2002; 
Birder and de Groat 2007; Kullmann et al., 2009). Urothelium cells have also been 
shown to release chemical mediators including ATP, acetylcholine, prostaglandins, 
nitric oxide (NO), peptides, neurotrophins and cytokines which are all capable of 
activating, modulating or inhibiting sensory nerves, ICC and the detrusor smooth 
muscle (Apodaca et al., 2007; Birder and de Groat 2007; Birder 2010) Figure 1.2. 
Evidence has shown that the urothelium also releases an unidentified urothelium
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derived inhibitory factor (UDIF) that exerts an inhibitory effect on the underlying 
detrusor muscle inhibiting its contractility (Hawthorn et al., 2000). The UDIF is mainly 
released in the bladder dome and the bladder neck and its release is mediated by 
muscarinic receptors and not a-adrenoceptor as it had originally been proposed 
(Templeman et al., 2002).
The sub-urothelium is located between the basement membrane of the urothelium and 
the luminal surface of the detrusor. It is made up of a rich network of sensory and 
effector nerve fibres (Birder 2001; Dickson et al., 2006), a network of blood vessels and 
capillaries embedded in a connective tissue matrix (Miodonski et al., 2001; Hossler and 
Kao 2007). Within this layer is also a network of interstitial cells whose physiological 
role is unclear but are thought to contribute to sensory processing and mediating 
communication between the urothelium and detrusor (McCloskey 2010; McCloskey 
2011). Evidence of the urothelium's role in detection of stimuli has emerged from 
ultrastructural and immunohistochemical studies that have shown the presence of both 
afferent and efferent nerves in close proximity to and within the urothelium (Jen et al., 
1995; Kunze et al., 2006; Birder et al., 2007). Additionally, the sub-urothelial 
population of interstitial cells may play a role in bladder sensory pathways (Sui et al., 
2004; Brading and McCloskey 2005; Ikeda et al., 2007; Grol et al., 2008). These cells 
may act to amplify bladder sensory responses and mediate signals between the 
urothelium and the detrusor directly or via afferent nerve fibres (Fry et al., 2007). The 
extensive linking of interstitial cells via numerous gap junctions and their close contact 
to nerves, in addition to their ability to respond to neurotransmitter release, makes them 
an ideal communication network between the urothelium and underlying bladder layers 
and nerves (Sui et al., 2004; Brading and McCloskey 2005; Ikeda et al., 2007; 
McCloskey 2010). A type of smooth muscle labelled the muscularis mucosae has also 
been identified within this layer (Paner et al., 2007; Heppner et al., 2011). The 
presence of a similar layer in the Gl tract has been shown to develop spontaneous 
phasic contractions (Uchida and Kamikawa 2007) and although its role is well 
documented in the Gl tract, its functional significance in the bladder is relatively 
unknown.
Within the literature there is a great deal of controversy regarding the nomenclature of 
the urothelium and its underlying layers - from the urothelium, sub-urothelium, sub­
mucosa, lamina propria etc. This may be due to the comparison of these layers to 
those of the gastrointestinal tract. In this thesis, the term mucosa will be used, and 
includes the urothelium and the underlying tissues down to the detrusor muscle 
bundles.
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The detrusor muscle, also known as the muscularis layer, is composed of 3 layers of 
smooth muscle (SM) fibres interspersed with connective tissue, rendering the bladder 
elastic. The inner and outer layers of the detrusor consist of longitudinal smooth 
muscle, with a circular layer in between allowing the detrusor to expand and contract 
during bladder filling and emptying (Martini and Nath 2009). The detrusor muscle 
bundles are large, often a few mm in diameter, and composed of smaller sub bundles 
(Brading 1987). The individual smooth muscle cells of the detrusor exhibit common 
features identical to other smooth muscle cells in the body and are generally long 
spindle shaped cells with a central nucleus. They have a diameter of 5-6pm in the 
region where the nucleus is located, and measure a few hundred microns in length 
(Andersson and Arner 2004). Among the smooth muscle cells can be found cells with 
long dendritic processes parallel to the muscle fibres and containing vimentin, an 
intermediate filament expressed by cells of mesenchymal origin (Smet et a i, 1996). In 
the trigone region, SM bundles are smaller and clearly differentiated into two layers, 
unlike in the dome and body where they are not arranged in distinct layers and run in 
all directions (Speakman et a!., 1987). The orientation and interaction between bladder 
SMCs is important as this determines the behaviour of the bladder wall and affects its 
shape and intraluminal pressure (DeLancey et a i, 2002).
Normal kidney function has an important role in the behaviour of the normal detrusor, 
especially during bladder filling. Urine production is dependent on low glomerular 
filtration pressure (GFP) and any increase in bladder pressure above the GFP 
ultimately prevents filtration and subsequently urine production ceases (Brading 1997b). 
It is therefore imperative that during bladder filling, intravesical pressure be maintained 
at a low threshold. The detrusor muscle layer is very compliant, which allows it to 
accommodate urine storage and then rapidly expel large volumes of urine in response 
to sudden increases in intravesical pressure following nervous stimulation, allowing for 
a synchronous contraction and hence micturition.
1.1.4 The  Urethra
The urethra extends from the neck of the bladder to the exterior of the body and its 
length varies between males (20cm) and females (3 -  4cm). The male urethra is 
divided into 3 sections -  proximal, membranous and spongy urethra (DeLancey et ai, 
2002). The urethra in both sexes passes through the urogenital diaphragm, and is 
composed of two distinct muscle layers and an inner epithelial membrane which lines 
the urethral lumen and is continuous with the bladder urothelium. The outer circular 
muscle layer is made up of relatively small striated muscles with the inner muscle layer
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comprised of slender smooth muscle bundles (DeLancey et a i, 2002). The urethral 
muscle bundles are capable of exerting tone on the urethral lumen over prolonged 
times effectively preventing urine leaking until bladder pressure exceeds urethral 
pressure and subsequently contraction of the detrusor enables micturition (Oelrich 
2005).
1.2 In n e r v a t io n  o f  th e  b l a d d e r
Bladder filling and voiding is under the control of the nervous system in conjunction 
with the detrusor muscle, urethral smooth muscles and the urethral sphincters. As the 
nervous system matures, voluntary control of micturition develops and is dependent on 
learned behaviour thereby making the micturition reflex very complex. There are 3 sets 
of peripheral nerves, belonging to the parasympathetic nervous system (PNS), 
sympathetic nervous system (SNS) and the somatic nervous system, which are 
involved in the innervation of the lower urinary tract. The pelvic parasympathetic 
nerves excite (contract) the bladder and relax the urethra, the lumbar sympathetic 
nerves inhibit the bladder body and contracts the bladder base and urethra, whilst the 
pudendal nerves contract the urethral sphincter (Yoshimura and Chancellor 2003) 
(Figure 1.3).
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Figure 1.2 -  Urothelium model highlighting various interactions between 
urothelium cells, bladder nerves, detrusor smooth muscle and ICCs. Mediators 
released due to urothelial receptor stimulation target bladder afferent and 
efferent nerves and other cell types within the bladder wall. Urothelial cells are 
also targets of neurotransmitters released from nerves; ACh, acetylcholine; Adr, 
adrenoceptor; BR, bradykinin receptor; H+, proton, MR, muscarinic receptor; NA, 
noradrenaline; NGF, nerve growth factor; NR, neurokinin receptor; NicR, 
nicotinic receptor; NO, nitric oxide; P2R, purinergic 2 receptor unidentified 
subtype; P2X and P2Y; purinergic receptors; PG, prostaglandin; SP, substance P; 
trkA, receptor tyrosine kinase A, high affinity receptor for nerve growth factor; 
TRPs, transient potential channels. Adapted from (Birder 2010).
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1.2.1  P a r a s y m p a t h e t ic  P a t h w a y
Parasympathetic pre-ganglionic neurons innervating the detrusor muscle and the 
vascular supply to pelvic genital organs, via the pelvic nerves and the vesicle plexus 
(Williamson-Kirkland and Berni 1980), originate in the S2-S4 sacral region of the spinal 
cord and converge in the sacral parasympathetic nucleus region (Yoshimura and 
Chancellor 2003) (Figure 1.3a). The parasympathetic post-ganglionic nerves release 
both acetylcholine (ACh) and non-adrenergic non-cholinergic transmitters (NANC) 
(ATP and NO) (Fowler et a i, 2008). The major excitatory mechanism of the bladder is 
via cholinergic transmission which releases ACh and results in detrusor contraction via 
M3 muscarinic receptors and subsequent micturition (Fowler et ai, 2008). ATP 
released via the NANC excitatory transmission acts on P2X purinergic receptors of the 
detrusor further enhancing contraction, while NO exerts inhibitory input to the urethral 
smooth muscles allowing for relaxation and urine outflow (Andersson and Arner 2004) 
(Figure 1.3b)
1 .2 .2  S y m p a t h e t ic  P a t h w a y
The inferior mesenteric ganglion connects the sympathetic preganglionic nerves to the 
post ganglionic neurons in the bladder, as well as to the postganglionic paravertebral 
ganglia and the pelvic ganglia (Yoshimura and Chancellor 2003). These sympathetic 
neurons innervate the bladder neck, vas deferens, seminal vesicles and the prostate 
via the sympathetic chain and the hypogastric plexus (Williamson-Kirkland and Berni 
1980). ACh release mediates ganglionic transmission in the sympathetic pathway, 
acting on ganglionic nicotinic receptors, causing release of noradrenaline (NA) and 
activation of (3-adrenoceptors, which inhibit the detrusor allowing the bladder body to 
relax. In addition, activation of a-adrenoceptors in the urethra and bladder neck, 
causes contraction of the bladder base and the urethral sphincter (Yoshimura and 
Chancellor 2003) (Figure 1.3b) closing the outlet and allowing the bladder to fill and 
store urine.
1 .2 .3  S o m a t ic  P a t h w a y
The S2-S4 sacral spinal cord region contains the efferent somatic neurons responsible 
for innervation of the external urethral sphincter and the external anal sphincter via the 
pudendal nerve (Williamson-Kirkland and Berni 1980) (Figure 1.3a). These efferent 
somatic neurons release ACh that acts on skeletal muscle-type nicotinic receptors 
resulting in contraction of the urethra (Yoshimura and Chancellor 2003). (Figure 1.3b)
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1 .2 .4  A f f e r e n t  P a  th w a  ys
The sacral dorsal root ganglia contain the pelvic and pudendal afferent nerves, while 
the rostral lumbar dorsal root ganglia contain the hypogastric afferent nerve. These 
afferent nerves contain axons that relay information from the lower urinary tract to the 
lumbosacral spinal cord and higher brain bladder control centres (Yoshimura and 
Chancellor 2003) and are composed of myelinated (A5) and unmyelinated (C) axons 
(Fowler et ai, 2008). The A5 fibres are activated at low bladder pressures (5-15 
mmHg) and respond to stretch as the bladder fills and to bladder contraction during 
voiding (Janig and Morrison 1986). Afferent C fibres on the other hand are insensitive 
to bladder filling and respond to noxious stimuli such as chemical irritation (Janig and 
Morrison 1986) and cooling (Jiang et a i, 2002). A5 fibres transmit information on 
bladder filling to the CNS and higher brain centres while C fibres, in the case of 
pathological conditions, convey nociceptive information leading to feelings of bladder 
pain (Beckel and Holstege 2011).
A dense network of sensory nerves has been identified in the sub-urothelial layer of the 
bladder in both animals and humans (Gosling and Dixon 1974; Gabella 1995), with 
some fibres showing projections into the urothelium and this may be crucial in the 
relaying of sensory information from the urothelium (Birder 2001; Wiseman et a i, 2002). 
ATP, ACh, prostaglandins and various other inflammatory mediators have been shown 
to either modulate afferent nerve firing or produce action potentials (England et ai, 
1996; Genzen et ai, 2001; Dang et ai, 2005; Dang et ai, 2008). The release of these 
substances from the urothelium and smooth muscle cells within the bladder wall has 
led to the inclusion of them as part of the sensory limb of the LUT (Apodaca et a i,
2007).
1.3 M ic t u r it io n  R efle x
The micturition cycle (Figure 1.4) is a coordinated process between the neural 
pathways in the brain and the spinal cord to control the activities of the urinary bladder 
and urethra (Chu and Dmochowski 2006). These neural pathways help maintain the 
reciprocal relationship between the bladder and the urethra and are organized as ‘on 
and off’ switching circuits (Fowler et a i, 2008). Bladder filling occurs at low luminal 
pressure when the bladder detrusor is relaxed and the urethral sphincter is closed. 
Bladder emptying on the other hand is facilitated by the rapid contraction of the 
detrusor muscle and relaxation of the urethral sphincter (Andersson and Arner 2004).
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1.3.1 B l a d d e r  f il l in g
During the bladder filling phase of the micturition cycle the somatic and the sympathetic 
nervous systems work together to enhance bladder compliance and to generate 
sufficient outlet resistance to maintain continence (Michel and Peters 2004). Urine 
storage is reliant on the ability of the urinary bladder to increase in size with increasing 
urine volume without an appreciable rise in bladder intravesical pressure. During 
bladder filling afferent activity increases, conveying the state of bladder distension, and 
subsequent desire to void (Chappie 2011). The increase in bladder size is thought to 
trigger the urothelium to generate transmitter release leading to increased afferent 
signalling mediated by the A-5 sensory fibres (Abrams 2003; de Groat 2004). The 
increase in bladder compliance during filling is mediated by noradrenaline which is 
released from sympathetic hypogastric nerves. This stimulates (3-adrenoceptors in the 
detrusor, which in humans mainly involves the (33-subtype, and thus detrusor relaxation. 
Sympathetic nerves also inhibit the parasympathetic stimulatory pathway, restraining 
detrusor contractility whilst allowing contraction of the internal and external urethral 
sphincters to allow bladder filling (Chu and Dmochowski 2006) without any 
considerable changes in bladder intravesical pressure.
Detrusor relaxation is accompanied by enhanced tone in the bladder neck, urethra and 
pelvic floor. Resistance in the bladder neck and proximal urethra is mainly due to 
smooth muscle tone, whereby NA stimulates c^-adrenoceptors to elicit contraction 
(Testa et ai, 1993; Taniguchi et a i, 1997; Nasu et ai, 2009). The distal urethra is 
primarily composed of striated muscle forming the external urethral sphincter 
(Bannowsky and Juenemann 2003). Its action is supported by the pelvic floor muscles 
and contraction of these muscles is mediated by nicotinic receptors activated by ACh 
released from somatic pudendal nerve (urethra) and sacral nerve fibres (pelvic floor) 
(Michel and Peters 2004; Michel and Hegde 2006).
1 .3 .2  B l a d d e r  e m p t y in g
Bladder volume during the filling phase is monitored by the pelvic afferent nerves and 
they relay information on the bladder state to the pontine micturition centre in the brain 
via the periaqueductal gray matter (Fowler 2002). The micturition reflex is initiated 
once the bladder volume has reached a critical threshold, via afferent nerves signalling 
to the micturition centre in the brain, thereby causing sensation of bladder fullness 
(Chancellor and Yoshimura 2004). The voluntary supraspinal pathways that initiate 
voiding are triggered once the urine volume in the bladder reaches 75% of bladder 
capacity causing the desire to void (Chu and Dmochowski 2006). Once this occurs,
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the micturition centre sends inhibitory input to the sympathetic and somatic centres in 
the spinal cord - to relax the internal and external sphincters - and stimulatory input to 
the parasympathetic centres leading to bladder activation via ACh release and M3 
receptor activation causing detrusor contraction and bladder emptying.
1 .3 .3  B la d d e r  p h a s ic  a c t i v i t y
Bladder rhythmic activity has been described since the studies of Mosso and Pellacani 
in 1882. Since then, in vitro and in vivo experiments on various animal species have 
confirmed that the bladder is rhythmically active during the bladder filling phase and 
this activity has been referred as autonomous activity (Drake et a i, 2003; Gillespie 
2004) and sometimes as phasic activity, spontaneous activity and non-micturition 
contractions. This activity involves waves of contraction and localised stretches of the 
bladder wall as it fills, and is different to micturition contractions (Gillespie 2004). The 
mechanisms generating these two types of bladder contractions, how they are 
regulated and their physiological significance has been investigated.
Using guinea pig bladder, Drake et a i (2003) showed that isolated resting bladder 
displayed small spontaneous increases in intravesical pressure resulting in waves that 
propagated throughout the bladder wall (Drake et ai, 2003). This activity was 
unaffected by atropine and tetrodotoxin thereby proving that it was not mediated by the 
CNS but rather an inherent property of the bladder itself. Muscarinic agonists 
increased the amplitude and frequency of this autonomous activity and this was 
inhibited by atropine, with TTX having no effect. The lack of inhibition of nicotinic 
responses by atropine and TTX implied that the postganglionic parasympathetic nerves 
responsible for micturition contractions did not generate this autonomous activity 
(Gillespie 2004) and therefore a different underlying mechanism.
Two hypotheses were suggested to explain the origins of bladder autonomous activity. 
The neurogenic theory suggested that the unstable contractions were caused by neural 
plasticity within the CNS giving rise to generalised, nerve-mediated excitation of the 
detrusor. This may result from inappropriate expression of spinal bladder reflexes, 
sensitisation of afferent terminals or as a result from damage to pathways arising from 
higher brain centres to the bladder ultimately causing inappropriate activation of the 
micturition reflex (de Groat 1997), whereas the myogenic theory suggested bladder 
phasic contractions are due to changes from within the bladder causing increased 
excitability and likelihood of spontaneous contractions due to enhanced electrical 
coupling between muscle cells (Brading 1997a). Since autonomous activity, phasic 
sensory discharge and non-micturition contractions are all features of the normal
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bladder filling, any modification to the mechanisms underlying them might be 
responsible for changes in pathological conditions (Gillespie 2004).
Bladder strips from various LUT conditions exhibit abnormal spontaneous mechanical 
activity (Sibley 1984; German et al., 1995; Mills et al, 2000). The abnormal activity 
observed contains elements of fused titanic tension which is not present in normal 
bladder. Evidence of altered bladder PCs has been described in numerous studies. 
Examination of human spinal cord injury bladders compared to normal bladder showed 
that there SCI bladders highly expressed connexion-43 gap junctions which in turn 
increased intracellular communication and subsequent increased bladder PCs 
(Haferkamp et al., 2004). Similarly, cell culture experiment performed on BOO cells 
also showed increased electrical coupling between muscle bundles via increased gap 
junctions, thereby contributing to increased PCs present in BOO (Li et al., 2007). 
Vahabi et al. (2011) using a streptozotocin-induced diabetic rat model which is 
commonly used to study LUT conditions showed pathological bladder had increased 
PCs compared to control bladders (Vahabi et al., 2011a)
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.4 - Micturition cycle showing bladder filling with no increase in bladder pressure. This is maintained until impulses relayed from 
sacral region of spinal cord to the brain signal a conscious desire to void at which point the parasympathetic nerves initiate detrusor 
traction due to an increase in bladder pressure and thus emptying of the bladder. Adapted from 
y.//www.hvuroloQV.com/services/bladder.php (Hudson Valley Urology P.C. 2007)
1.4 B la d d e r  P h a r m a c o l o g y
Bladder pharmacology is complex, with numerous types of receptors and ion channels 
found throughout the bladder, and involved in the various functions. These include 
muscarinic receptors, adrenoceptors, nicotinic receptors and purinergic receptors
1.4.1  M u s c a r in ic  R e c e p t o r  S u b t y p e s  a n d  C l a s s if ic a t io n
Currently, there are five muscarinic receptor subtypes that have been identified and are 
designated Mr M5 (Caulfield and Birdsall 1998). The M1-M5 genes encode for 
muscarinic receptor glycoproteins which have been shown to mirror structural features, 
of the seven transmembrane helix, G-protein coupled receptor family (Caulfield and 
Birdsall 1998). A comparison of the different muscarinic receptor subtypes in various 
tissues is shown in Table 3.1 below. Bladder smooth muscle contains a mixed 
population of the different subtypes with the M2 and M3 muscarinic receptors being 
found on the detrusor smooth muscle. In addition, muscarinic receptors can be found 
on the urothelium and on presynaptic sympathetic and parasympathetic nerve endings 
(Caulfield and Birdsall 1998).
Muscarinic receptors are classified as being part of a family that when activated, are 
able to exert their effect by coupling to a G-protein. G-protein coupled receptors 
(GPCRs) are composed of seven transmembrane helices which contain an 
extracellular N-terminus and an intracellular C-terminus. In their inactive conformation, 
the Ga subunits are bound to guanine diphosphate (GDP). Upon activation by a ligand 
(agonist), the receptor undergoes a conformational change and substitutes the GDP for 
guanine triphosphate (GTP) thus activating it (Rang and Dale 2007). Once activated, 
there are two principal signal transduction pathways involving GPCRs: the 
phophatidylinositol pathway and the cAMP pathway, shown in Figure 1.5.
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Figure 1.5 - M2 and M3 muscarinic receptor second messenger systems in the 
detrusor. Direct detrusor contraction occurs via second messenger 
diacylglycerol (DAG) and inositol triphosphate (IP3) upon receptor activation by 
acetylcholine (ACh). On binding to M2 receptors, ACh causes indirect detrusor 
contraction by inhibition of cAMP levels thereby reversing the relaxation effect 
due to p-adrenoceptors following stimulation by noradrenaline (NA). Adapted 
from (Chess-Williams 2002).
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1.4.2 M uscarinic  Receptors on the Detrusor
The distribution of muscarinic receptors in the bladder is not uniform. The bladder 
dome has the highest density of muscarinic receptors whereas the bladder neck 
contains the lowest (Saito et al., 1997). Even though the M^Ms muscarinic receptor 
subtypes have been seen in bladders of various species, the M2 and M3 receptors are 
the most abundant, occurring at a ratio of 3:1 respectively in several species including 
humans and pigs, and 9:1 in rats (Chess-Williams 2002). In spite of the M3 receptor 
being the minor population, in all species to date it is responsible for direct detrusor 
contraction. It is thus the main mediator of detrusor contractions in the bladder (Chess- 
Williams 2002; Stevens et al., 2007). The functional role of the majority M2 receptor 
subtype is unclear but it has been proposed that it may have a role in indirectly 
mediating bladder contractions by enhancing M3 receptor activated contractile 
responses. This has been shown using M2, M3 and M2/M3 double knockout mice 
(Ehlert et al., 2005). Another study using rats proposed that M2 receptor stimulation 
inhibits sympathetically mediated relaxation via (3-adrenoceptors, which in turn leads to 
more efficient bladder emptying (Hegde and Eglen 1999). In certain diseased states 
and experimental models, M2 receptor function has emerged in studies of neurogenic 
human bladder (Pontari et al., 2004) and following outflow obstruction in rats 
(Braverman et al., 1998; Braverman and Ruggieri MR 2003). Bladders from 
denervated rats show increased M2 receptor density, exhibiting functional affinity more 
similar to M2 than M3 receptors (Braverman et al., 1998).
M2 and M4 muscarinic receptors coupled via the Gj and G0 subunit inhibit adenylate 
cyclase subsequently reducing cAMP formation, while M3 and M5 receptors are 
coupled to Gq/11 and stimulate phospholipase C causing the release of intracellular 
calcium from the sarcoplasmic reticulum initiating detrusor contraction (Scarpero and 
Dmochowski 2003; Rang and Dale 2007).
Bladder phasic contractions and tone can also be activated and enhanced via the Rho 
kinase signalling pathway shown in Figure 1.6. Rho kinases (ROCKs) are 
serine/threonine kinases that are involved in various cellular functions of which there 
are two known isoforms namely ROCK-I and ROCK-II (Fukata et al., 2001; Riento and 
Ridley 2003). Rho A, a small GTPase regulated by guanine-nucleotide-exchange 
factors (GEFs) is the main activator of ROCK (Peters et al., 2006). A role for ROCK in 
bladder function via muscarinic acetylcholine receptors has been reported and extends 
to not only these but also to purinoceptors, neurokinin and bradykinin receptors 
(Wibberley et al., 2003; Quinn et al., 2004; Schneider et al., 2004; Takahashi et al.,
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2004; Braverman et al., 2006). Stimulation of GEFs by muscarinic receptors results in 
the activation of Rho A which in turn results in GTP binding to Rho. This subsequently 
interacts with ROCK leading to increased myosin light chain phosphorylation and 
contractility via myosin light chain phosphatase inactivation. ROCK also promotes 
actin fibre formation by activating LIM-kinase which effectively inactivates cofilin - an 
actin depolymerisation factor - eventually enhancing contraction. ROCK inhibition by 
compounds such as fasudil and Y27632 results in SM relaxation (Peters et al., 2006).
1.4 .3  M u s c a r in ic  R e c e p t o r s  o n  t h e  U r o t h e l iu m
Muscarinic receptors have been demonstrated on the urothelium and suburothelium of 
the bladder. Porcine urothelium was found to express a higher density of muscarinic 
receptors compared to the detrusor layer (Hawthorn et al., 2000). Studies on the rat 
and human urothelium layer confirmed the presence of mRNA and receptor proteins for 
all the receptor subtypes ( M 1 - M 5 )  (Tyagi et al., 2006). The expression pattern of the 
muscarinic receptor subtypes in humans shows the presence of Mt subtype in basal 
cells, M2 on umbrella cells, homogenous distribution of M3 and M4, with the M5 
occurring in a decreasing gradient from the luminal surface to the basal cells 
(Bschleipfer et al., 2007). In human bladder mucosa, the M2 subtype is the most 
abundant as confirmed by RT-PCR results (Mansfield et al., 2005).
1 .4 .4  P r e s y n a p t ic  m u s c a r in ic  r e c e p t o r s  in  th e  b l a d d e r
Muscarinic receptors are also found on both the parasympathetic and sympathetic 
nerve endings regulating acetylcholine (ACh) and noradrenaline release respectively 
(Chess-Williams 2002). These receptors can either enhance or inhibit transmitter 
release. The facilitatory mechanism seems to involve activation of pre-junctional Mi 
receptors that in turn increase ACh release, while the inhibitory mechanism does the 
opposite by decreasing ACh and is mediated by either M2 or M4 receptor subtypes 
(Somogyi and de Groat 1999).
1 .4 .5  A d r e n o c e p to r  r e c e p t o r s  in  th e  b la d d e r
The effects of noradrenaline from the sympathetic system and adrenaline from the 
adrenal glands are mediated by a- and (3-adrenoceptors receptors. Functional, 
molecular biology and radioligand binding techniques have identified the various 
subtypes of adrenoceptors present in the bladder. Initially, (3-adrenoceptors were 
classified into (3r  and (32-subtypes, but in the last 20 years, a third subtype (33-AR has 
been identified (Michel and Hegde 2006). Although all three subtypes have been 
shown in bladders from various species, in the human bladder, greater than 95% of all
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(3-AR mRNA belongs to the (33-subtype (Nomiya and Yamaguchi 2003). In the rat and 
pig bladders (33> (32 subtype, while in the rabbit and mouse bladder, the (32 subtype is 
predominant. The guinea pig bladder expresses all three subtypes (Michel and Vrydag 
2009). (3-adrenoceptor distribution in the bladder is varied and is species dependent, 
with (33-adrenoceptors being predominant in pig and humans (Yamanishi et al., 2002). 
Bladder smooth muscle relaxation upon (3-adrenoceptor stimulation has been shown in 
many species including rat, guinea pig, cats, dogs, pigs, monkeys and humans, with 
the maximum relaxation effect being similar across species (Michel and Vrydag 2009). 
Bladder relaxation occurs mainly in the detrusor and not necessarily in the bladder 
neck, and involves to a minor extent cAMP formation, whereas BKCa potassium 
channel and L-type calcium channels appear to play an important role (Brown et al., 
2008; Frazier et al., 2008; Hristov et al., 2008). The urothelium also contains (3- 
adrenoceptors, which upon stimulation activate the adenylate cyclase pathway in 
bladder urothelial cells and initiates an increase in intracellular calcium triggering NO 
production (Birder et al., 2002).
The a r adrenoceptors are classified into three subtypes namely a1A-, a1B- and a1D- 
(Schwinn and Price 1999; Schwinn and Roehrborn 2008). In the bladder, they are 
located in the urothelium, smooth muscle and afferent nerves. The different subtypes 
can be distinguished pharmacologically based on their affinities for c^-adrenoceptor 
antagonists (Michel and Vrydag 2009). Walden et al. (1997) have extensively 
researched the localization of this class of receptors and they found that in the prostate 
and urinary bladder of monkeys, rats and humans, the a1A-subtype is the major subtype 
present on the smooth muscle cells (Walden et al., 1997). The distribution of all the 
subtypes is species specific (Schwinn and Roehrborn 2008). The a1A-subtype 
regulates smooth muscle tone in the bladder neck whereas the a1D-subtype is involved 
in bladder function at the level of the spinal cord. The a1B-subtype primarily functions to 
regulate blood pressure via contraction of small resistance vessels (Yamada and Ito 
2011).
Beside muscarinic receptors, the bladder possesses a whole range of other receptors 
that have different roles in bladder function. ATP acts on purinergic receptors and play 
a role in modulation of bladder afferent signalling. Within this family of receptors are 
the metabotropic P2Y receptors and the ionotropic P2X receptors discussed in more 
detail in chapter 5. ATP is primarily released from the urothelium of various species 
(Ferguson et al., 1997; Sadananda et al., 2009; Kumar et al., 2010). The bladder also 
contains tachykinin receptors consisting of substance P, neurokinin A and neurokinin B 
which act on NK1, NK2 and NK3 receptors respectively (Andersson 2002; Canda et al.,
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2006). NK1 and NK2 receptors are present in the detrusor, whereas NK2 is also 
present on the bladder urothelium (Ishizuka et al., 2000; Birder 2010). These receptors 
have both sensory and efferent functions including perception of pain in bladder, 
regulation of micturition threshold and nerve excitability (Maggi 1995; Gu et al., 2000; 
Andersson 2002).
Bradykinin receptors are expressed in the bladder detrusor smooth muscle and on 
basal and apical cell of the urothelium and help in detrusor contractility. The effects of 
bradykinin are mediated by B1 and B2 receptors and they have a role in normal and 
pathological conditions (Lecci et al., 1999; Chopra et al., 2005; Fabiyi and Brading 
2006). In addition, endothelin-1 receptors stimulate proliferation of urinary bladder 
detrusor contractions (Ukai et al., 2006; Ukai et al., 2008).
Our understanding of normal bladder function, though much increased in recent years, 
is still limited, as is our understanding of the pharmacology of pathological conditions of 
the bladder, thus further research in this area is needed.
1.5 O v e r a c t iv e  B la d d e r
1.5.1 D e f in it io n
The International Continence Society (ICS) has defined Overactive Bladder (OAB) as 
urinary urgency with or without urge incontinence usually accompanied by frequency 
and nocturia (Abrams et al., 2003). The key symptom of OAB is urgency, the sudden 
compelling desire to void that is impossible to defer (Abrams 2003). Frequency is 
defined as a patient complaint of voiding too often, whereas nocturia is the complaint of 
waking up more than 2-3 times a night to void. Urinary incontinence is the complaint of 
involuntary leakage of urine, while urge incontinence is the involuntary loss of urine 
immediately preceded by or accompanied by urgency (Abrams et al., 2003). Other 
types of urinary incontinence include stress incontinence, whereby one has involuntary 
leaking of urine upon exertion of force such as coughing or sneezing, and mixed 
incontinence where urgency accompanies the involuntary leakage upon exertion of 
force (Chu and Dmochowski 2006)
1.5.2 P r e v a l e n c e  o f  OAB
According to the World Health Organisation (WHO), bladder problems affect an 
estimated 200 million people worldwide and have a great impact on the quality of life of 
affected individuals (Hunskaar et al., 2000). OAB is a condition that affects people of 
all walks of life regardless of age, sex or race. In a population based survey in 6
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European countries by Milsom et al. in 2001, 16,776 individuals were interviewed 
directly or by phone. They found the overall prevalence in individuals ^40 years to be 
16.6% (Milsom et al., 2001). Frequency was the most reported OAB symptom at 85%, 
followed by urgency at 54% and urge incontinence at 36%. 60% of affected individuals 
had sought medical assistance but only 27% were undergoing medical treatment. 
(Milsom et al., 2001). A longitudinal population survey of LUTS in women >20 years of 
age between 1991 and 2007 by Wennberg et al. showed cumulative incidences of Ul, 
urgency and OAB were 21%, 20% and 20% respectively (Wennberg et al., 2009). 
There was an increase in overall prevalence of OAB going from 17% in 1991 to 26% in 
2007 (Wennberg et al., 2009). With regards to age and OAB, the incidence of OAB 
symptoms increases with advance in age and this was equally apparent in both men 
and women (Milsom et al., 2001; Irwin et al., 2006).
1.5.3 Ca u s e s  o f  OAB
The symptoms of OAB are attributed to the involuntary contraction of the bladder 
detrusor muscle during the filling phase and the causes are widely varied. There are 
the transient reversible causes such as an excess intake of alcohol or caffeine, stool 
impaction, certain pharmaceutical drugs and restricted mobility (Chu and Dmochowski 
2006). Non-transient causes of OAB can be grouped as follows: neurogenic due to 
some kind of spinal cord injury, myogenic due to obstruction or hyperplasia, 
inflammatory caused by interstitial cystitis and lastly idiopathic due to no known defined 
cause (Semins and Chancellor 2004). The International Continence Society (ICS) has 
grouped detrusor overactivity (DO), a urodynamically measurable phenomenon, into 
two types - phasic and terminal. Phasic DO is commonly seen in idiopathic cases and 
has characteristic waveform and may or may not lead to urinary incontinence. 
Terminal DO is characterised by a single involuntary contraction at the point when the 
controllable desire to void is normally experienced but cannot be suppressed, leading 
to bladder emptying (Abrams 2003).
1.5.4 Pa t h o p h y s io l o g y  o f  OAB
The exact mechanisms underlying OAB are still largely unknown but studies in both 
humans and animal models have shown the following changes in affected individuals:- 
increased spontaneous myogenic activity, altered responsiveness to stimuli, fused 
tetanic contractions and changes in smooth muscle ultrastructure (Steers and Klausner 
2008) Patchy denervation, enlarged sensory neurons, hypertronic ganglion cells and 
enhanced spinal micturition reflex are some of the findings observed upon examination 
of the micturition reflex and innervation in models of OAB (Steers and Klausner 2008).
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The normal detrusor is not well coupled electrically and relies on the densely 
innervated muscle bundles to respond to stimuli from the SNS or the PNS. Biopsies 
performed on severe OAB patients have revealed patchy denervation leading to an 
increase of connective tissue between the muscle bundles leading to complete 
denervation and detrusor hypertrophy (German et al., 1995). Enhanced contractile 
activity of the bladder can result from increased electrical coupling of the muscles via 
close abutments between myocytes and the presence of protrusion junctions. This 
then allows electrical stimuli to spread across the muscle generating uninhibited 
contractions in response to even the slightest low grade stimuli (Steers and Klausner
2008).
Nerve growth factor (NGF) is a naturally occurring molecule that is actively involved in 
the stimulation and differentiation of nerves and neuronal growth after injury. The 
patchy denervation observed in OAB bladders suggests certain death of bladder 
neurons (Chu and Dmochowski 2006). Data from animal models associated with 
increased nerve growth factor have shown altered membrane conductance, and thus 
excitability of dorsal root Ganglia (DRG) neurons and this is further supported by 
evidence of increased NGF in patients with OAB, benign prostatic hyperplasia and 
interstitial cystitis (Chu and Dmochowski 2006).
The urothelium was traditionally seen as just a passive barrier that protected the 
underlying bladder layers from the toxic effects of urine. Ongoing research has 
changed this perception as the urothelium's role is emerging as an important one in the 
normal functioning of the bladder. The urothelium and suburothelium have been 
shown to have a rich supply of sensory (afferent) nerves and during bladder filling, 
several neurotransmitters are released and act on these afferent nerves to convey 
impulses to the CNS causing bladder emptying (Kumar and Chappie 2005). The 
mediators released by the urothelium and suburothelium can initiate or depress bladder 
activity. ATP released after urothelial stretch acts on P2X2/3 purinergic receptors on 
afferent nerves to initiate voiding (Kumar and Chappie 2005). This is supported by a 
study which showed that mice, which were deficient of P2X receptors, exhibited a 
decrease in urinary frequency and an increase in bladder volume and capacity (Chu 
and Dmochowski 2006). Other urothelial mediators contributing to the 
mechanosensory theory are nitric oxide (NO) - an afferent nerve inhibitor - which has 
been shown to relax the bladder, and an unidentified urothelium derived inhibitory 
factor (UDIF) that depresses bladder contractions (Kumar and Chappie 2005).
25
1.5.5 M a n a g e m e n t  o f  OAB
Due to the varied causes of the symptoms of OAB, afflicted patients must undergo a 
basic evaluation that covers complete history, urinalysis and a physical examination 
(Chu and Dmochowski 2006). The lower urinary tract is innervated by nerves within 
the S2 to S4 region of the spinal cord. A neurologic assessment focusing on this 
region is also recommended to evaluate bladder function (Dwyer and Rosamilia 2002). 
Presence of bacteria, haematuria and pyuria can be analysed by cultures and 
urinalysis (Dwyer and Rosamilia 2002). Effective management and treatment of OAB 
requires several approaches working in conjunction - both pharmacological and non- 
pharmacological (Ouslander 2004). Pharmacological intervention often involves using 
anticholinergic drugs that block bladder muscarinic receptor mediated pathways. 
Extreme cases of OAB may require surgical denervation of the bladder to reduce the 
overactivity. Non-pharmacological interventions involve alteration of lifestyle, changing 
diet, performing pelvic exercises, restricting caffeine and alcohol intake and, last but 
not least bladder training (Lavelle et al., 2006).
1.6 P h a r m a c o l o g ic a l  T r e a t m e n t  o f  O A B
Pharmacotherapy directed at the afferent and efferent mechanisms that control the 
bladder is the 1st line treatments of OAB in the U.K. The majority of drugs used are 
directed peripherally, to act on muscarinic receptors of the bladder (Kumar and 
Chappie 2005). They target the symptoms rather than the cause, since the aetiology is 
not understood, and are therefore limited in efficacy. The following are some of the 
major treatment options available for OAB.
1.6.1 A n t ic h o l in e r g ic s
Anticholinergics are the most commonly used agents and include oxybutynin, 
tolterodine, darifenacin, solifenacin, propiverine and trospium (Sellers and Chess- 
Williams 2012). Of the more established anticholinergics available for use, oxybutynin, 
tolterodine and trospium are available worldwide, with propiverine availability being 
restricted to only the U.K. The most recently introduced agents are darifenacin and 
solifenacin (Abrams and Andersson 2007), fesoterodine (Khullar et al., 2008) and 
imidafenacin, which is currently only approved and marketed in Japan (Michel and 
Hegde 2006). Although this class of drugs is the first line pharmacotherapy used for 
OAB treatment, their use is significantly hindered due to their significant side effects 
such as dry mouth, constipation, blurred vision and urinary retention, thereby causing 
major non-compliance issues (Sellers and McKay 2007). The action of these agents at 
other muscarinic receptors in other body systems is the main cause of the reported
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adverse effects. In the bladder, anticholinergics target the muscarinic receptors on the 
detrusor with relative selectivity for M2 or M3 receptors, in an attempt to limit adverse 
reactions. They work mainly by decreasing the amplitude of normal and involuntary 
contraction of the bladder while at the same time increasing the bladder volume at first 
contraction and thus increasing bladder functional capacity (Kumar and Chappie 2005). 
There is increasing evidence suggesting that these agents may also be acting on 
receptors present in the urothelium/sub-urothelium, ICC and afferent nerves. To help 
ease the side effects associated with anticholinergics, novel delivery systems have 
been developed e.g. extended transdermal release mechanisms, which have 
considerably decreased side effects and are well tolerated (Hill et al., 2006; Kaplan et 
al., 2006). Due to the side effects of anticholinergics, there has been a drive to develop 
novel more effective drugs.
1 .6 .2  a r ADRENOCEPTOR ANTAGONISTS
Previous pharmacological and molecular biology studies indicated that selective a1A- 
adrenoceptor antagonists could be effective in the treatment of urinary obstruction in 
patients with benign prostatic hyperplasia (BPH) with fewer cardiovascular side effects 
than conventional anti-muscarinics (Walden et al., 1997; Andersson and Hedlund 2002; 
Michel 2010). Terazosin, doxazosin, alfuzosin, tamsulosin and silodosin are the 
currently prescribed c^-adrenoceptor antagonists for the treatment of BPH and LUTS 
(Schwinn and Roehrborn 2008). The selectivity of these antagonists is varied with 
alfuzosin, doxazosin and terazosin being relatively long acting and non-subtype 
selective showing equal selectivity for the 3 subtypes. Tamsulosin on the other hand is 
relatively selective for a1A- and a1D adrenoceptors both in vivo and in vitro with less 
affinity for a1B-subtype (Noble et al., 2009). These agents have been shown to 
alleviate the irritative symptoms associated with BPH such as frequency, nocturia and 
urgency in addition to relieving the dynamic component of bladder outlet obstruction 
(Sellers and McKay 2007) via an unknown mechanism. The proposed putative 
mechanism involved is thought to be at the level of the CNS and the spinal cord.
1 .6 .3  (S-ADRENOCEPTOR AGONISTS
Drugs targeting (3-adrenoceptors in the LUT are agonists, specifically (33-selective 
agonists. The majority of this class of drugs are under various states of preclinical or 
clinical development. Mirabegron (YM 178) is the most advanced candidate for this 
class of agents, having shown positive clinical proof of concept results as well as dose 
ranging studies (Chappie et al., 2008; Chappie et al., 2010). The mechanism of action 
is to mediate relaxation of the detrusor, and it has been shown that the newly
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developed (33 adrenoceptor agonists work in this way on the human detrusor 
(Yamanishi et al., 2006). There is a population of (33-receptors that have been 
identified in different cell types in the bladder including afferent nerve terminals 
(Limberg et al., 2010). Studies performed on bladder sheets from SCT mice have 
shown that (33-receptor agonist can reduce afferent firing by direct action on these 
nerves (Kanai et al., 2011).
1.6.4 B o tu lin u m  To x in  A (BTX-A)
Botulinum toxin (BTX) is a neurotoxic protein produced by Gram positive Clostridium 
botulinum (Apostolidis 2011). Of the seven serotypes of the botulinum toxin (BTX), 
BTX-A and BTX-B are the most commonly used in the treatment of LUT disorders 
(Charrua et al., 2011). The use of BTX in the treatment of bladder dysfunction 
symptoms has been very effective, although it is not fully understood how it works in 
the bladder. The benefits are long lasting over a period of several months and can be 
repeated (Aoki and Guyer 2001). The mechanism of action of BTX involves connection 
of the toxin to the neuronal membrane, subsequent internalization and finally it is able 
to exert its intracellular effects. Its mechanism of action in the bladder was originally 
thought to involve prevention of vesicular release of ACh therefore decreasing 
involuntary contractions of the detrusor, but ongoing research has challenged this idea. 
It has been proposed that its mechanism of action may be on afferent 
neurotransmission, as postulated by Apostolidis et al. (2006). These authors proposed 
that BTX-A efficacy is dependent on inhibition of several neurotransmitters including 
ACh, ATP and substance P, and downregulation of purinergic P2X3 and TRPV1 
(Apostolidis et al., 2005) thus causing decreased activation, bladder contractility and 
electrical coupling (Apostolidis et al., 2006). BTX-A is currently being used clinically 
although it has not yet been licensed due to insufficient information on its mechanism 
of action.
1.6.5 A l t e r n a t iv e  t r e a t m e n t s  f o r  OAB
Substance P, neurokinin A and neurokinin B represent the tachykinin family of peptides. 
They can be found in both the CNS and PNS and are involved in the sensory arm of 
micturition (Sellers and McKay 2007). Locally at the bladder, they are released from 
capsaicin sensitive afferent nerves (Holzer 1988) and facilitate neurotransmitter release, 
smooth muscle contraction and neurogenic inflammation (Maggi et al., 1993). 
Tachykinin released at the bladder can act via neurokinin receptor 2 (NK2) found on 
the detrusor muscle to induce OAB (Sellers and McKay 2007). NK2 receptor 
antagonists have been shown to decrease hyperactivity in rats but not yet in humans
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(Lecci et al., 1998). The most recent development pertaining to the use of tachykinins 
in control of bladder activity is its use at the spinal cord level.
Bladders from several species including humans have been shown to contain the 
following potassium channels - ATP sensitive (K Atp ) channels, calcium activated large 
conductance channels (BKCa) and small conductance channels (SK) (Sellers and 
McKay 2007). In vitro studies and animal models have demonstrated that K channel 
openers can inhibit bladder contractility (Darblade et al., 2006). The use of these drugs 
in vivo in humans has been plagued with obstacles such as vascular effects that 
warrant further investigation into OAB treatment.
The bladder urothelium and sensory nerves contain the transient receptor potential V1 
vanilloid receptors (TRPV1) which have recently been linked to OAB pathogenesis. 
Women with sensory urgency had increased expression of TRPV1 in the trigone 
mucosa (Liu et al., 2007). TRPV1 agonists such as resiniferatoxin works by 
desensitizing C-fibre afferents by binding to the receptor and this subsequently 
increases bladder capacity - for a limited period of time - in OAB patients with burning 
urinary sensation (Cruz et al., 1997). A novel vanilloid receptor TRPA1 has recently 
been identified in the bladder neurons (Andrade et al., 2006) and is a new drug target 
for treatment of bladder urgency.
Neuromodulation is used in patients that are unable to tolerate anticholinergics, have 
refractory OAB or other co-existing neurogenic conditions. This technique uses mild 
electrical stimulation of pelvic nerves (S3 nerve root) via centrally implanted electrodes 
in the sacral foramen (Thon et al., 1991). A consensus has not been reached as to the 
exact mechanism of action. Suitable candidates have a permanent surgical unilateral 
implant that stimulates the S3 nerve root and is attached to a small pacemaker placed 
within the sub-dermal pocket in the buttock region (Kohli and Patterson 2009).
In summary the current treatment options are limited and there is a need to develop 
novel or more effective therapies for this distressing disorder. In order to achieve this, a 
greater understanding of both normal and pathological functioning of the bladder is 
required.
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1.7 T h es is  A im s  a n d  O b je c t iv e s
The aims of the thesis are:-
>  Investigate the phasic contractions that develop naturally in isolated pig bladder 
strips and determine any functional and structural heterogeneity between the 
different regions of the pig bladder using an in vitro tissue organ bath technique.
> Explore the effect of the mucosa (urothelium/sub-urothelium) on the 
development of phasic contractions and determine whether these PCs can be 
modulated cholinergically.
>  Functionally investigate the role of interstitial cells in the development of PCs 
using imatinib (Glivec); a tyrosine kinase inhibitor, and determine the 
expression and localisation of bladder ICCs using immunohistochemistry and 
confocal microscopy.
>  Investigate transmitter release (ATP) due to mechanical stretch on pig bladder 
strips obtained from the different bladder - dome, body and trigone.
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C h a pter  2
Fu n c tio n a l  c h a r a c te r is a tio n  o f  ph a sic
CONTRACTIONS IN THE PIG URINARY BLADDER.
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2.1 In tr o d u c tio n
It is widely accepted that during the filling phase involuntary phasic contractions (PCs) 
occur in the urinary bladder of several species, including man. This was first 
discovered in 1882 by Mosso and Pellacani from their studies on healthy female 
volunteers and from experimental studies on dogs. In their experimental studies the 
PCs were eliminated following spinal cord transection, suggesting the contractions 
were controlled via central neural mechanisms (Mosso and Pellacani 1882). The 
presence of PCs in the bladder was corroborated ten years later, in 1892 by 
Sherrington, who observed PCs in bladders of monkeys, cats and dogs. His 
experiments went on to show the sustained presence of PCs even after spinal 
transection and complete peripheral denervation (Sherrington 1892), and following 
bladder removal and maintenance in vitro the contractions still persisted, leading to the 
conclusion that the phasic activity was an inherent property of the bladder (Sherrington 
1892). These two major findings set the stage for the on-going discussion to this day 
as to the origin and role of PCs in the bladder.
2 .1.1 O r ig in  a n d  r o l e  o f  B la d d e r  P h a s ic  C o n t r a c t io n s
Since the work of Mosso & Pellacani and Sherrington, several studies have been 
performed to investigate bladder phasic activity and its origins, and several hypotheses 
have been proposed. Using a cat model, Gjone established that bladder PCs are 
influenced by a dual sympathetic and parasympathetic innervation (Gjone 1965). Plum 
and Colfelt (1960) showed that following denervation, if no damage occurred to the 
bladder; phasic activity persisted and subsequently coined the phrase "autonomous 
bladder" to explain the inherent PCs that occur (Plum and Colfelt 1960). Further 
experiments using spinal anaesthesia and parasympathetic ganglion blockage did not 
inhibit the PCs and this solidified the notion that the bladder phasic activity was an 
intrinsic property of the bladder wall.
Isolated bladders from many species including man are rhythmically active in vitro and 
this 'autonomous' activity has been shown to involve localised stretches of the bladder 
wall and waves of contraction (Gillespie 2004). Although the exact mechanism 
involved in this autonomous activity is unknown, various theories have been put 
forward speculating the origin of these bladder PC waves. Initially, it was thought that 
the PCs were myogenic in origin but this may not be the case. In vitro studies using 
isolated rabbit bladders exhibited continued phasic contractions even in the presence 
of atropine and tetrodotoxin which had no effect on both the electrical and mechanical 
activity of bladder smooth muscle thus suggesting a myogenic origin (Liu et al., 1998).
32
It has also been postulated that PCs may involve a network of pacemaker cells in the 
bladder wall in conjunction with interstitial cells driven by both excitatory and neural 
inputs (Drake et al., 2003; Gillespie et al., 2003). The fact that the autonomous phasic 
activity is different to that generated by the typical detrusor micturition contractions 
caused by post-ganglionic parasympathetic nerves leaves open the possibility that 
within the bladder is a complex, coordinated mechanism capable of eliciting PCs and 
rises in intra-vesical pressure (Gillespie et al., 2003). Several studies have identified a 
distinct sub-urothelial layer of cells with similar morphological characteristics as 
myofibrobrasts (Sui et al., 2002; Wiseman et al., 2003; Wu et al., 2004). These cells 
form a dense electrical network between the urothelium and the afferent nerves 
underneath, which is capable of responding to neurotransmitter release. In addition to 
this, their close connection to sub-urothelial afferent nerves makes them ideally placed 
to exert a modulatory effect on bladder function (Wu et al., 2004). Interstitial cells (ICC) 
and myofibroblasts cells in this region expressing muscarinic M3 receptors are capable 
of eliciting PCs that may be propagated via the network of large myelinated and small 
unmyelinated fibres (Wiseman et al., 2002).
The urothelium may also play a role in eliciting or modulating bladder PCs, due to the 
fact that it is capable of releasing various mediators such as ACh, ATP and NO that 
may act on the underlying afferent nerves, ICC and detrusor muscle present in the 
bladder. (Birder 2006). A recent study reported that removal of the mucosa from 
bladder strips from the pig bladder dome region resulted in delayed development of 
PCs compared to strips with the mucosa present (Akino et al., 2008). This finding 
supports a role for the urothelium/suburothelium in PC development or regulation, and 
points to the possibility of the sub-urothelium being the ideal site of integration and 
coordination of PCs.
Bladder phasic contractions from normal detrusor strips have been described as being 
distinctly irregular and arise from baseline. This is in contrast to contractions observed 
in detrusor strips from bladders in different pathological conditions, which appear as 
fused tetanic contractions (Brading 1997b). The role of these bladder phasic 
contractions is still not clearly understood. It is possible that they may be involved in 
the pathways that relay information on bladder fullness although their origin and exact 
physiological role is unknown. The relationship of these PCs to the non-voiding 
contractions reported in urodynamic studies needs to be investigated further, but it is 
clear that in pathological conditions, these PCs are increased.
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2 .1 .2  S m o o th  m u s c le  p h a s ic  c o n t r a c t io n s  in  p a t h o lo g ic a l
CONDITIONS
Functional differences have been reported in the phasic activity of isolated bladder 
strips from normal human bladders and those from patients with pathological conditions 
(Sibley 1984; Harrison et al., 1987; Kinder and Mundy 1987) and animal models (Sibley 
1984; Sibley 1987; Sethia et al., 1990; Bramich and Brading 1996). Functionally, 
bladders from pathological conditions exhibit increased electrical coupling between 
muscle bundles. This results in enhanced cell to cell coupling, thought to be 
responsible for the fused tetanic contractions observed in the unstable bladder, which 
is absent in normal detrusor. This enhanced abnormal phasic activity has been 
reported in various pathological conditions. Cultured SMCs from rat bladders with 
bladder outlet obstruction showed enhanced cell-to-cell communication compared to 
those obtained from normal rats (Li et al., 2007). Inhibition of this enhanced 
communication using a gap junction inhibitor led to the conclusion that increased cell- 
to-cell communication may contribute to the increased PCs observed in BOO. Isolated 
bladder strips from streptozotocin-induced diabetic rats - a model of bladder 
dysfunction - showed increased PCs compared to strips from control rats (Nakahara et 
al., 2004; Stevens et al., 2006; Vahabi et al., 2011b). In human studies, bladders 
obtained from patients with detrusor overactivity due to spinal cord injury (SCI) 
exhibited increased expression of connexin-43 gap junctions between SMCs 
(Haferkamp et al., 2004). This shows enhanced intracellular communication between 
SMCs and subsequently increased PCs.
Although there is a paucity of information on the PCs in individual regions of the 
bladder, a few differences have been noted. Experiments investigating the effect of 
removal of the urothelium on spontaneous activity of the bladder have shown the 
trigone to be different to the dome, in that the trigone exhibits no delay in the 
development of PCs in comparison to the dome. This finding suggests that the 
urothelium has no effect in the development of PCs in the trigone and may therefore 
lack the ability to release mediators that may enhance PCs (Akino et al., 2008). 
Immunohistological studies on guinea pig bladder have shown mucosal heterogeneity 
between the dome, lateral wall and trigone. This study reported that there were 
differences in the distribution of cells that stained positive for neuronal NO synthase 
and cGMP between the urothelium and sub-urothelium in the trigone, lateral wall and 
dome (Gillespie et al., 2004; Gillespie et al., 2005). A recent study looking at structural 
differences between the bladder dome and trigone examined mRNA expression of cold 
cut biopsies and revealed that the dome contained a relatively higher SM content in
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comparison to the trigone, reflecting a well-developed network of sub-urothelial 
myofibroblasts and muscularis mucosae in the dome (Sanchez et al., 2011).
In pathological conditions bladders show marked structural differences compared to 
normal bladders. The use of light and electron microscopy has shown detrusor from 
unstable bladder to contain increased elastin and collagen between the muscle 
bundles, subsequently causing patchy structure and loss of intrinsic nerve connections 
(Gosling et al., 1986; Harrison et al., 1987). Using electron microscopy Elbadawi et al 
(1993) described widened intercellular spaces, scarce intermediate cell junctions which 
are common in normal tissue and finally increased protrusion junctions and cell-cell 
support. The cell-cell abutments and protrusion junctions were proposed to be 
involved in the generation of OAB myogenic contractions and the increased electrical 
coupling between muscle cells (Elbadawi etal., 1993a; Elbadawi eta i ,  1993b).
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2 .2  C h a p t e r  A im s
The aims of this chapter were:-
>  To characterize the phasic contractions that develop in vitro in isolated pig 
urinary bladder strips in the different regions of the bladder dome, body and 
trigone,
>  To determine the role of the mucosa in the development of these PCs and 
any functional heterogeneity between the different regions.
>  To relate this to differences in the histology of the bladder layers.
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2 .3  M a t e r ia l s  a n d  M e th o d s
2.3 .1  Ex p e r im e n t a l  A n im a l s
Urinary bladders from White Landrace and Duroc female pigs were acquired fresh from 
the local abattoirs. The pigs were aged between 4-6 months and body weights were 
between 70-80kgs. The bladders were separated from the abdominal viscera and cut 
at the proximal urethra/bladder neck. The bladders were immediately placed in cold 
(4°C) modified Krebs’ bicarbonate buffer containing 118.4mM NaCI, 11.7mM D- 
Glucose, 24.9mM NHC03, 4.7mM KCI, 1.15mM MgS04, 1.15mM KH2P 0 4 and 1.9mM 
CaCI2 for transport to the laboratory.
2 .3 .2  Tis s u e  P r e p a r a t io n
Upon arrival at the laboratory, harvested bladders were processed immediately. The 
bladders were stripped of any excess fat and ligaments and these were disposed of 
according to the university guidelines regarding animal tissue handling. The ventral 
side of the bladder was identified and the bladder was then cut into the 3 major regions 
- dome, body and trigone as shown in figure 2.1. Firstly, the dome was removed by 
dissecting across the top 1/3 of the bladder. The bladder was then cut open 
longitudinally through the ventral side to expose the urothelium lining and the trigone 
region of the bladder. The trigone was separated from the bladder body and all three 
sections were then placed in cold Krebs' (4°C) and stored in the refrigerator. The 
tissue was used within 48 hours.
2 .3 .3  B l a d d e r  S t r ip  P r e p a r a t io n  f o r  f u n c t io n a l  s t u d ie s
Bladder strips measuring approximately 1-1.5cm length x 2-4mm width x 4-6mm depth 
were dissected from the three regions - dome, body and trigone. One strip per pair 
was left intact whilst the second strip was carefully denuded of the mucosa by 
dissecting away the urothelium and the underlying loose sub-urothelial layer, down to 
the detrusor along the natural plane of dissection as previously described (Sellers et al., 
2000; Templeman et al., 2002; Templeman et al., 2003; Akino et al., 2008).
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2 .3 .4  In  V i t r o  T is s u e  B a th  P r e p a r a t io n
Bladder strips were mounted in tissue baths, attached at one end to tissue holders and 
at the other end by Dynamometer UF1 force transducers (Pioden Controls Ltd. UK) 
using surgical thread Figure 2.2. The tissue strips were then maintained in warmed 
Krebs' solution at 37°C and continuously gassed with 95% 0 2 and 5% C 0 2. A pH of
7.4 was maintained under these conditions due to the buffering established by the C 0 2 
and NaHC03. Tissue strips were allowed to equilibrate under a load of 1g for 60 
minutes with the Krebs' buffer replaced every 15 minutes. The tension developed by 
the tissues was measured via the isometric force transducers connected to a Powerlab 
data acquisition system (ADInstruments, UK) which converted the analogue signal to 
digital and using 'Chart5' software (ADInstruments, UK) for analysis of the acquired 
data.
2 .3 .5  In v e s t ig a t io n  o f  B a s a l  P h a s ic  A c t iv it y
Bladder strips were observed for the development of phasic contractions and 
measurements of amplitude and frequency were taken at one and two hours following 
tissue set up. Development of phasic activity in the different bladder regions was also 
recorded
Amplitude and frequency measurements of the phasic activity were taken over a five 
minute period at the 1 hour and 2 hour time points. Amplitude was the peak amplitude 
in the selected 5 minute period (Figure 2.3). For frequency, 30% of the peak amplitude 
was calculated and used as a threshold to define a single contractile event as used 
previously in the laboratory (Vahabi et al., 2011a) and proposed by Imai et al. (2001). 
Any contractions above the threshold line were counted as single contractile events as 
shown in Figure 2.3. Wet tissue weight was recorded at the end of each experiment in 
order to normalize data to account for differences in tissue weight and size.
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Force transducer
*  Tissue HolderSurgical Thread
Tissue
Krebs Buffer Out 
(Waste Solution)Krebs Buffer In
95% 0 21 5% C 02
Figure 2.2 - Double-walled glass tissue bath (Adapted from (Longhurst and Uvelius 
2001).
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2 .3 .6  H is t o l o g ic a l  a n a l y s is  o f  t h e  p ig  b l a d d e r
Two methods of tissue preparation were investigated to determine which provided 
better structural integrity of the tissue for subsequent histological staining and 
measurement of the different bladder layers thickness. For each tissue preparation 
method, six pieces of tissue from each bladder region were prepared accordingly for 
sectioning and staining.
2.3.6.1 Liver-bladder-liver sandwich preparation
The first tissue preparation method involved using bladder sections (1.5x1.5x0.5cm) 
from the three bladder regions sandwiched between pieces of pig liver to provide 
support for the urothelium as shown in Figure 2.4. The liver-bladder-liver sandwich 
was immediately sprayed with cryofreeze spray and placed at -80°C before sectioning 
at 10micron thickness using a cryostat and mounting on polylysine coated slides. 
Sections were subsequently fixed in cold (4°C) paraformaldehyde for 15 minutes, 
washed in 1X phosphate buffered saline (PBS) then immersed in cold methanol (-20°C) 
for 4 minutes, cold acetone (-20°C) for 2 minutes and finally washed again with 1X PBS 
ready for histology staining.
2.3.6.2 Paraffin embedded tissue preparation
In the second method, fresh pig bladder tissues were fixed using neutral buffered 
formaldehyde 10% v/v (Leica Microsystems, Milton Keynes, U.K.) for at least 2 hours. 
These were then placed onto IP III histology cassettes (Leica microsystems, Milton 
Keynes, U.K.) and placed in a Shandon Elliott duplex tissue wax automatic processor 
(Shandon Elliott Inc., PA, U.S.A.) whereby the tissue was initially dehydrated in 50% 
industrial methylated spirit (IMS) for 90 minutes, 70% IMS for 60 minutes, three times 
in 99% IMS for 60 minutes and twice in 99% IMS for 90 minutes. The tissue was then 
cleared three times using Sub-X for 90 minutes and finally immersed in molten wax for 
90 minutes and the last step in the processor in molten wax for 120 minutes. The 
tissue was then transferred into a glass container of molten wax and placed in a 
vacuum oven at a temperature of 60° - 70°C at 60cmHg pressure for 30 minutes to 
eliminate any air pockets remaining in the tissue. Tissue mould bases (Leica 
microsystems, Milton Keynes, U.K.) were filled with molten wax and the tissue was 
removed from the histology cassettes and aligned to the correct orientation in the base. 
The tissue cassette was then placed over the mould and pressed into place ensuring 
that wax filled the cassette and this was then placed on a cold plate to cool to allow the 
wax to set ready for sectioning at 3 microns on a Leica SM 2400 microtome ((Leica 
microsystems, Milton Keynes, U.K.).
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2 .3 .7  H is t o l o g ic a l  s t a in in g
Two staining techniques were used and compared in order to measure the bladder 
layers in the three bladder regions, haematoxylin and eosin stain (H&E) and Masson's 
trichrome stain (MTS), which stain different components of the tissue sections thus 
enabling distinguishing of the different structures present.
2.3.7.1 Haematoxylin and Eosin staining
Prior to staining, the paraffin wax embedded tissues underwent a de-waxing stage. 
This was performed by immersing the slides in Sub-X three times for five minutes 
followed by a rehydration step whereby the slides were placed in IMS three times for 5 
minutes. Frozen and fixed liver-bladder-liver sandwich sections and de-waxed paraffin 
embedded sections were immersed in filtered Harris haematoxylin solution for 1 minute 
and rinsed in tap water until clear. The slides were then immersed in 1% eosin for 1 
minute and again rinsed in tap water until clear. Subsequent dehydration in ascending 
alcohol solution (50% - 1 minute, 70% - 1 minute, 80% -1 minute, 95% - 2 minutes and 
100% - 2 minutes) was performed and then the sections were cleared using xylene for 
2 minutes in the fume hood. DPX (Sigma Aldrich, Dorset, U.K.) was used to mount 
coverslips and the slides were left to air dry ready for microscopic analysis.
2.3.7.2 Masson's trichrome stain
A MTS kit (Sigma Aldrich, Dorset, U.K.) was used. Fixed sections were allowed to 
mordant in pre-heated Bouin's solution at 56°C for 15 minutes and allowed to cool in 
tap water. The yellow colour that developed on the slides was removed by several 
rinses in tap water. The slides were then immersed in Weigert's iron haematoxylin 
solution for 5 minutes, rinsed with tap water for 5 minutes and then placed in Biebrich 
scarlet-acid fuchsin stain for 5 minutes followed by a rinse with tap water. The slides 
were then immersed in phophotungstic/phosphomolybdic acid solution for 5 minutes, 
aniline blue solution for 5 minutes, 1% acetic acid for 2 minutes and the slides were 
finally rinsed and dehydrated through increasing alcohol concentrations, cleared in 
xylene and allowed to air dry for cover slip mounting with DPX.
2.3.7.3 Bladder layer measurements
Each tissue section from each of the three bladder regions had 6 measurements taken 
for each layer - urothelium, suburothelium and detrusor. The measurements obtained 
were combined and averaged to provide the results presented in this chapter. Figure
2.5 shows an example of how measurements were taken.
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2 .3 .6  Da t a  a n d  s t a t is t ic a l  a n a l y s is
All data are expressed as mean ± standard error of the mean (SEM). Amplitude 
measurements are shown as absolute grams of tension per mg of tissue weight to 
account for differences in tissue weight. Frequency is the number of contractions per 5 
minute period. Comparison of data from intact vs. denuded bladder strips was 
performed using an unpaired Student's t test. A comparison of data from the 3 bladder 
regions was performed using a one-way ANOVA with a Bonferroni post-hoc test. 
p<0.05 was considered significant.
Urothelium, sub-urothelium and detrusor layer thickness was compared across the 
three bladder regions. Comparison of thickness dimensions within each layer of the 
bladder was performed using a Student's t test whereas inter-region analysis was 
performed using a one-way ANOVA with a Bonferroni post-test.
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2 .4  R e s u lts
Representative PCs that developed in bladder strips from the dome, body and trigone 
are shown in Figures 2.6 - 2.8 respectively. The PCs that developed in intact strips 
from the three regions appear similar in shape with all contraction peaks appearing 
regular with a constant baseline (Figure 2.6a, Figure 2.7a & Figure 2.8a). Removal of 
the mucosa did not alter the baseline but did affect the waveform with the shape of 
contractions becoming fused and irregular (Figure 2.6b, Figure 2.7b & Figure 2.8b).
2.4.1 Tim e  to D e v e l o p m e n t  o f  P C s a n d  E f f e c t  o f  M uco sa  R em o va l  
in  P ig  B la d d e r  D o m e , B o d y  a n d  Tr ig o n e
Phasic contractions were observed in 96.7% of all bladder strips examined from the 
three bladder regions. For each bladder region, 10 intact and 10 denuded strips were 
examined (n=10 animals). 90% of the strips from the bladder dome developed PCs in 
comparison to 100% of strips from the body and trigone. One strip of intact and one 
strip of denuded dome did not develop PCs. The time taken to develop PCs in intact 
strips from the dome, body and trigone regions was 17.2 ± 4.0 minutes, 17.7 ± 7.4 
minutes and 10.7 ± 3.9 minutes respectively (Figure 2.9a). In contrast, removal of the 
mucosa significantly increased the time to develop PCs in denuded dome strips to 60.3 
± 6.7 minutes (Figure 2.10a, ***p<0.0001). In the body region, mucosa removal also 
increased the time for PC development to 44.4 ±11.8  minutes, although this was not 
significantly increased versus intact tissues (Figure 2.10b). For the trigone, mucosa 
removal did not affect the time taken to develop PCs, being 7.3 ± 2.1 minutes in 
denuded strips and not significantly different to the intact strips (Figure 2.10c).
Comparison of the time to development of PCs in intact strips in the three bladder 
regions showed no significant differences (Figure 2.9a). In contrast, in the denuded 
bladder strips, comparison between the dome, body and trigone showed the time to 
development of PCs to be significantly less in trigone vs. the dome and body regions 
(Figure 2.9b).
47
(6) uojsuaj.
Int
act
 B
od
y
~a
(0
( 6 )  u o j s u d j .
$O-Q
■§3C
•§
3*pcto
oto
to
SI
t0
.Q .
45to
I■2-Qc
<0co3o
scoo
o<0to>cQ.
0  
to o> c
1  o o
2!
t :to.3o
"too
.1
CD
csi
23.3)
Int
act
 T
rig
on
e
( 6 )  u o j s u a x
OCoO)£■3■§3C•§
■Ocre
o
<TJ
I<0
t
I-2-Qc
toco'<&o
£coo
tore-ca
o
too>c
oo2
t :re•co
re0
1
oID
ooc\i
2!3
.o >
Int
act
 S
trip
s 
b) 
De
nu
de
d 
Str
ips
(s u iu i) eu ijj.
oTfo00 oCD oCM o
a>cou>
-aom
aEoa
(Z (suitu) 0LUJ1
+1cCTSa>5
2!<xs
isTOQ
a>c:oO)
*0cTO
$o-Q
qT5o■0CD■c
I
CO.a£ _Co 'qJ'*» cCD o ^ .O) a  C: .TO -c
.5* TO 
"D ^■o3C*8
3s■DcTO
OTO
OrQ
IIC■0c:TO
”qTS■§
_  o> fC II
"  of co c  O g
0 2 * *iS
t * .§> t<!> £ 3^ -O
sCOo oVA
CDs £Io>
c\i
2? ■
.0)5 u. co
CO
a)
80n
Dome
a>E
60-
40-
20 -
IIntact Denuded
b)
80n
Body
60-
40-
20 -
iIntact Denuded
c)
so-
Trigone
_  60-Jco
I  40-d>E
20 -
0- IIntact Denuded
Figure 2.10 - Time to development of PCs in intact vs. denuded strips o f a) dome, 
b) body and c) trigone. Data are mean ± SEM; n=9 (dome), n=10 (body and 
trigone). ***p<0.0001 vs. intact.
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2.4.2 A m p l it u d e  a n d  f r e q u e n c y  o f  p h a s ic  c o n t r a c tio n s  in  pig
BLADDER STRIPS AND THE EFFECT OF MUCOSA REMOVAL
The amplitude of PCs in intact bladder strips was significantly greater in strips from the 
trigone region versus the dome and body (Figure 2.11a). Following removal of the 
mucosa, the amplitude of PCs remained significantly greater in denuded strips versus 
strips from the dome and body regions Figure 2.11b). Removal of the mucosa resulted 
in only a slight increase in amplitude of PCs in the body and trigone regions although 
not significantly so compared to intact strips (Figure 2.12).
Frequency of PCs was greater in intact strips of the dome and body versus the trigone 
although not significantly so (Figure 2.13 & 2.14). Removal of the mucosa significantly 
decreased the frequency of PCs in the dome and body whereas in the trigone, removal 
of the mucosa only slightly and non-significantly increased frequency (Figure 2.13 and 
2.14).
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2.4 .3 E f f e c t  o f  tim e  o n  th e  a m p l it u d e  a n d  f r e q u e n c y  o f  P C s
Comparison of the amplitude of PCs at 1 hr vs. 2hrs in intact strips of the dome, body 
and trigone bladder regions showed no significant differences at the two time points 
(Figure 2.15a). Denuded strips on the other hand showed significant increase in the 
amplitude of PCs at 2hrs vs. 1hr time point in all three bladder regions (Figure 2.15b). 
With regards to frequency, intact strips from the three regions were not significantly 
different in the number of contractions over time (Figure 2.16a), whereas in the 
denuded strips, a significant increase in the frequency of PCs at 2hrs compared to 1 hr 
was observed in the dome and body. In contrast the denuded strips of trigone showed 
similar frequency at the two time points (Figure 2.16b).
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2.4.4 I n v e s t ig a t io n  o f  u r o th e l iu m ,  s u b - u r o th e l iu m  a n d  d e t r u s o r
LAYER THICKNESS IN PIG BLADDER DOME, BODY AND TRIGONE REGIONS
The different layers of the bladder wall were clearly distinguishable using the two 
different staining methods. For the H & E stain, nuclei and basophilic structures 
stained blue whereas the cytoplasm and acidophilic structures stained a light to dark 
red colour (Figure 2.17, Figure 2.18 a & b). In contrast, the MTS method stained cell 
nuclei black, connective tissue and collagen blue and the cytoplasm and muscle fibres 
red (Figure 2.17, Figure 2.18 c & d). Much better structural integrity was preserved 
using wax embedding, and thus histological measurements of the bladder layers were 
taken using sections of tissue prepared by this method. Figure 2.19 shows example 
MTS on 3 micron full thickness paraffin embedded slides from the three bladder 
regions showing the urothelium, sub-urothelium and detrusor muscle bundles in all the 
three bladder regions. A similar layer to the muscularis mucosae described by 
Fleppner et al. (2011) was visible in sections from the dome and body but not the 
trigone.
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Figure 2.17 - Comparison of H & E vs. Masson's trichrome staining o f liver- 
bladder-liver sandwich sections from the dome. A and B: H&E stain; C and D: 
MT stain on 10 micron thick sections. Left panel - 4X; Right panel - 10X 
magnification of highlighted region. U - urothelium, SU - suburothelium, MB - 
muscle bundle, L - liver.
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Figure 2.18 - Comparison of H & E vs. Masson's trichrome staining o f paraffin 
embedded bladder sections from the dome. A and B: H&E stain; C and D: MT 
stain on 4 micron thick sections. Left panel - 10X; Right panel - 20X  
magnification of highlighted region. U - urothelium, SU - suburothelium, MB - 
muscle bundle, L - liver.
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Figure 2.19 - Typical example of MTS on wax embedded sections from a) dome, b) 
body and c) trigone regions showing the urothelium (U), sub-urothelium (SU), 
muscularis mucosae (MM) and the detrusor muscle bundles (MB); 4X  
magnification.
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A comparison of the measurements taken from the different bladder layers in the three 
bladder regions is shown in Figure 2.20. In the dome region (Figure 2.20a) bladder 
layer thickness increased from the urothelium to the detrusor. Using one way ANOVA, 
the sub-urothelium and detrusor layers of the dome were significantly thicker than the 
urothelium layer in the dome. There were no significant differences between the 
suburothelium and the detrusor layers of the dome. In the body region (Figure 2.20b) 
the detrusor layer was significantly thicker than both the urothelium and suburothelium, 
with no significant differences observed between the urothelium and suburothelium. 
For the trigone region, the suburothelium and detrusor layers were both significantly 
thicker than the urothelium (Figure 2.20c) with no significant differences noted between 
the suburothelium and detrusor layers.
Comparison of the individual layers between the three regions is shown in Figure 2.21. 
The thickness of the urothelium was similar in the dome, body and trigone regions 
(Figure 2.21a), whereas the suburothelium layer was significantly thicker in the trigone 
compared to the dome and body regions (Figure 2.21b). Comparison of the detrusor 
layer revealed that the detrusor of the body region was significantly thicker compared 
to the dome and trigone regions. No differences were noted in comparing the dome 
and trigone detrusor layers (Figure 2.21c).
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2.5 D iscussion
In vitro studies of isolated bladders have shown that phasic spontaneous contractions 
(PCs) develop without any stimulation, although little is known regarding the origin and 
physiological role of these PCs. These phasic contractions have been attributed to the 
release of mediators from the urothelium that may generate spontaneous action 
potentials that rapidly propagate throughout the detrusor causing bladder contractions 
(Hashitani et al., 2001). In the present study, spontaneous phasic contractions did not 
develop in all bladder strips used. In the dome, 90% of the 20 strips used developed 
PCs while in the body and trigone regions, 100% of 20 strips developed PCs. This is in 
contrast to a study which reported that 19% of 191 strips from the pig bladder dome 
developed PCs and 89% of the 19 strips from the trigone developing PCs (Sibley 1984). 
The same study also reported that 20% of 139 strips and 71% of 7 strips from the 
human dome and trigone bladder regions respectively developed PCs (Sibley 1984). 
Roosen et al (2009) reported that 68% of 28 trigone strips from male guinea-pig 
bladders developed PCs compared to 38% of 21 strips from the dome (Roosen et al., 
2009). Differences in species, bladder size and bladder composition may account for 
the observed differences in development of PCs development. Age may also have an 
effect on the differences observed, although there is no evidence in the literature..
Analysis of the time taken for development of PCs in intact (mucosa/urothelium present) 
and denuded (urothelium absent) strips revealed that denuded strips from the dome 
and body took significantly longer to develop PCs compared to intact strips, whereas in 
the trigone which no difference in PC development time was seen between intact and 
denuded strips. These findings are similar to those published by Akino et al (2008) 
who showed that the time required for PCs to develop was shorter in intact strips of the 
dome compared to their denuded counterparts. Similarly, that study also found that the 
intact and denuded strips of the trigone were similar in PC development time (Akino et 
al., 2008). Comparing between the three bladder regions, intact strips were similar in 
PCs development time although denuded strips from the dome and body were 
significantly different to the trigone.
From these results, it is possible to propose that there is an excitatory mechanism 
present in intact strips that allows for faster development of PCs that is lacking in 
denuded strips. The urothelium has been shown to contain a variety of receptors and 
ion channels and has the ability to release various mediators such as ATP (Ferguson 
et al., 1997), ACh (Yoshida et al., 2006) and NO (Birder 2006). There is also published 
literature on an unidentified urothelium derived inhibitory factor (UDIF) (Hawthorn et al.,
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2000). The presence of receptors and the release of various transmitters by the 
urothelium, coupled with the presence of a network of myofibroblasts and interstitial 
cells (ICCs) in close proximity to nerves may implicate the urothelium in the initiation of 
action potentials that can propagate down the bladder detrusor causing spontaneous 
contractions. Take away the urothelium, and this development of PCs is significantly 
delayed. Exactly which type of cell is responsible is not clear, but what is clear is that 
this mechanism does not seem to be present in the trigone, suggesting a functional 
difference in generation of PCs in the bladder regions, which may reflect the different 
physiological roles of these regions.
When amplitude and frequency measurements of PCs between intact and denuded 
strips across the 3 bladder regions were compared, the denuded strips had PCs of 
greater amplitude than intact strips in the body and trigone, although this was not 
significant. These results are consistent with Akino et al. (2008) who showed no 
differences in amplitude between intact and denuded strips from the dome and trigone. 
However, differences in PCs in the trigone were again apparent with significantly 
greater amplitude compared to the dome and body in intact and denuded tissues.
Measurements of frequency of PCs showed intact strips of the trigone to have 
significantly lower frequency compared to the dome and body. Removal of the mucosa 
significantly reduced frequency of PCs in the dome and body but increased the 
frequency (non-significantly) in the trigone, again illustrating differences between the 
three regions in the PCs and the role of the mucosa. In the dome and body, the 
urothelium may release mediators that can mediate PCs, hence the intact strips exhibit 
a greater number of contractions than the denuded strips without the urothelium. 
These mediators may act on the underlying nerves, ICCs or the detrusor muscle. The 
process of denuding the bladder strips ultimately removes the urothelium and part of 
the sub-urothelium, and thus would subsequently affect mediator release and response 
by the myofibroblast and ICC network present in the suburothelium (Wiseman et al., 
2002). This may explain why denuded strips have fewer contractions per 5 min period 
than the intact strips. It is also possible that the tissue damage as a result of removal 
of the urothelium may be responsible for the decrease in the number of PCs and 
subsequent impairment in function. However, since removal of the urothelium did not to 
affect the trigone region, tissue damage does not appear to occur
Amplitude and frequency of PCs at 1 hr and 2hr time points was also assessed 
between the dome, body and trigone. Comparison of PCs across the 3 regions 
showed no significant differences in amplitude of intact strips between 1 hr and 2hr time
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points. In denuded strips, the amplitude was significantly increased in all regions at the 
1 hr versus the 2hr time points. Frequency comparison between the regions in intact 
strips showed no significant differences between the 1 hr and 2hrs time points. In 
denuded strips the frequency of PCs from the dome and body was significantly higher 
at 2hrs compared to the 1 hr time point, whereas for the trigone, no difference was 
observed at the 1 hr and 2hr time points.
The differences observed functionally between the bladder regions may lie in a 
different morphology and composition of the bladder wall in these regions and thus 
were investigated histologically. In order to accurately measure the different layers of 
the bladder wall histologically, it was imperative to ensure the tissue remained intact 
throughout the tissue processing (freezing, sectioning and staining procedures). In 
initial experiments using frozen bladder tissues, the urothelium layer became detached 
from the rest of the bladder during sectioning. This led to the use of the liver-bladder- 
liver sandwich method, in order to provide support for the delicate urothelium and help 
maintain its integrity for measurements. Staining of the bladder sections prepared in 
this way showed that in some regions of the bladder urothelium were not sufficiently 
supported and ultimately had separated from the bladder. Also tissue integrity was not 
optimal. Paraffin embedded tissue sections proved to be the better method to maintain 
tissue integrity and was therefore the method of choice for analysis of the different 
bladder layers. Comparison of the two most commonly used stains on the paraffin 
embedded section showed the MTS method to achieve the better contrast of the tissue 
structure and accurate demarcation of the different layers for measurements.
Previous studies comparing between the bladder trigone region and the main detrusor 
(body) showed no apparent differences in the composition of the urothelium (Romih et 
al., 2005; Thomas et al., 2005; Sun 2006). This supports the findings of the present 
chapter since no significant differences were observed in the thickness of the urothelial 
layer between the dome, body and trigone regions. Comparison of the sub-urothelium 
layer on the other hand showed the dome and trigone to have significantly thicker layer 
compared to the body. Drake et al. (2003) has shown the spread of bladder 
autonomous activity from the dome region to the rest of the bladder (Drake et al., 2003).
In contrast, detrusor thickness was greatest in the body compared to the dome and 
trigone regions. As previously stated bladder SMCs need to be able to stretch to 
accommodate bladder filling. At the same time, once urine levels reach threshold 
levels, the sudden increase in bladder intravesical pressure results in neural overload 
and hence the sudden synchronized contraction of the bladder to allow for micturition
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(Brading 1997b). The presence of a thicker detrusor layer in the body possibly due to a 
higher concentration of muscle bundles appears to makes sense in order to allow it to 
function in fulfilling the micturition cycle. Thus histological findings in the present study 
highlight structural differences in the bladder wall which may underlie the functional 
differences observed. Although, it is probable that the differences lie at the cellular 
level, in the role of the different cell types.
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2 .6  S u m m a r y  a n d  C o n c l u s io n s
The experimental results presented in this chapter demonstrate that there are 
differences in functional characteristics of the pig bladder across the dome, body and 
trigone regions.
>  Major differences are observed particularly between the trigone versus the 
dome and body implying functional heterogeneity between the trigone and the 
dome and body.
>  Structurally, there are also marked differences in the different bladder layers 
across the three regions, particularly in the sub-urothelium. These differences 
may play a role in how these distinct regions function and will be further 
investigated in subequent chapters
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C h a p te r  3
C h o lin e r g ic  M o d u la tio n  of P h a sic  
A c t iv it y  in P ig B la d d e r  D o m e , Bo d y  a n d  
T r ig o n e .
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3.1 In t r o d u c tio n
3.1 .1  M u s c a r in ic  r e c e p t o r s  in  th e
In the bladder detrusor, there is a heterogeneous population of M2 and M3 muscarinic 
receptors as evidenced by molecular and binding studies. The ratio of M2:M3 receptors 
is 3:1 in human and pig bladders and has been shown to be as high as 9:1 in rats 
(Wang et al., 1995; Yamaguchi et al., 1996; Baselli et al., 1999; Yamanishi et al., 2000). 
Although the M2 subtype outnumbers the M3, it is the latter that has been credited with 
the direct contraction in vitro of the detrusor muscle. To date, this has been shown in 
mice (Choppin 2002; Canda et al., 2009), humans (Chess-Williams et al., 2001; 
Fetscher et al., 2002), pigs (Sellers et al., 2000), rats (Longhurst et al., 1995; Wang et 
al., 1995), guinea pig (Noronha-Blob et al., 1989) and the rabbit (Choppin et al., 1998). 
M3 receptor gene knock-out studies performed on mice showed a significant reduction 
in bladder contraction (95%) with the remaining 5% being attributed to M2 receptor 
function (Matsui et al., 2002). M2 and M3 double knock-out viable mice showed 
absolutely no muscarinic receptor mediated contractions (Matsui et al., 2002).
Muscarinic receptors in the bladder are also located on both parasympathetic and 
sympathetic pre-junctional nerve endings where they play a role in the regulation of 
neurotransmitter release. Inhibition of ACh release is attributed to either M2 or M4 
receptors whereas enhancement of ACh release is due to N\<\ receptors. This increase 
in ACh is via pathways involving L-type calcium channels and protein kinase C 
(Somogyi and de Groat 1999). Distinguishing between M2 and M4 subtypes and 
establishing the one that is responsible for inhibition of ACh release has proved to be 
challenging, as both subtypes are negatively coupled to adenylate cyclase and cause a 
decrease in cyclic adenosine monophosphate (cAMP) levels and the available 
antagonists do not discriminate between the M2 and M4 receptors (Chess-Williams 
2002). In humans, the M4 subtype may be responsible for the inhibition of ACh release 
(D'Agostino et al., 2000) whereas in mice, the M2 subtype is primarily responsible for 
the regulation of noradrenaline (NA) release (Trendelenburg et al., 2003; 
Trendelenburg et al., 2005).
Molecular studies have shown that muscarinic receptors are also present in the bladder 
urothelium of several species including human (Mansfield et al., 2005; Tyagi et al., 
2006; Bschleipfer et al., 2007) and mouse (Zarghooni et al., 2007). In human studies, 
within the urothelial layers, the Mi subtype is mainly expressed in the basal layer, with 
the M2 receptor subtype being expressed in the umbrella cells and the M3 - M5 
subtypes expressed heterogeneously in all layers of the urothelium (Bschleipfer et al.,
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2007). Studies using immunohistochemistry to localise muscarinic receptors in the 
mouse bladder have demonstrated a similar distribution of the various receptor 
subtypes to the human bladder (Zarghooni et al., 2007). M2 and M3 immunopositive 
reactive staining has been used to confirm presence of these receptors in human 
bladder detrusor (Mukerji et al., 2006). Expression of muscarinic receptors on bladder 
afferent neurons has been confirmed by Nandigama et al. (2010) who reported the 
expression of M2, M3 and M4 receptors on mouse bladder afferent neurons but were 
unable to detect the Mi or M5 subtypes. M2 and M3 receptors have also been shown to 
be expressed in nerve fibre bundles and in the dorsal root ganglion of small and 
medium sensory neurons in the sub-urothelium (Mukerji et al., 2006). This finding 
strongly supports the theory that processing of sensory information may be mainly via 
cholinergic control (Nandigama et al., 2010). Muscarinic receptors are also expressed 
on ICCs, as shown in immunohistochemical studies of guinea pig bladders, which 
revealed the expression of the M3 receptor subtype on suburothelial ICCs (Grol et al., 
2009) and on myofibroblast-like cells in human bladder sub-urothelium (Mukerji et al., 
2006).
Although there is a lot of information on muscarinic receptors in the detrusor and how 
important a role they play in bladder function, relatively little is known about these 
receptors in the urothelium, nerves and ICCs and what their functions is at these other 
locations. Non-neuronal ACh is released from bladder urothelium and sub-urothelium 
layers (Yoshida et al., 2006; Yoshida et al., 2008) and it is not clear what it does in the 
bladder but it is possible that it may act on receptors located in the underlying nerves, 
muscles and ICCs and subsequently enhance bladder phasic activity especially in 
pathological conditions.
3.1.2 C h o lin e rg ic  m o d u la tio n  o f  PC s
Investigation of the origin of bladder spontaneous contractions in neonatal and adult 
rats showed that these normal PCs that occur naturally in both isolated strips and 
whole bladders can be modulated cholinergically using low concentrations (50nM) of 
muscarinic agonist (Kanai et al., 2007; Vahabi et al., 2011a). It is not clear whether 
PCs that develop in the pig bladder can be modulated in a similar manner and is thus 
investigated in this chapter. In OAB (Andersson and Yoshida 2003) and ageing 
(Yoshida et al., 2004), ACh release has been shown to be increased and may 
contribute to the enhanced PCs observed in these conditions and several other 
pathological conditions.
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Muscarinic receptors have been investigated and implicated in a number of 
pathological conditions of the bladder. Various studies have shown that there is 
enhanced sensitivity of the bladder detrusor to muscarinic agonist in several disease 
states including denervation (Braverman et al., 1998), BOO (Speakman et al., 1987), 
diabetes (Mimata et al., 1995), ageing (Yu et al., 1997) and hyper-reflexic bladder 
(Martin et al., 1997). In a study involving children with recurrent urinary tract infections, 
it was noted that there was increased selective sensitivity of bladders to CCh 
(Werkstrom et al., 2000). In cases of chronic BOO, the detrusor supersensitivity 
experienced is thought to be due to parasympathetic denervation (Harrison et al., 1987; 
Speakman et al., 1987). In animal experiments using rats, it was observed that the M2 
receptor density in the bladder increased by 60% following denervation (Braverman et 
al., 1998) an effect not observed in rats with obstructed bladder whose responses were 
still mediated by the M2 receptor subtype (Krichevsky et al., 1999).
Urothelial muscarinic receptor activation leads to a release of various factors including 
ATP, which is involved in bladder sensory mechanisms (Kullmann et al., 2008; 
Burnstock 2009). Stimulation of urothelial muscarinic receptors by agonists also 
induces the production of an unidentified urothelium derived inhibitory factor (UDIF) 
which inhibits detrusor contraction (Hawthorn et al., 2000). These responses mediated 
by muscarinic receptors may possibly be altered in other bladder disease states as 
evidenced by increased population of M2 and M3 receptors in the urothelium from rats 
with partial BOO (Kim et al., 2008). Ruggieri et al. (2006) using rats showed that in 
bladder pathologies resulting from hypertrophy due to denervation led to the 
upregulation of the M2 receptor subtype and it becomes the primary mediator of 
bladder contraction (Ruggieri and Braverman 2006). It is possible that increased ACh 
in pathological conditions may act on the muscarinic receptors present in the bladder 
thereby leading to increased PCs.
3.1.3 Pharmacological tools for investigation of muscarinic receptors
The use of muscarinic agonists and antagonists has been on the front line of 
identification of functional and pharmacologic responses of the different muscarinic 
receptor subtypes. This progress has been hampered mainly due to the lack of 
selectivity of the available antagonists for a single muscarinic subtype thereby 
hindering pharmacological characterization (Scarpero and Dmochowski 2003). The 
problem of lack of selectivity is compounded by the fact that tissues also express more 
than one subtype of receptors making it more challenging to determine the function of a 
particular subtype.
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There are various muscarinic agonists and antagonists available that have been 
utilized in the pharmacological identification and characterisation of receptor selectivity 
profiles. Radioligand binding experiments involving ligands such as [3H]pirenzepine 
and [3H]N-methylscopalamine have been used in the determination of differences in 
antagonist equilibrium dissociation constants (Kd) in order to discriminate the various 
receptor subtypes, and functional experiments have been performed on cells or organs 
expressing the specific subtype of interest as a conclusive confirmation (Caulfield and 
Birdsall 1998).
Some of the main muscarinic agonists and antagonists used in functional investigation 
studies of receptor subtypes include pirenzepine, methoctramine, 4-Diphenylacetoxy- 
N-methylpiperidine methiodide (4-DAMP), tropicamide, oxotremorine, carbamycholine 
(carbachol - CCh), arecaidine and (+)-cis-dioxolane. Table 3.1 shows some of these 
muscarinic antagonists and their respective pKB value range at the receptor subtypes. 
It is important to note that these antagonists are not exclusively selective but rather 
relatively selective for the different subtypes at the shown ranges.
Pirenzepine has a high affinity for Mi receptors (7.8 - 8.5) and a low affinity for M2 and 
M3 receptors (6.3 - 6.7 and 6.7 - 7.1 respectively). It has a moderate (7.2 - 7.6) to high 
(7.7 - 8.1) affinity for M4 receptors. Overall, pirenzepine is tenfold selective for the M-i 
receptor over the other subtypes. Methoctramine has a high affinity for M2 receptors 
(7.8 - 8.3) and is similarly tenfold more selective for the M2 receptor over the others. 4- 
DAMP exhibits a high affinity for M3 receptors (8.9 - 9.3) and a moderate affinity for M2 
(7.8 - 8.4). In contrast, 4-DAMP has an affinity tenfold lower at M2 vs. M3 receptors 
(Sellers and Chess-Williams 2012).
The affinity of pirenzepine for the M4 receptor in conjunction with the high affinity of 
methoctramine and 4-DAMP for this receptor presents the problem of distinguishing M2 
or M3 from the M4 receptor (Caulfield and Birdsall 1998). Tropicamide, a slightly 
selective M4 antagonist, has been used to distinguish M4 from the other receptors 
(Lazareno and Birdsall 1993) but its affinity for the different subtypes (as shown in 
Table 3.1) makes it an inconclusive determinant of the M4 receptor subtype (Sellers 
and Chess-Williams 2012).
The use of muscarinic agonists in the identification of receptor subtypes has also not 
been hugely successful. Similarly, this is due to the issue of lack of selectivity of the 
available agonists for specific receptor subtypes. Carbachol is a non-specific 
muscarinic agonist and has been widely used in vitro functional investigations in the 
bladder but it is not selective for any of the five subtypes (Sellers and Chess-Williams
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2012). Oxotremorine methiodide (Oxo-M), (+)-cis-dioxolane and arecaidine are also 
high affinity muscarinic agonists lacking selectivity for any of the receptor subtypes. 
Arecaidine has been used in functional studies of the bladder due to its selectivity for 
muscarinic receptors over nicotinic receptors (Gillespie et al., 2003). There is the 
added complication of potency when using agonists as well, which complicates things, 
as the response may differ in different tissues - so agonists are not normally used for 
receptor characterisation.
78
in i
CN
CD 6.
9-
7.
2
8.
9-
9.
0
6.1
 -
6.
3
CO
CD
8.
0-
8.
1
Un
kn
ow
n
7.1 
-8
.1
7.
4-
8.
1
8.
4-
9.
4
8.0
-8
.8
8.0 
8.7
o
00
iIs- 7.
8
Re
ce
pto
r 
Su
bty
pe
CO
T -
iIs-
CD 6.
3-
6.
9
8.
9-
9.
3
6.
9-
7.
4
7.
2-
7.
8
8.
4-
8.
9
CO
CM 6.
7 8.3 N"CO 8.3 9.0 7.4 COIS iCO
CD 7.
8-
7.
8-
8.
0-
8.
2-
7.
0- i^
8.5 CO 9.2 7.2 7.5 7.8 CO2
7.
8-
7.1 
- i
CD
00
ioIs-' 7.
3-
7.
5- i^
An
tag
on
ist
Pi
re
nz
ep
ine
Me
th
oc
tra
mi
ne
Q_
<Q1
Hi
mb
ac
ine
AF
-DX
 
38
4
Da
rif
en
ac
in
Tr
op
ica
mi
de
■O0
.C
■Q
soo
0
0 ^ r  
3) 10
•is 0  00 W
g> 0
R- 0qj co
>2 •Q OD 0 C  CD 
Q  (0 CD
€  =  
i  8 
■o 50 CD
o
cto£3
-C
C> m C «
“O C 3 (0o 4s
•£ jo
12 o
■ocCO
330
Q.O 0 >■a o
D_ CO0 O o
Is-' CD CD
H-.
o CO
0
CN
c 0
c Sto O 0 O '-3 “O
s §.=c0 ■ - C 2. co0 Q . CD13 _  O)0 ^  T- 
£ c =£ n s °0 12 -O "£ o -  £ C ^  CQ E 0 Q . 0 3  <1> ^  =  hS O C =v. 0 0 >tP O '
■a %3  S  £  <8
*  I  8 5
- o r a
p- ^  c
00
■o000
o c roC 00 o ^  0 _  _00 "5 
* 3*5a 3 § w  
%
1  ■§ P  § *
0S 3 ^ : 
0 o ^  w 
§ !O '*- CD .  -Q >Q cc 3 9>- ? *  SC  0
£  o co0  'is • -^  -3  Q . CD12 0 o  ■2 -S CJ o  
C  43  P CM0 ■>, - § > ? &  ra
3  & t «^  '■§ W 01 .S V. ©^ " 3 0 ^  
0)  O  —
s  i ' f i g0 P 0 op— sS Q . CNJ
CDIs-
3.2 Chapter A ims
The aim of this chapter was:
> Investigate whether phasic contractions (PCs) of the pig bladder dome, body, 
and trigone can be modulated cholinergically.
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3.3 Materials and Methods
Fresh pig bladders used in the experiments presented in this chapter were collected 
and prepared as described in chapter 2 section 2.3.1. Experiments were performed on 
intact and urothelium-denuded tissue strips of approximately 3x3x1 Omm from the dome, 
body and trigone regions of the pig bladder. Tissue strips were set up in tissue baths 
and allowed to equilibrate, as described in chapter 2 section 2.3.4 for 60 minutes under 
a load of 1g. Following equilibration, baseline measurements of amplitude and 
frequency of PCs were taken. Following this, the strips were incubated with low 
cumulative concentrations of carbamylcholine chloride (carbachol - CCh) at 
concentrations of 0.01, 0.05, 0.07, 0.1, 0.2, 0.3, 0.4 and 0.5pM. Strips were incubated 
with each concentration of CCh for 10 minutes prior to addition of the next 
concentration. Amplitude and frequency measurements of PCs were taken during the 
last 5 minutes with each concentration as described in chapter 2 section 2.3.5.
In separate experiments, the effect of muscarinic antagonists on basal phasic activity 
was investigated. Intact and denuded bladder strips from the dome, body, and trigone 
were set up in tissue baths as described above and allowed to equilibrate under a load 
of 1g for 30 minutes. The tissues were then incubated with different concentrations of 
muscarinic antagonists for 30 minutes and the amplitude and frequency of PCs was 
measured. Methoctramine was used at concentrations of 100nM, 300nM and 1pM 
whereas 4-Diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP) was used at 3, 
10 and 30nM concentrations. Each tissue was subjected to only one concentration of 
antagonist.
The effect of muscarinic antagonists on CCh-modulated PCs was also investigated. 
The tissues were incubated with the muscarinic antagonist for 30 minutes after which 
cumulative concentrations of CCh were added, as above. Measurement of the 
amplitude and frequency of PCs was then performed.
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3.4 Data and Statistical Analysis
Amplitude and frequency measurements were recorded as described in chapter 2 
section 2.3.5. Baseline measurements were taken during the last 5 minutes of the 60 
minute equilibration period. To investigate the effect of CCh, measurements of 
amplitude and frequency were taken during the last 5 minutes with each concentration 
of the drug. To calculate the change in amplitude, the baseline measurements before 
addition of the drug were subtracted from the amplitude and frequency measurements 
in the presence of the drug. Statistical comparison for the effect of carbachol on PCs 
was via repeated measures one-way ANOVA with Dunnett's post-test comparing all 
data vs. control (baseline). A Student t-test was used to compare amplitude and 
frequency data between intact vs. denuded strips. Analysis of the effect of 
methoctramine and 4-DAMP on basal PCs was performed using a one-way ANOVA 
with a Bonferroni post hoc test. Inter-tissue comparison between the three bladder 
regions was performed via a 2-way ANOVA with a Bonferroni post hoc test.
Intra-tissue differences in the data from CCh modulated experiments were analysed 
using a one-way ANOVA, while inter-tissue comparisons were made using a 2-way 
ANOVA, both performed with Bonferroni post hoc tests. All data presented in this 
chapter is shown as mean ± SEM. Statistical significance was measured at 95% 
confidence interval with p values < 0.05 considered significant. Experiments on dome 
and body regions were performed on n=7 strips for each bladder region whereas for 
the trigone n=5 strips ere used (each strip from a separate bladder).
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3.5 Results
3.5.1 Effect of CCh on the amplitude of basal phasic contractions
Isolated strips from all bladder regions developed PCs. This phasic activity was 
significantly increased by the addition of increasing concentrations of the muscarinic 
agonist CCh. Figures 3.1 - 3.3 show experimental traces of intact and denuded strips 
from the dome, body and trigone regions respectively. The effect of increasing 
concentrations of CCh on the amplitude of PCs is shown in figures 3.4 - 3.6. In intact 
strips from the dome region, CCh significantly increased the amplitude of PCs at 0.01 - 
0.5pM CCh concentrations (Figure 3.4a) when compared to control, whereas in the 
denuded strips, CCh significantly increased the amplitude of PCs at 0.05 - 0.5pM CCh 
(Figure 3.4b). In the body region, CCh again significantly increased amplitude of PCs 
in intact strips at 0.2pM - 0.5pM CCh (figure 3.5a), whereas in their denuded 
counterparts, amplitude was significantly increased at 0.05 - 0.5pM CCh versus the 
control (Figure 3.5b). CCh did not significantly increase the amplitude of PCs in strips 
of intact trigone (Figure 3.6a). In denuded strips of trigone on the other hand CCh 
significantly increased amplitude at 0.01 - 0.1 pM CCh, although this effect was not 
observed at the higher concentrations of CCh (Figure 3.6b).
3.5.2 Effect of CCh on the frequency of basal phasic contractions
The effect of CCh on the frequency of PCs is shown in figures 3.7 - 3.9. Analysis of 
intact strips from the three bladder regions showed that CCh had no significant effect 
on the frequency of PCs in the dome and trigone regions (Figure 3.7a and Figure 3.9a). 
On the other hand, in the body regions, CCh significantly increased the frequency of 
PCs only at 0.07pM and 0.2pM CCh concentration (Figure 3.8a). In denuded strips, 
CCh significantly increased the frequency of PCs in the dome (Figure 3.7b) between 
0.03pM - 0.3pM CCh while in denuded strips of the body CCh significantly increased 
the frequency of PCs between 0.05pM - 0.2pM CCh (Figure 3.8b). CCh had no effect 
on the frequency of PCs in denuded strips from the trigone region.
Comparisons of the effect of CCh on PCs between intact vs. denuded strips showed 
that in the dome (Figure 3.10a) and trigone (Figure 3.10c) regions denuded strips had 
significantly greater amplitude of PCs than their intact counterparts. In the body 
(Figure 3.10b), the difference was not significant between intact and denuded strips. 
Comparisons of the effect of CCh on the frequency of PCs between intact and denuded 
strips showed that in the dome (Figure 3.11b) denuded strips had significantly greater 
frequency at 0.05pM, 0.07pM and 0.1 pM CCh, although no significant differences were
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observed between intact and denuded strips from the body and trigone (Figure 3.11 a 
& c respectively).
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Figure 3.4 - Effect of increasing concentrations of carbachol on the amplitude of 
phasic contractions in bladder strips from a) intact and b) denuded dome. All 
data are presented as mean ± SEM; *p<0.05, **p<0.01, ***p<0.001 vs. control (OpM 
CCh); n-7.
88
0.004-.
******0  0.003-
3</)(/) **
0 .002-
U)
£
^  0.001-
0.000 I I1 ■ ■ I T TT T
0.01 0.1 1
Log [CCh] nM
a)
0.005-1
***
0.004- **
**
3  (/) 0.003- ■— 3
I "  °^  CJ) 0.002-
0.001-
10.1
Log [CCh] )iM
b)
Figure 3.5 - Effect of increasing concentrations of carbachol on the amplitude of 
phasic activity in bladder strips from a) intact and b) denuded body region. All 
data are presented as mean ± SEM; *p<0.05, **p<0.01, ***p<0.0001 vs. control 
(OpM CCh); n-7.
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Figure 3.6 - Effect o f increasing concentrations of carbachol on the amplitude of 
phasic activity in bladder strips from a) intact, b) denuded trigone region. All 
data are presented as mean ± SEM; **p<0.01, ***p<0.0001 vs. control (OpM CCh); 
n=5.
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Figure 3.7 - Effect o f increasing concentrations of carbachol on the frequency of 
phasic contractions on bladder strips from a) intact and b) denuded dome region. 
All data are presented as mean ± SEM; *p<0.05, **p<0.01, ***p<0.001 vs. control 
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Figure 3.8 - Effect of increasing concentrations of carbachol on the frequency of 
phasic contractions in bladder strips from a) intact and b) denuded body region. 
All data are presented as mean ± SEM; *p<0.05, **p<0.01 vs. control (OpM CCh); 
n-7.
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Figure 3.9 - Effect of increasing concentrations of carbachol on the frequency of 
phasic contractions in bladder strips from a) intact and b) denuded trigone 
region. All data are presented as mean ± SEM, n=5.
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Figure 3.10 - Effect of increasing concentrations of carbachol on the amplitude of 
PCs in intact and denuded strips from the pig bladder a) dome, b) body and c) 
trigone regions. Data are presented as mean ± SEM, n=6, *p<0.05, **p<0.01 and 
***p<0.0001 vs. corresponding concentration of CCh in intact strips; Note the 
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3.5.3 Effect of muscarinic antagonists on the amplitude and frequency
O F  B A S A L  PCS
Figures 3.12 and 3.13 respectively show the effect of methoctramine on the amplitude 
and frequency of basal PCs in intact and denuded strips from the three bladder regions. 
Incubation with methoctramine had no significant effect on either the amplitude or the 
frequency of basal PCs in any of the different regions of the bladder, at all 
concentrations investigated.
The effect of 4-DAMP on the amplitude and frequency of basal PCs in the different 
bladder regions is presented in figures 3.14 and 3.15 respectively. Analysis of the 
amplitude data showed that no significant differences were observed in the presence 
vs. the absence of 4-DAMP in both intact and denuded tissue strips (Figure 3.14). 
Similarly, 4-DAMP also had no effect on the frequency of PCs in both intact and 
denuded strips from the three bladder regions (Figure 3.16).
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Figure 3.12 - Effect o f increasing concentrations of methoctramine on the 
amplitude of PCs in intact and denuded strips from the pig bladder a) dome, b) 
body and c) trigone regions. Controls have been treated with vehicle only, n=6, 
data are presented as mean ± SEM. Note the differences in the scales used.
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Figure 3.13 - Effect o f increasing concentrations of methoctramine on the 
frequency of PCs developing in intact and denuded strips from the pig bladder a) 
dome, b) body and c) trigone regions. Controls have been treated with vehicle 
only, n=6, data are presented as mean ± SEM
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presented as mean ± SEM.
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Figure 3.15 - Effect of 4-DAMP on the frequency of basal PCs in intact and 
denuded strips from the pig bladder a) dome, b) body and c) trigone regions. 
Controls have been treated with vehicle only, n=6, data are presented as mean ± 
SEM.
100
3 .5 .4  In v e s tig a tio n  o f  th e  m usca rin ic  re c e p to r  sub types  m edia ting th e
EFFECT OF CCH ON PHASIC CONTRACTIONS.
The effect of methoctramine on the amplitude of CCh-modulated phasic contractions in 
the different bladder regions is presented in figures 3.16 - 3.18. No significant 
differences were observed in the effects of CCh on amplitude of PCs in the absence 
and presence of different concentrations of methoctramine in intact strips from the 
dome, body and trigone (figures 3.16a, 3.17a & 3.18a respectively). This was also the 
case for denuded tissue strips (figures 3.16b, 3.17b & 3.18b) from the three regions.
Methoctramine also had no effect on the frequency of CCh-modulated phasic 
contractions of intact strips from the body (Figure 3.21a) and trigone (Figure 3.22a) 
regions. In intact strips of dome, methoctramine significantly decreased the frequency 
of PCs when used at 300nM concentration (0.03pM CCh). Methoctramine similarly 
showed no effect on the frequency of CCh-modulated PCs of denuded strips from the 
dome (Figure 3.20b) and body (Figure 3.21b) regions, whereas in the denuded strips of 
the trigone, there was a significant decrease with 300nM methoctramine (0.1 pM CCh - 
Figure 3.22b).
Figures 3.22 - 3.24 show the effect of 4-DAMP on the amplitude of CCh-modulated 
phasic contractions. 4-DAMP had no effect on the amplitude of PCs in intact strips 
from the dome, body or trigone (figures 3.22a, 3.23a & 3.24a respectively). 4-DAMP 
also had no significant effect on the amplitude of PCs in denuded strips from the body 
and trigone regions (figures 3.23b & 3.24b). In contrast, 4-DAMP significantly 
increased the amplitude of PCs in strips from the dome at 3nM 4-DAMP (0.1 pM CCh - 
Figure 3.22b).
Analysis of the effect of 4-DAMP on frequency of CCh-modulated PCs are shown in 
figures 3.25 - 3.27. In the dome region (Figure 3.26a), the frequency of PCs in intact 
strips was significantly decreased by 10nM 4-DAMP (0.1 pM CCh), although in the body 
(Figure 3.26a) and trigone (Figure 3.27a) there was no effect. There was also no 
significant effect observed with 4DAMP on the frequency of PCs in denuded strips from 
the body and trigone (Figure 3.26b & Figure 3.27b respectively) with strips from the 
dome showing a significant decrease when treated with 30nM 4-DAMP (Figure 3.25b).
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Figure 3.16 - Effect o f increasing concentrations of methoctramine on the 
amplitude of CCh-modulated PCs in a) intact and b) denuded strips from the pig 
bladder dome. Data are presented as mean ± SEM, n=6. Note the difference in 
scales used. The effect of antagonist in the following graphs only show two 
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of the response.
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Figure 3.19 - Effect of increasing concentrations of methoctramine on the 
frequency of CCh-modulated PCs in a) intact and b) denuded strips from the pig 
bladder dome. Data are presented as mean ± SEM, n=6, *p<0.05 vs. control.
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Figure 3.20 - Effect o f increasing concentrations of methoctramine on the 
frequency of CCh-modulated PC in a) intact and b) denuded strips from the pig 
bladder body. Data are presented as mean ± SEM, n=6.
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Figure 3.21 - Effect of increasing concentrations of methoctramine on the 
frequency of CCh-modulated PCs in a) intact and b) denuded strips from the pig 
bladder trigone. Data are presented as mean ± SEM, n=6, *p<0.05 vs. control.
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Figure 3.25 - Effect of increasing concentrations of 4DAMP on the frequency of 
CCh-modulated PCs in a) intact and b) denuded strips from the pig bladder dome. 
Data are presented as mean ± SEM, n=6, *p<0.05, **p<0.01 vs. control.
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Figure 3.26 - Effect o f increasing concentrations of 4DAMP on the frequency of 
CCh-modulated PCs in a) intact and b) denuded strips from the pig bladder body. 
Data are presented as mean ± SEM, n=6.
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Figure 3.27 - Effect of increasing concentrations of 4DAMP on the frequency of 
CCh-modulated PCs in a) intact and b) denuded strips from the pig bladder 
trigone. Data are presented as mean ± SEM, n=6.
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3.6 D iscussion
The urinary bladder has been shown to contain a heterogeneous population of M2 and 
M3 muscarinic receptors. There is a lot of information on the function of these 
receptors in the detrusor compared to the other areas of the bladder where they are 
found. In normal conditions, bladder contractility is under parasympathetic nervous 
system control whereby the primary input is via acetylcholine-induced excitation of 
post-junctional muscarinic receptors. Determination of the muscarinic receptors 
responsible for these contractions in the bladder has been mainly due to use of 
relatively subtype selective muscarinic agents (Abrams et al., 2006). All of the 
muscarinic receptor subtypes are present in the detrusor of several species including 
humans but the M2 and M3 receptor subtypes are predominant with the M2 
outnumbering the M3 receptor at a 3:1 ratio (Longhurst et al., 1995; Wang et al., 1995; 
Yamaguchi et al., 1996; Baselli et al., 1999; Yamanishi et al., 2000). The minority M3 
subtype is responsible for the direct detrusor contraction In vitro (Sellers et al., 2000; 
Chess-Williams et al., 2001; Fetscher et al., 2002).
Pharmacological characterization of the five muscarinic receptor subtypes has been 
undermined due to the lack of agonist and antagonist selectivity for any single receptor 
subtype. Antagonist affinities obtained using radioligand binding techniques combined 
with affinity constants obtained from functional experiments have been used to define 
and differentiate the different muscarinic receptor subtypes. Mi receptors have a high 
affinity for pirenzepine and a low affinity for methoctramine. M2 receptors on the other 
hand have a high affinity for methoctramine and low affinity for pirenzepine and 4- 
DAMP. M3 receptors exhibit a high affinity for 4-DAMP and low affinity for 
methoctramine. M4 receptors have a relatively high affinity for 4-DAMP and 
methoctramine thereby making it difficult to distinguish these receptors from M2 and M3. 
M5 receptors are characterized by having a moderate affinity to 4-DAMP and a low 
affinity to methoctramine (Caulfield 1993).
Receptor subtypes responsible for detrusor contractions have been determined using 
some of the antagonists listed in table 3.2. In this study, investigation of whether 
naturally occurring basal PCs in the pig bladder could be modulated cholinergically was 
performed in addition to determination of the receptor subtypes responsible for these 
bladder PCs. This was performed using methoctramine, and 4-DAMP on CCh 
modulated PC. Isolated pig bladder strips from the dome, body and trigone regions 
developed intrinsic PC when set up in the tissue baths. The PC amplitude was
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modulated by low concentrations of CCh, non-selective muscarinic agonist which 
activated the ACh receptor thereby causing smooth muscle contraction.
In the dome and body regions, in intact and denuded strips, CCh significantly increased 
the amplitude of PCs in a concentration-dependent manner. The amplitude of CCh- 
modulated PCs in the dome and body is less than in the trigone. The trigone strips 
especially denuded strips exhibited 50% greater amplitude than those from the dome 
and body. CCh modulation had a greater effect on the frequency of PCs in denuded 
strips compared to their respective intact strips in the dome and body regions whereas 
CCh had no effect on frequency in the trigone region.
The data obtained from amplitude and frequency measurements of CCh-modulated 
PCs showed that removal of the urothelium resulted in greater amplitude and
frequency. This may be due to the fact the urothelium normally may be releasing a
substance that inhibits PCs. Published data has shown that the urothelium releases an 
unidentified urothelium derived inhibitory factor (UDIF) that inhibits bladder contractions 
(Hawthorn et al., 2000). Removal of the mucosa subsequently eliminated the
possibility of UDIF release and therefore could explain the greater amplitude and
frequency of PCs. The bladder urothelium has also been shown to have a higher 
metabolic rate than the detrusor muscle (Hypolite et al., 1993) and its removal 
significantly increases the responses to a range of contractile agents (Dveksler et al., 
1987; Maggi etal., 1987; Pinna etal., 1992; Levin etal., 1995).
It is now well established that there are two main sources of ACh in the bladder : a 
neuronal tetrodotoxin (TTX) sensitive source and TTX-resistant non-neuronal source 
(Yoshida et al., 2004; Yoshida et al., 2008). Using guinea pigs and rats, Zagorodnyuk 
et al (2009) showed that in whole bladder and isolated intact bladder strips treated with 
physostigmine - an acetylcholinesterase inhibitor - powerful phasic contractions were 
recorded and not affected by TTX. The same was observed using denuded strips and 
frequency recorded was similar to intact strips. Further treatment with hyoscine - an 
antimuscarinic - significantly inhibited the frequency of contraction by up to 83 ± 6% 
suggesting that the on-going TTX resistant PC recorded is due to endogenous non­
neuronal ACh not released from the urothelium (Zagorodnyuk et al., 2009). This could 
very well possibly be the same in the denuded tissue strips whose frequency is 
decreased in the presence of muscarinic antagonists. The antagonist experimental 
data collected suggests that the basal PCs that developed may not have been due to 
endogenous ACh release, but this may not necessarily be true. One explanation for 
this is that the lack of muscarinic receptor agonists with selectivity and antagonist with
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high selectivity for a single receptor (Scarpero and Dmochowski 2003). Tissue also 
express more than one subtype which further makes the determination of the function 
of a single receptor subtype very difficult (Caulfield and Birdsall 1998).
A major drawback for the experiments performed in this chapter is the lack of 
confirmation that the basal phasic contractions were due to ACh release. This could 
have been overcome by performing confirmatory experiments using atropine which is a 
non-selective antagonist. The presence of continuing PCs validate presence of ACh 
and a possible role in PCs. A different approach would have been to add an 
acetylcholinesterase inhibitor such as neostigmine or physostigmine to prevent the 
breakdown of ACh in the tissue bath. If ACh was indeed being released, an increase in 
PCs would have confirmed this.
The effect of methoctramine and 4DAMP on CCh-modulated PCs showed no 
significant effect on the amplitude of CCh-modulated PC in all three bladder regions. 
The PCs observed in these experiments when blocked by the muscarinic antagonist 
may be due to different pathways such as CCh acting on other muscarinic subtypes 
present in the bladder. There are numerous sites at which CCh may be acting on 
making a specific determination complex. All five muscarinic receptor subtypes have 
been shown to be present in the bladder urothelium (Bschleipfer et al., 2007), in 
addition to the muscarinic receptors present in the detrusor. There is also a population 
of ICC and afferent nerves that express various receptors at which CCh can exert an 
effect. It is this heterogeneous population expressing both excitatory and inhibitory 
receptors throughout the bladder wall that complicates the task of identifying a single 
subtype responsible for PCs.
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3.7 Summary/C onclusions
These experiments have shown that:-
>  PCs in the pig bladder can be modulated cholinergically and similar to previous 
chapter results, there were some functional differences observed particularly in 
the trigone compared to the dome and body regions.
>  The muscarinic antagonist experiments suggest that basal PCs in the pig 
bladder are not due to endogenous ACh but this observation requires further 
investigation.
> Data obtained in this chapter reveals that it is not clear to determine which 
receptor subtype(s) are responsible in mediating the effects of CCh on pig 
bladder PCs.
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C h a p te r  4
In v e s tig a tio n  of  c -K it  p o s it iv e  c ells  in
THE PIG URINARY BLADDER
118
4.1 In t r o d u c tio n
The discovery of interstitial cell of Cajal (ICCs) is credited to the Spanish 
neuroanatomist and Nobel laureate Ramon y Cajal whom these cells were aptly named 
after (Cajal 1893). He described these ICCs as fibroblast-like in appearance and 
histological staining with silver nitrate and methylene blue led to the assumption that 
ICCs were primitive neurons. Advances in the fields of light and electron microscopy 
proved that these cells were neither neurons nor Schwann cells (Rolle et al., 2007). 
ICCs have been morphologically described as being spindle or stellate shaped cells 
connected via gap junctions and nerves and containing numerous mitochondria and 
intermediate filaments (Blyweert et al., 2004). The discovery that ICCs express the 
proto-oncogene c-Kit led to the development of antibodies against c-Kit and 
subsequent rapid accumulation of knowledge with regards to their function and 
localization in various tissues.
4.1.1 ICCS AND THEIR FUNCTION IN THE GASTROINTESTINAL TRACT
ICCs were first identified in the gastrointestinal (Gl) tract and early developmental 
studies using mice showed that ICCs were of great importance in the function and 
maintenance of this system. Torihashi et al. (1997) and Kluppel et al. (1998) both 
showed that ICCs and smooth muscle cells (SMCs) arise from the same mesenchymal 
precursors (Torihashi et al., 1997; Kluppel et al., 1998) but the normal development of 
ICCs is dependent on expression of the c-Kit proto-oncogene, which encodes for the 
protein KIT - a tyrosine kinase receptor. Experiments performed using mice have 
proven that expression and signalling of ICCs via the KIT receptor is essential for the 
normal development and onset of Gl electrical rhythmicity that maintains intestinal 
peristaltic waves (Torihashi et al., 1997). This pacemaker function of ICCs is strongly 
supported by their localization in tissue analysed by electron microscopy. This is 
mainly due to their close association with nerve terminals and gap junctions within the 
Gl smooth muscle cells (SMCs) suggesting a connection between nerves and muscle 
(Faussone Pellegrini et al., 1977; Yamamoto 1977). ICCs have also been shown to act 
as non-neural stretch receptors in the Gl muscle and this subsequently affects slow 
wave frequency and smooth muscle excitability (Won et al., 2005).
Several subtypes of ICCs have been described in the Gl tract with the largest density 
of ICCs occurring within the myenteric plexus (ICC-MP). This group of ICCs is 
composed of interconnected multi-polar cells whose main function is to act as 
pacemakers initiating slow wave activity in adjacent circular and longitudinal smooth 
muscles (Brading and McCloskey 2005; Komuro 2006). There are also intramuscular
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ICCs (ICC-IM) present in the intestinal muscle layer of the Gl tract and these can be 
differentiated into two groups - ICCs of the circular muscle (ICC-CM) and ICCs of the 
longitudinal muscle (ICC-LM). Both of these classes are bipolar cells distributed 
around the muscle cells and along nerve bundles (Komuro 2006). They are mainly 
involved in transmission of signals from enteric neurons to SMCs (Brading and 
McCloskey 2005). Other types of ICCs have been described in the Gl sub-mucosa 
(ICC-SM) and sub-mucosal plexus (ICC-SMP), in the deep muscular plexus (ICC-DMP) 
and within the sub-serosal layer (ICC-SS). All of these different types of ICCs have 
been demonstrated along the length of the digestive tract and their distribution patterns 
are entirely dependent on their anatomical location (Faussone-Pellegrini and Cortesini 
1985; Hagger etal., 1998; Torihashi etal., 1999).
4 .1 .2  I n t e r s t i t i a l  c e l l s  in  th e  u r in a r y  b la d d e r
Besides Gl ICCs, urinary tract ICC have been the second most widely studied. Bladder 
ICCs were first identified by Smet et al. (1996) in the human and guinea pig bladder. 
This finding was confirmed by Gillespie et al. (2004). ICC identification was possible 
due to the specific immunoreactivity of these cells to anti-c-Kit antibodies. Investigation 
of urinary bladder properties has led to the identification of a novel class of cells 
resembling the ICCs of the gut, though their physiological function in the bladder is not 
fully understood. The nomenclature or terminology used for these cells outside of the 
Gl tract has been controversial. This controversy has mainly stemmed from the fact 
that there are a number of subpopulations of these cells, leading to a heterogeneous 
population of this class of cells in the bladder wall, localized in different layers and with 
different morphologies. These cells have been referred to as interstitial cells (IC), 
interstitial-like cells, ICCs and myofibroblasts. During the "Vth International Symposium 
on ICC" held in Ireland in July 2007 the consensus was to refer to them as ICCs 
(McCloskey 2010), although within the literature this is still not consistent, and in this 
thesis bladder interstitial cells will be referred to as ICC. The definition of ICC 
encompasses cells found in various tissues, including the bladder, urethra, ureter and 
blood vessels, possessing physiological and morphological characteristics of ICC but 
not necessarily the "typical" physiological function of ICC in the Gl tract where they 
initiate contractile activity (McCloskey 2010).
ICC were originally visualized using the technique of silver staining but since then, the 
rapid accumulation of information pertaining to this novel class of cells has led to the 
development of several immuno-histological techniques to identify them (Brading and 
McCloskey 2005). Determination of ICC localization in the urinary bladder has been
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possible due to the availability of antibodies directed against a number of proteins and 
molecules expressed in these cells including c-Kit, vimentin, connexin-43, and cyclic 
guanidine monophosphate (cGMP) (Smet et al., 1996; Sui et al., 2002; Wiseman et al.,
2003). Investigation into the targets of cGMP signalling in human and guinea pig 
bladders following nitric oxide stimulation by Smet et al (1996) indicated a population of 
cells similar to gut ICCs, due to their morphological appearance. The same study also 
showed immunopositive staining for vimentin - an intermediate filament - typically 
present in ICC and other cells of mesenchymal origin, leading to speculation of ICC 
presence in the bladder (Smet et al., 1996). These findings have since been confirmed 
by Gillespie et al (2004) (Gillespie et al., 2004). Immunostaining for connexin-43 in 
conjunction with desmin has also been used to identify ICC in the basal and urothelial 
layers of the bladder (Sui et al., 2002). The use of antibodies has helped establish c- 
Kit as a selective marker for ICC since it is exclusively expressed by ICC but not by 
SMCs or fibroblasts (Maeda et al., 1992; Hirst and Ward 2003). Various studies of 
guinea pig bladder (McCloskey and Gurney 2002; Davidson and McCloskey 2005) and 
human bladder (Johnston et al., 2010) have shown ICC to be located throughout the 
bladder wall and classed into two main groups - detrusor ICC (ICC-DT) and sub- 
urothelial ICC (ICC-SU).
Detrusor ICCs are located along the boundary of smooth muscle cells and run in 
parallel to the muscle bundles (Davidson and McCloskey 2005). They can also be 
found between the muscle bundles and have close interaction with cholinergic nerves 
in this area (Kubota et al., 2011). This morphological finding supports the hypothesis 
that these ICC are ideally placed to function as pacemakers in the detrusor as well as 
convey cell-to-cell communication similar to those in the Gl tract. This hypothesis has 
not been widely accepted because isolated muscle bundles have been shown to 
independently develop PCs.
Sub-urothelial ICC are sometimes referred to as myofibroblasts due to their 
characteristic spindle and stellate morphology, with several branches emanating from a 
central soma, and the fact that they form a well-connected network linked via gap 
junctions (Sui et al., 2002). This network is thought to be involved in bladder signalling 
pathways from the urothelium and may modulate the sensory processes involved in the 
initiation of the micturition reflex (Sui et al., 2002; Grol et al., 2009) see Figure 4.1. As 
previously stated in chapter 2, the urothelium is capable of releasing various mediators, 
which may act on bladder ICC and their different receptors. Sub-urothelial ICC have 
been shown to possess muscarinic M3 receptors (Grol et al., 2009), making them an 
ideal site for urothelially released mediators such as ACh. Within the sub-urothelium
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layer is an extensive microvasculature network and within this network, a novel class of 
perivascular ICC has been identified in the human bladder. Dual labelling of human 
bladder biopsies with phalloidin-tetramethylrhodamine, which binds filamentous actin, 
and anti-Kit showed close connection between ICC, small arterioles and venules, in 
which Kit positive cells ran parallel along the blood vessels on the outer surface 
(Johnston et al., 2010). The action of mediators on ICC combined with the network of 
nerves in and amongst smooth muscle bundles, may allow for rapid relay of information 
and subsequent development of bladder contractions. Thus ICC may also play a role 
in the development of bladder PCs.
The location of ICC in the bladder is for the most part consistent between different 
species. In the guinea pig bladder three populations of ICC have been described, 
located in the connective tissue between muscle bundles, adjacent to the detrusor 
bundle boundary and scattered among and within smooth muscle cells (Hashitani et al.,
2004). cGMP-positive ICCs have also been shown to be present beneath the 
urothelium and on the outer muscle layers of guinea pig bladders (Gillespie et al., 2004; 
Gillespie et al., 2005). In the normal human bladder, ICCs have been shown to be 
present in between muscle bundles and in the sub-urothelium layer (Piaseczna 
Piotrowska et al., 2004; Van der Aa et al., 2004). Mouse bladder ICCs have been 
shown in between muscle bundles and in the outer part of the detrusor layer but not in 
the urothelium or sub-urothelium layers (Lagou et al., 2006).
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Figure 4.1 - Localization of ICC in the sub-urothelium and detrusor layers of the 
guinea pig urinary bladder wall and the relationship with nerve fibres and 
detrusor. ATP - adenosine triphosphate, NO - nitric oxide, SCF - stem cell factor, 
ACh - acetylcholine. Adapted from (Kubota et al., 2011).
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4 . 1 .3  C -K /r  STRUCTURE AND FUNCTION
The c-Kit proto-oncogene encodes for a type III receptor tyrosine kinase, Kit, and has 
been shown to be structurally similar to platelet-derived growth factor receptors 
(PDGFRs) (Kitamura and Hirotab 2004). It is primarily made up of an extracellular 
ligand binding domain composed of five immunoglobulin-like repeats, a hydrophobic 
trans-membrane domain, a negative regulatory juxtamembrane domain and finally a 
tyrosine kinase domain split into two regions, namely TK-1 and TK-II domains 
separated by a variable length insert sequence (figure 4.3) (Kitamura and Hirotab 2004; 
Webster et al., 2006). In humans, there are four isoforms of c-Kit that have been 
described, due to alternative RNA splicing, and these are characterised by the 
presence or absence of a serine residue in the kinase insert region (Lennartsson and 
Ronnstrand 2006). Stem cell factor (SCF) is the activating ligand for c-Kit and it is 
expressed by endothelial and fibroblast cells throughout the body. c-Kit expression on 
the other hand is restricted and primarily located on mast cells, hematopoietic cells, 
melanocytes, ICCs, vascular endothelial cells, testis, breast glandular epithelial cells, 
sweat glands and the brain (Lennartsson and Ronnstrand 2006). SCF exists as two 
splice forms - a membrane associated form containing a transmembrane domain and a 
soluble form. The membrane associated isoform has been shown to induce prolonged 
c-Kit phosphorylation (Huang et al., 1992; Miyazawa et al., 1995). Binding of the SCF 
to c-Kit activates the receptor and results in the dimerization of two receptor monomers 
(Blume-Jensen et al., 1991) thereby bringing two c-Kit tyrosine kinase domains close to 
each other leading to autophosphorylation of tyrosine residues primarily outside the 
kinase domains but also within on residues 823 and 900 (Lennartsson et al., 2003; 
Voytyuk et al., 2003; Maulik et al., 2004). Autophosphorylation leads to two main 
events - increased kinase activity and creation of high affinity interaction sites for 
proteins (Pawson 1995). Interaction of the proteins with the activated receptor results 
in phosphorylation and initiation of signal transduction of numerous pathways 
(Lennartsson and Ronnstrand 2006).
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Figure 4.3 - Structure of the receptor tyrosine kinase c-Kit showing the two 
kinase domains TKI and TKII - Adapted from (Webster et al., 2006).
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4 .1 .4  IC C  IN BLADDER PATHOLOGICAL CONDITIONS
The extensive research that has been performed on ICCs of the Gl tract has attributed 
various motility disorders such as gastroparesis, chronic idiopathic intestinal pseudo­
obstruction and gastrointestinal stromal tumours (GISTs) to the loss of ICC function in 
different regions of the digestive tract (Sanders 2006). Building on the knowledge of 
ICCs in the Gl tract has led to a rapid advancement and collection of information on 
bladder ICC and although the precise function of these cells in normal bladder function 
is still not clear, it has been suggested that these cells may have a greater role in 
pathological conditions of the bladder, such as overactive bladder. Biers et al. 
demonstrated that bladders from patients with OAB exhibited significantly more c-Kit 
positive ICC in comparison to normal bladders, thereby suggesting that bladder ICC 
may play some kind of role in the pathophysiology of OAB (Biers et al., 2006). Using a 
guinea pig bladder outlet obstruction (BOO) model, Kubota et al. (2008) showed that 
animals with BOO displayed increased voiding frequency and an increased incidence 
of non-voiding contractions. The sub-urothelium thickness was also increased and 
immunohistochemical staining confirmed an increased expression of ICC in the sub- 
serosal layer of the BOO bladders compared to normal bladders. It is thought that the 
altered distribution of ICC may contribute to bladder overactivity pathophysiology 
(Kubota et al., 2008).
In OAB patients, there is increased urgency and frequency which may be explained by 
increased electrical coupling between SMCs via ICC gap junctions, leading to the 
enhanced excitability of the detrusor muscle as shown in Figure 4.1 (Brading 1997a). 
Subsequently, spontaneous excitation due to phasic activity may propagate down the 
muscle bundles by a longer distance, causing synchronous contraction thereby 
increasing intravesical pressure within the bladder and the sudden urgency (Hashitani 
2006).
Imatinib mesylate (Gleevec®, Glivec®, Novartis Pharmaceuticals) - a 2- 
phenylaminopyrimidine derivative - commonly known as imatinib is a specific tyrosine 
kinase enzyme inhibitor which is used in the treatment of c-Kit positive gastrointestinal 
stromal tumours (GISTs) and Philadelphia chromosome-positive chronic myeloid 
leukaemia (CML) (Kubota et al., 2004). Imatinib is specific for tyrosine kinase domains 
in the Abelson proto-oncogene (abl), c-Kit and PDGFRs. The active sites of tyrosine 
kinases have a binding site for ATP and are actively involved in a process known as 
tyrosine phosphorylation. This process entails the transfer of an ATP terminal 
phosphate to tyrosine residues on its substrates. The mechanism of action of imatinib
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involves its binding to the ATP-binding site and inhibition of the tyrosine kinase's ability 
to phosphorylate its substrates thereby inhibiting the enzymatic activity (Takimoto and 
Calvo 2008). Imatinib has been shown to suppress phasic contractility of smooth 
muscle in various organs including human uterus and small intestines (Popescu et al., 
2006), guinea pig bladder (Kubota et al., 2004; Kubota et al., 2006) and the guinea pig 
gall bladder (Lavoie et al., 2007)). In a study by Vahabi et al., imatinib decreased the 
amplitude and frequency of carbachol induced PCs in both normal and streptozotocin- 
induced diabetic rat bladder strips in a concentration dependent manner (Vahabi et al., 
2011c). In human bladders, imatinib also inhibited EFS evoked smooth muscle 
contraction and spontaneous activity in overactive detrusor with the effect being less 
significant in normal detrusor tissue (Biers et al., 2006).
4 .1 .5  IMMUNOHISTOCHEMISTRY
immunohistochemistry (IHC) is a histological technique used to determine the 
distribution and localization of various biomarkers expressed in different regions of 
histological tissue. This technique employs the principle of antigen-antibody interaction 
and is now widely used in various medical diagnoses including detection of abnormal 
cells in tissue with cancerous tumours. The visualization of the antigen-antibody 
reaction is made possible by the use of fluorophores bound to the antibodies which can 
be viewed using a fluorescent microscope. There are two main IHC methods that are 
commonly used -  direct and indirect IHC.
4.1.5.1 Direct Method
This is a one-step staining method that utilizes a single antibody linked to a fluorophore 
such as Fluorescein Isothiocyanate (FITC). The antibody recognizes the target 
molecule (antigen) and binds to it and the attached fluorophore is detected by 
microscopy.
4.1.5.2 Indirect Method
The indirect method differs from the direct method due to the fact that it uses two 
antibodies making it more sensitive since the fluorescent signal is amplified. The 
primary antibody is unlabelled and binds to the antigen of interest. The secondary 
antibody, which is raised against the IgG of the animal species in which the primary 
antibody has been raised in, is labelled with the fluorophore and reacts with the primary 
antibody to form a complex that can be viewed under the fluorescent microscope.
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4.1.5.3 Confocal Scanning Laser Microscopy (CSLM)
High resolution optical images with depth selectivity can be obtained using confocal 
scanning laser microscopy (CSLM). This microscopy technique employs a process 
known as optical sectioning that makes it possible to obtain in-focus images from 
selected depths. As the name suggests, a laser beam is passed through a light source 
aperture and an objective lens is used to focus this beam into a small focal volume on 
the surface of a specimen which in this case is fluorescent (Figure 4.4). The light 
reflected from the specimen is collected by the objective lens and directed onto a beam 
splitter which directs a portion of this light into a detection apparatus. In the case of 
fluorescent microscopy, the detection apparatus contains a filter which effectively 
blocks the original excitation wavelength and allows the fluorescent wavelength across 
through a pinhole. This light intensity is detected by a photomultiplier tube thereby 
transforming the light signal into an electrical signal which is effectively recorded and 
viewed on a computer as one pixel. As the laser scans over the plane of interest -  in 
this case the slide containing the stained sample tissue -  a whole image is thus 
obtained pixel by pixel (Claxton et al., 2011). The images presented in this chapter 
were obtained using a Zeiss LSM 510 scanning laser microscope.
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Figure 4.4 - Schematic representation of the principal components and optical 
pathway utilised in a scanning laser confocal microscope. Adapted from
(Claxton et a!., 2011).
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4.2 Chapter A ims
The aims of this chapter were:-
>  Investigate the role of ICC in phasic contractions of the dome, body and 
trigone regions of the pig bladder.
>  To identify and localise c-kit positive cells in the pig urinary bladder
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4 .3  M a t e r ia l s  a n d  M e th o d s
4 .3 .1  F u n c t io n a l  in v e s t ig a t io n  o f  th e  r o l e  o f  c -K it  p o s it iv e  c e l l s  in  t h e
PIG BLADDER
Bladders for these experiments were collected and prepared as described in Chapter 2 
section 2.3.1 and placed in cold (4°C) Krebs' buffer prior to experiments being 
performed. Experiments were performed on intact and denuded strips from the dome, 
body and trigone regions of the pig urinary bladder.
Tissue strips of approximately 3 x 3 x 10mm were suspended in tissue baths using 
non-absorbable surgical suture silk and allowed to equilibrate for a period of 60 
minutes. Strips were bathed in Krebs' buffer maintained at 37°C and continuously 
bubbled with 95% 0 2/5% C 02. Tissues were washed with fresh Krebs' buffer every 15 
minutes for the duration of the equilibration period. After 60 minutes, the tissue strips 
were incubated with cumulative concentrations of imatinib mesylate (imatinib) at 
concentrations of 1, 5, 10, 20 and 50pM. Tissues were incubated with each 
concentration for 20 minutes before addition of the next concentration. In control 
experiments, an equal volume of vehicle (dH20 ) was added in place of the drug. After 
the final concentration (50pM), the tissues were washed and left for 2-3 minutes and 
then demounted and the wet tissue weight recorded.
In separate experiments carbachol (CCh) was used to increase phasic contractions 
(PCs) and tissues were then incubated with increasing cumulative concentrations of 
imatinib as above. Experimental traces from both protocols are shown in figure 4.5.
4 .3 .2  IMMUNOHISTOCHEMISTRY OF THE PIG BLADDER
4.3.2.1 Tissue Preparation for immunohistochemistry
Tissue pieces of approximately 2 x 2cm isolated from the dome and body region and 1 
x 1cm from the trigone region were prepared as described in chapter 2 section 2.3.6.1 
and shown in figure 2.4. Prior to sectioning on the cryostat, tissues were removed and 
stored in -20°C, and then the frozen liver-bladder-liver sandwich tissue blocks were 
placed in a cryostat maintained at -20°C for 30 minutes. 10 and 12 micron thick 
sections were cut and placed on polylysine coated slides and stored in tissue slide 
chambers at -20°C until used for immuno-histochemical staining.
4.3.2.2 Optimisation of Immunohistochemistry Protocol
IHC optimisation was performed to ensure the immuno-detection of the specific 
antigens of interest in the bladder tissue. Optimal conditions were determined for
1 3 2
tissue section thickness, method of fixation and antibody incubation times and 
concentrations for each individual antibody.
10 and 12 micron thick sections were used for the IHC optimisation. Two different 
fixation protocols were also used. Briefly, method 1 involved immersing slides in cold 
acetone for 2 minutes and air drying prior to IHC staining. Method 2 involved fixing 
slides using 4% PFA for 15 minutes then washing slides in 1X PBS for 10 minutes. 
Slides were subsequently placed in ice cold methanol (4 minutes), ice cold acetone (2 
minutes) and finally washed in 1X PBS and allowed to air dry at RT prior to IHC 
staining (See section 2.3.6 for full protocol).
For antibody optimisation, 1 hr and overnight incubation times were investigated at 
different concentrations for each antibody. For the smooth muscle actin antibody 
optimisation, concentrations of 1:100 and 1:200 were used, with concentrations of 
1:150 and 1:300 for both c-Kit and vimentin.
4.3.2.3 Immunohistochemistry protocol
Frozen sections were removed from the freezer (-20°C) and left to warm up to room 
temperature (RT) for 20 minutes. The slides were fixed in ice cold (-20°C) acetone for 
ten minutes and left to air dry. A hydrophobic delimiting barrier pen was used to outline 
around the tissue to minimize the amount of reagents used. Once completely dry, the 
slides were blocked with a 5% donkey serum (DS) in 1% bovine serum albumin (BSA) 
solution for 45 minutes at RT. Primary antibodies (Abeam, Cambridge, U.K - Table 4.1) 
were diluted in phosphate buffered saline (PBS) with 0.3% DS and 180pL per tissue 
section was added on to the sections immediately after blocking and incubated 
overnight at 4°C in a humidified chamber. The slides were then washed 3 times in 1X 
PBS for 5 minutes each wash and the secondary antibodies (Invitrogen U.K - Table 
4.1), diluted in 1% BSA in 1X PBS were added at 180pL per tissue section for 1 hour at 
RT in the humidified chamber. Two more washes were performed with 1X PBS and the 
slides were subsequently immersed in 1% Sudan Black B (SBB) for 5 minutes in the 
dark at RT and then washed 8-10 times with 1X PBS until the washes ran clear. The 
slides were covered in foil and mounted with cover slips using vectorshield hard set 
mounting medium with DAPI (Vector laboratories, Peterborough, U.K.). Finally the 
slides were sealed using clear nail varnish, placed in a slide holder wrapped in foil and 
stored at 4°C ready for confocal laser microscopy.
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4
4.4 Data and Statistical A nalysis
Amplitude and frequency of PCs were recorded and measured as described in chapter 
2 section 2.3.5. Measurements for these experiments were taken during the last 5 
minutes of the equilibration period for baseline, and then during the last 5 minutes with 
each concentration of imatinib. All data are presented as mean ± SEM. Amplitude is 
shown as absolute tension per mg of tissue and frequency as the number of contractile 
events within the 5 minute measurement period. Intra-tissue statistical analysis of 
baseline vs. effects of imatinib in the different bladder regions was performed using a 
Student's t test. A Student's t test was also performed to compare responses in intact 
vs. denuded tissue strips. Comparison of responses in the different bladder region was 
performed via repeated measures one way ANOVA with a Bonferroni post hoc test. P 
values < 0.05 were considered significant.
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4.5 Results
4 .5 .1  F u n c t io n a l in v e s tig a tio n  o f  th e  r o l e  o f  c -K it  p o s itiv e  c e l l s  in th e
PIG BLADDER
The effect of imatinib on the phasic contractions of isolated pig bladder strips was 
investigated. Representative experimental traces showing the effect of imatinib on 
naturally occurring PCs in the different bladder regions are presented in figure 4.5. At 
all concentrations investigated, Imatinib exhibited no effect on the amplitude of PCs in 
both intact and denuded strips of the dome, body and trigone regions (figures 4.6, 4.7 
and 4.8 respectively). Statistical comparison of intact strips treated with cumulative 
concentrations of imatinib (1 - 50pM) vs. control between all the 3 bladder regions 
showed no significant differences observed. This was also mirrored in comparisons 
performed on denuded tissue strips between all 3 regions as well.
Analysis of the effect of imatinib on the frequency of PCs in intact strips from the dome, 
body and trigone is presented in Figure 4.9a, Figure 4.10a and Figure 4.11a. No 
significant effect of imatinib was observed in intact strips from the three bladder regions. 
Similarly, analysis of frequency measurements performed on denuded tissue strips 
from the dome, body and trigone (Figure 4.9b, Figure 4.10b and Figure 4.11b 
respectively) also showed that imatinib had no significant effect on the number of 
contractile events measured.
Figure 4.12 shows sample experimental traces of the effect of imatinib on CCh 
modulated PCs across the three bladder regions. Imatinib had no effect on neither the 
amplitude (figures 4.13 - 4.15) nor the frequency (figures 4.16 - 4.18) of CCh 
modulated PCs from both intact and denuded bladder strips of the dome, body and 
trigone regions.
Experiments performed to evaluate the effect of the vehicle (data not shown) revealed 
that in both intact and denuded tissue strips from all three bladder regions, there was 
no significant effect on the amplitude and frequency of PCs and CCh modulated PCs.
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Figure 4.5 - Representative traces showing the effect o f imatinib on phasic 
contractions from intact and denuded a) dome, b) body and c) trigone bladder 
regions.
Q) 0.0020n3W(/)
0.0015-
o
o>
*o> 0.0010-
a>■o3 0.0005-
Q.
< 0.0000-
T
1 5 10 20 50
Imatinib Concentration (\iM)
a)
0.0020-1
0 3(0
S 0.0015H
0.0010-
=  0.0005-
0.0000 0 1 5 10 20 50
Imatinib Concentration (|iM)
b)
Figure 4.6 - Effect of imatinib on the amplitude of PCs (normalised for tissue 
weight) in a) intact and b) denuded strips of pig bladder dome. All data are 
presented as mean ± SEM, n=6.
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Figure 4.7 - Effect of imatinib on the amplitude of PCs (normalised for tissue 
weight) in a) intact and b) denuded strips of pig bladder body. A ll data are 
presented as mean ± SEM, n=6.
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Figure 4.8 - Effect of imatinib on the amplitude of PCs (normalised for tissue 
weight) in a) intact and b) denuded strips o f pig bladder trigone. All data are 
presented as mean ± SEM, n=6.
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Figure 4.9 - Effect of imatinib on the frequency of PCs (normalised for tissue 
weight) in a) intact and b) denuded strips of pig bladder dome. All data are 
presented as mean ± SEM, n=6.
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Figure 4.10- Effect of imatinib on the frequency of PCs (normalised for tissue 
weight) in a) intact and b) denuded strips of pig bladder body. All data are 
presented as mean ± SEM, n=6.
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Figure 4.11 - Effect o f imatinib on the frequency of PCs (normalised for tissue 
weight) in a) intact and b) denuded strips of pig bladder trigone. All data are 
presented as mean ± SEM, n=6.
1 4 3
Intact
Denuded
i  l  5:40 1:15:00 1:23:20 1:31:40 1:40:00 1:48:20 1:56:40 2:05:00 2:13:20 2:21:40 2:30:00 2:38:20 2:46:40 2:55:00 3:03:20 3:11:' jg
Intact
Denuded
V t  16:40 1:15:00 1:23:20 1:31:40 1:40:00 1:43:20 1:56:40 2:05:00 2:13:20 2:21:40 2:30:00 2:38:20 2:46:40 2:55:00 3:03:20 3:111 *  1 3:2
c) 5 Intact
Denuded
Figure 4.12 - Representative traces showing the effect o f imatinib on CCh 
modulated phasic contractions from intact and denuded a) dome, b) body and c) 
trigone bladder regions.
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Figure 4.13 - Effect of imatinib on the amplitude of CCh modulated PCs 
(normalised for tissue weight) in a) intact and b) denuded strips o f pig bladder 
dome. All data are presented as mean ± SEM, n-4.
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Figure 4.14 - Effect o f imatinib on the amplitude of CCh modulated PCs 
(normalised for tissue weight) in a) intact and b) denuded strips o f pig bladder 
body. All data are presented as mean ± SEM, n-4.
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Figure 4.15 - Effect o f imatinib on the amplitude of CCh modulated PCs 
(normalised for tissue weight) in a) intact and b) denuded strips of pig bladder 
trigone. All data are presented as mean ± SEM, n=3.
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Figure 4.16 - Effect o f imatinib on the frequency of CCh modulated PCs 
(normalised for tissue weight) in a) intact and b) denuded strips of pig bladder 
dome. All data are presented as mean ± SEM, n=4.
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Figure 4.17- Effect of imatinib on the frequency of CCh modulated PCs 
(normalised for tissue weight) in a) intact and b) denuded strips o f pig bladder 
body. All data are presented as mean ± SEM, n=4.
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Figure 4.18- Effect of imatinib on the frequency of CCh modulated PCs 
(normalised for tissue weight) in a) intact and b) denuded strips o f pig bladder 
trigone. All data are presented as mean ± SEM, n=3.
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4.5.2 IMMUNO-HISTOCHEMISTRY OF THE PIG BLADDER
Results of the optimisation experiments showed that for each bladder region, the most 
effective concentration of the SMA antibody was 1:200, whereas for vimentin 1:300 
was the ideal concentration. Antibody concentration of 1:300 was used for c-Kit 
experiments because using a higher concentration was only increasing background 
autofluorescence. Optimised antibody concentrations were used to stain 12 micron 
thick sections that were fixed using the second fixative method, with overnight primary 
antibody incubation at 4°C. All secondary antibodies were used at a 1:500 dilution.
Using dual immunohistochemistry, it was possible to identify smooth muscle bundles 
that stained positive for a-smooth muscle actin and also for the vimentin filament. This 
was observed in all 3 regions of the pig bladder dome, body and trigone and is shown 
in the images presented in Figures 4.19, 4.20 and 4.21 below. The different 
components of the bladder wall; urothelium, sub-urothelium and the detrusor smooth 
muscle bundles, can be seen in Figure 4.19, which is tissue from the dome region, 
whilst figures 4.20 depict positively stained smooth muscle bundles from the dome. 
Detection of ICC and c-Kit positive cells was attempted by use of antibodies directed 
against c-Kit and vimentin. Figure 4.22, 4.23 and 4.24 show the resulting 
immunofluorescent staining obtained with these antibodies in the dome, body and 
trigone regions respectively. In all of these figures, it is possible to see positive staining 
for vimentin. In contrast, no specific immunofluorescent staining for c-Kit could be 
observed (Figure 4.22a, Figure 4.23b and Figure 4.24b). Figure 4.25 shows images 
from the negative control where the primary antibody was omitted.
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Figure 4.19 - Immunofluorescent dual staining performed on 12 micron sections 
of pig bladder dome showing a) Dapi b) vimentin (green), c) a-smooth muscle 
actin (red) and d) combined overlaid stain image showing the urothelium (U), 
sub-urothelium (SU), muscle bundle (MB) and blood vessels (BV); magnification 
20X. The vimentin stain is localised within the urothelium, suburothelium, in and 
around smooth muscle bundles (green stain).
Figure 4.20 - Immunofluorescent dual staining performed on 12 micron sections 
of pig bladder dome showing a) Dapi (blue), b) vimentin (green), c) a-smooth 
muscle actin (red) and d) combined overlaid stain image showing the smooth 
muscle bundles (MB) and blood vessels (BV); magnification 20X. The vimentin 
stain is localised within the urothelium, suburothelium, in and around smooth 
muscle bundles (green stain).
Figure 4.21- Immunofluorescent dual staining performed on 12 micron sections 
of pig bladder body; a) Dapi b) vimentin (green), c) a-smooth muscle actin (red) 
and d) combined overlaid stain image showing the urothelium (U), sub- 
urothelium (SU), muscle bundle (MB) and blood vessels (BV); magnification 20X. 
The vimentin stain is localised within the urothelium, suburothelium, in and 
around smooth muscle bundles (green stain).
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Figure 4.23 - Dual immunofluorescent staining performed on 12 micron thick pig 
bladder body sections using a) dapi (blue) b) c-Kit (red), c) Vimentin (green) and 
d) combined dual stain image showing urothelium (U), magnification 20X. c-Kit 
antibody produced only non-specific background staining.
d)
Figure 4.24- Dual immunofluorescent staining performed on 12 micron thick pig 
bladder trigone sections using a) dapi (blue) b) c-Kit (red), c) Vimentin (green) 
and d) combined dual stain image showing muscle bundle (MB), magnification 
20X. c-Kit antibody produced only non-specific background staining.
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4.6 D iscussion
Interstitial cells of Cajal discovered by Ramon y Cajal are a group of specialized cells in 
the gastrointestinal tract that drive the peristaltic activity of the gut. They have been 
shown to play a role in signal transmission from nerves to smooth muscle in the Gl 
tract (Sanders 1996; Horowitz et al., 1999). Since then, research of non-GI ICCs in 
other body systems has become a focus of interest. ICCs in the urinary tract have 
been the most widely studied non-GI ICCs (McCloskey 2011). Smet et al. (1996) was 
the first to identify cells reminiscent of gut ICCs in the guinea pig and human bladder. 
These authors described cells with lateral processes or branches that stained positive 
for vimentin, a specific marker which is found in cells of mesenchymal origin including 
ICCs but not in SMCs leading to the speculation that the urinary bladder may contain 
ICC-like cells. This finding was further corroborated by Gillespie et al. (2004). ICCs 
have also been shown to display specific immunoreactivity for antibodies directed at c- 
Kit, a tyrosine kinase receptor (Hashitani 2006; Lang et al., 2006).
The functional role of ICC in the bladder is not clear, however they may function as a 
sensory network, acting as intermediates between the urothelium and detrusor and 
afferent innervation (McCloskey 2010; McCloskey 2011). They can generate 
spontaneous action potentials (Metzger et al., 2008) and may modulate phasic activity 
(Vahabi et al., 2011c). In chapters 2 and 3, spontaneous phasic contractions were 
observed in isolated pig bladder strips from the different bladder regions and it was 
logical to investigate whether ICC play a role in these PCs in the pig bladder as seen in 
previous studies by Vahabi et al. (2011) in rat bladder and in human bladder (Johnston 
et al., 2010). Although c-Kit positive cells have been found in the pig lower urinary tract 
(Metzger et al., 2008), the precise location in the pig bladder has not been investigated.
4.6.1 Functional Investigation of the Effect of Imatinib in Pig Bladder 
Dome, Body and Trigone
To investigate the role of c-Kit positive cells in the PCs observed in isolated strips of pig 
bladder, imatinib, a specific inhibitor of the tyrosine kinase receptor KIT was used. 
Imatinib has been used previously as a pharmacological tool to investigate ICC and 
their role in mediating bladder phasic contractions. Imatinib has been shown to 
suppress contractile smooth muscle activity in bladders from several species including 
human and rat (Biers et al., 2006; Vahabi et al., 2011c), also in guinea pig stomach 
(Hashitani et al., 2008), guinea pig bladders (Kubota et al., 2004; Kubota et al., 2006), 
human gall bladder (Lavoie et al., 2007) and mouse small intestine (Shimojima et al., 
2005). In the present study, increasing cumulative concentrations of imatinib had no
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effect on the amplitude of PCs in either intact or denuded strips from the pig bladder 
dome, body and trigone regions. This is in contrast to several published data that have 
shown an inhibitory effect of imatinib in the bladder. Biers et al. (2006) demonstrated 
that in human bladder from patients with OAB, imatinib had a greater effect in inhibiting 
detrusor contraction in comparison to strips from normal human bladders. Another 
study on guinea pig bladder also showed a dose dependent inhibitory effect of imatinib 
on the amplitude of spontaneous activity (Kubota et al., 2004; Kubota et al., 2006). 
Using rat bladders, Vahabi et al. (2011) showed that imatinib decreased the amplitude 
of CCh-induced PCs in both control and streptozotocin-induced diabetic bladder strips 
in a dose dependent manner although in the latter, the inhibitory effect was only 
evident at the higher imatinib concentrations (10 pM and 50 pM).
Imatinib also had no effect on the frequency of PCs in all three bladder regions in both 
intact and denuded tissues. These results are in line with Min et al. (2011) and Kubota 
et al. (2004, 2006) who showed that cumulative increasing concentrations of imatinib 
had no effect on the frequency of whole rat bladder preparations. In contrast, imatinib 
has also been shown to decrease the frequency of CCh-induced PCs in bladder strips 
of control and diabetic rats (Vahabi et al., 2011c).
Effect of Imatinib on Carbachol Modulated Phasic Contractions in the Pig 
Bladder Dome, Body and Trigone
Various studies using animal models have shown increased PCs in bladders afflicted 
with different bladder dysfunctions including DO and OAB (Mills et al., 2000; Drake et 
al., 2006). In addition, immunohistochemical evidence has shown an increased 
number of ICCs in bladders of patients with OAB compared to normal bladders (Biers 
et al., 2006). Using a guinea pig BOO model Kubota et al. (2008) also demonstrated 
that BOO bladder tissue exhibited a widely distributed population of ICCs in the sub- 
urothelial layer compared to normal guinea pig tissue (Kubota et al., 2008).
In this study, carbachol (CCh), an analogue of acetylcholine (ACh) was used to 
modulate the phasic contractions that developed in the pig bladder tissue strips, to 
mimic the increased activity seen in OAB and then the effect of imatinib on these PCs 
was investigated. Comparison of amplitude of PCs between control strips and imatinib 
treated strips showed that imatinib had no effect on the amplitude in both intact and 
denuded tissue strips from all three bladder regions. This supports published data on 
rat bladders showing imatinib to have no effect on the amplitude of PCs when ACh was 
included in the experiments (Min et al., 2011).
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Imatinib also did not have any effect on the frequency of the CCh modulated PCs in 
intact and denuded tissue strips from the dome, body or trigone regions, again in line 
with Min et al. (2011) who showed that even in the presence of ACh, imatinib did not 
have any effect on the frequency of PCs (Min et al., 2011).
The reason for the lack of effect of imatinib on PCs of the pig bladder in the present 
study is not clear. One reason could be species differences. Previous studies that 
have shown an effect of imatinib on PCs have been performed on rat (Vahabi et al., 
2011c), guinea pig (Kubota et al., 2004; Kubota et al., 2006) and human bladder (Biers 
et al., 2006; Popescu et al., 2006). Another possible explanation for the lack of effect 
of imatinib on PCs could be the age of the tissue. Unpublished data by Vahabi et al. 
has shown imatinib to have a significant effect in juvenile pig bladders (6 week old). 
The experiments presented in this chapter were performed on tissue from adult pigs (at 
least 6 months old) and thus it is possible to deduce that age may play a role. It is also 
possible that although ICC in the pig bladder might be involved in PCs, this particular 
class of cells may not necessarily express the c-Kit receptor and this could explain the 
lack of effect of imatinib on pig bladder PCs. Although c-Kit positive cells have been 
shown previously in the upper and lower urinary tract of the pig, the study did not 
precisely identify them in the bladder (Metzger et al., 2008). Thus, this was a key aim of 
the present study, to identify c-Kit positive cells in the pig bladder.
4 .6 .2  Id e n t if ic a t io n  o f  c -K it  P o s it iv e  C e l l s  in  t h e  P ig  U r in a r y  B l a d d e r  b y
IMMUNOHIS TOCHEMIS TR Y
ICCs express c-Kit, a proto-oncogene that encodes for the tyrosine kinase receptor KIT. 
These cells also have immunoreactivity for vimentin, connexin-43 and cyclic guanine 
monophosphate (cGMP) (Smet et al., 1996; Sui et al., 2002; Wiseman et al., 2003), 
although c-Kit is exclusively expressed by these cells and not in SMCs or fibroblasts. 
In the present study to investigate the presence of ICC in the pig urinary bladder, 
antibodies directed against c-Kit, vimentin and SMA were used. Histological studies of 
bladders from different species have shown ICC to be distributed in the sub-urothelium 
layer, between and along smooth muscle bundles and perivascularly (Johnston et al., 
2010). In the present study, the results show positive immunofluorescent staining for 
SMA and vimentin in tissues from all three of the pig bladder regions but not for c-Kit. 
Vimentin, a type III intermediate filament, is one of the major cytoskeletal components 
of cells. It is expressed in cells of mesenchymal origin, of which ICC are included 
(Johnston et al., 2010). In this study, the results presented were also able to show that 
vimentin is located in between the muscle bundles and along the boundary of SMCs in 
the bladder wall with the highest concentration located within the suburothelium layer.
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This distribution is similar to that described in human bladders (Sui et al., 2002; 
Johnston et al., 2010) and guinea pigs (McCloskey and Gurney 2002; Davidson and 
McCloskey 2005).
With regards to the identification of c-Kit, there was a high level of non-specific binding 
with the c-Kit antibody used in the present study. The antibody was raised against the 
human anti-c-Kit protein, although predicted to have cross species reactivity with pig 
tissue. This made it difficult to definitively identify c-kit positive cells in the pig bladder, 
as has been shown in previous studies (McCloskey and Gurney 2002; Biers et al., 
2006; Johnston et al., 2010). The fact that the tissues did stain positively for vimentin 
filaments implies that there is a population of ICC, but without c-Kit specific staining it is 
not possible to make conclusions whether c-kit positive cells are present.
The lack of available antibodies specific for pig antigens was a major limitation in the 
present study. Both the c-kit antibodies used were reactive to human and mouse but 
with predicted reactivity to pig, and since there is substantial similarity between the pig 
and human bladder these particular antibodies were selected. The lack of a definite 
identification of c-Kit via immunohistochemistry may therefore not be an achievable aim 
until more specific porcine-directed antibodies become commercially available. To 
conclusively identify c-Kit positive ICC in the pig bladder, time and expense allowing, 
the use of non-fluorescent methods of detection and/or PCR could have been utilised.
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4.7 Summary/C onclusion
> Imatinib mesylate had no effect on the amplitude or frequency of PCs of both 
intact and denuded tissue strips from the dome, body or trigone regions of the 
pig bladder. This applied to both the inherent phasic contractions and CCh 
modulated phasic contractions and suggests that c-Kit positive cells are not 
involved in these PCs in the pig bladder.
>  Although a population of ICC was identified in the pig bladder, using antibodies 
directed at vimentin, without specific c-Kit staining, c-kit positive cells could not 
be conclusively identified.
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C h a p te r  5
In v e s tig a tio n  of A TP  R elea se  fro m  P ig  
U r in a r y  B la d d e r
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5.1 Introduction
Adenosine triphosphate (ATP) is one of the most important biomolecules and has a 
vital role as the source of energy for all living cells. It is primarily composed of a 
nitrogenous base (adenine), a sugar backbone (ribose) and a chain of 3 ionised groups 
(phosphates) attached to the ribose (Bodin and Burnstock 2001). In addition to its 
function as an energy source, ATP has also been revealed to act as a neurotransmitter. 
Although acetylcholine (ACh) is the key excitatory transmitter in the bladder, 
neurotransmission due to ATP is also important. In the parasympathetic nerves 
innervating the bladder, ATP is co-released with ACh to mediate detrusor contraction 
(Burnstock 2009). The purinergic system constantly relays information on the state of 
the bladder to the CNS and initiates detrusor contraction, while the cholinergic system 
maintains the detrusor contraction to enable micturition (Abbracchio et al., 2009). In 
addition, Ferguson et al. (1997) highlighted the important sensory role of ATP in the 
bladder when they showed ATP release from rabbit bladder urothelial cells in response 
to pressure changes/stretch. This ATP acts on purinergic receptors located in cells of 
the sub-urothelial plexus and subsequently modulates bladder afferent signalling. 
Release of ATP in the bladder has been shown in various species including guinea pig 
(Burnstock et al., 1978), rabbit (Ferguson et al., 1997), rat (Sadananda et al., 2009), 
human (Kumar et al., 2010) and pig bladder (Sadananda et al., 2012).
5.2 P u r i n e r g i c  s i g n a l l i n g  in t h e  b l a d d e r
There are two major sources of ATP required for signalling in the bladder - specific 
release of ATP from nerves, as evidenced by the presence of vesicles in both 
sympathetic and parasympathetic nerves (Burnstock et al., 1978), and non-neuronal 
release in response to sheer stress, chemical stimuli and pressure changes (Pearson 
and Gordon 1979; Coutts et al., 1981).
5.2.1 Ne u r o n a l  A TP
In most animal species, detrusor contraction is initiated by the parasympathetic 
nervous system via dual muscarinic-purinergic activation by ATP co-released with ACh 
(Burnstock et al., 1978; Hoyle 1996). This is in contrast to healthy human bladders 
whose contractions are predominantly mediated by ACh which binds to detrusor 
muscarinic receptors thereby enabling contraction (Bayliss et al., 1999; Yoshida et al., 
2001). ATP makes up part of the NANC (atropine-resistant) component of detrusor 
contraction and is thought to be especially important in pathological conditions.
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5 .2 .2  N o n -n e u r o n a l  A T P
Bladder urothelial cells have been labelled “sensor-transducers” to describe their ability 
to release and respond to various neurotransmitters (Sun and Chai 2010). It is now 
well established that the urothelium can release ATP due to mechanical stimulation 
(Ferguson et al., 1997), low frequency field stimulation, by cholinergic and purinergic 
agonists (Calvert et al., 2001) and acid, but not tachykinins or capsaicin (Sadananda et 
al., 2012).
Release of ATP has been shown in various species including guinea pig (Burnstock et 
al., 1978), rabbit (Ferguson et al., 1997), rat (Sadananda et al., 2009), human (Kumar 
et al., 2010) and pig bladder (Sadananda et al., 2012). ATP may be released not only 
from urothelial cells but also to a lesser extent from myofibroblast/ICC and detrusor 
(Cheng et al., 2011).
5.2.3 P urinergic  receptors
Purinergic receptors belong to a family of transmembrane molecules thought to play a 
vital role in various physiological functions such as neuronal transmission, smooth 
muscle contraction and inflammation (Gever et al., 2006). There are several members 
in this class of receptors. P1 purinergic receptors are G-protein coupled and are 
activated by adenosine (Burnstock and Kennedy 1985). P2 purinergic receptors are 
sub-divided into ionotropic (P2X) ligand gated ion channels and metabotropic (P2Y) G- 
protein coupled receptors (Fredholm et al., 1994; Ralevic and Burnstock 1998). P2Y 
receptors are mainly activated by adenosine triphosphate (ATP), adenosine 
diphosphate (ADP), uridine diphosphate (UDP), uridine triphosphate (UTP) and uridine 
diphosphate glucose (UDP-glucose) nucleotides whereas P2X receptors are activated 
mainly by ATP. To date, seven P2X receptor subtypes have been identified and they 
all share a similar structural topology consisting of two transmembrane molecules with 
an extended extracellular loop where ATP binds and an intracellular carboxyl and 
amino termini of various lengths as shown in figure 5.1 (Brake et al., 1994; Ennion et 
al., 2000; Jiang et al., 2000). The functional receptor is composed of two or three of 
these subtypes creating a transmembrane pore.
Various experimental techniques including molecular, functional and X-ray 
crystallography studies have been employed to elucidate the composition of functional 
P2X receptors and the current consensus is that P2X channels exist as homomeric or 
heteromeric units. Of the seven subtypes of P2X channels, there are four types that 
have a role in urinary bladder function - homomeric P2X-t, homomeric P2X2, homomeric 
P2X3 and heteromeric P2X2/3 (Gever et al., 2006).
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5.2.3.1 P2X channels in the bladder
Homomeric P2Xi channels have been shown to be densely distributed within the 
detrusor of the urinary bladder (Valera et al., 1995; Burnstock and Knight 2004). The 
role of P2X^ in smooth muscle contractility emerged from experiments that showed 
ATP as the main neurotransmitter involved in non-adrenergic non-cholinergic (NANC) 
atropine resistant detrusor contractions in the guinea pig bladder (Burnstock 1972). It 
is now well established that these channels mediate the purinergic component of nerve 
mediated smooth muscle contraction in sympathetically and parasympathetically 
controlled systems (Hoyle et al., 1989; Valera et al., 1995) by co-releasing ATP with 
ACh to initiate contraction
P2X2 channels located on sensory and autonomic neurons of the peripheral nervous 
system suggest a role in afferent and efferent signalling pathways (Cockayne et al., 
2005). In the bladder they have possible pacemaker activity and a role in smooth 
muscle contraction as they are expressed on ICC and smooth muscle cells (Burton et 
al., 2000; Burnstock and Lavin 2002). Homomeric P2X3 and heteromeric P2X2/3 
channels are expressed on unmyelinated C-fibres and myelinated A5 sensory afferents. 
P2X2/P2X3 deficient mice studies have confirmed that these channels play a role in 
mediating the primary sensory effects of ATP (Burnstock 1999; Burnstock 2001; 
Burnstock 2003) are found in epithelial tissues such as the urothelium, which has led to 
the concept that they may modulate mechanosensory and chemosensory responses in 
the bladder since ATP released from the urothelium can activate these channels on 
adjacent primary sensory afferents (Burnstock 2003; Burnstock 2009).
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5 .2 .4  R o le  o f  A T P  & p u r in e r g ic  s ig n a ll in g  in  p a t h o l o g y  o f  the  b la d d e r
Purinergic signalling has been implicated in a number of pathological conditions such 
as bladder outlet obstruction (OBB), spinal cord injury (SCI), interstitial cystitis/painful 
bladder syndrome (IC/PBS), diabetes and also in ageing (Sun and Chai 2010). This is 
due to the important role of purinoceptor signalling functions in both sensory 
transduction and maintenance of the normal bladder. The relationship of cholinergic 
and purinergic modulation in pathological conditions of the bladder is inverse, in that 
the former is diminished while the latter is enhanced. The mechanisms underlying 
increased urothelial release of ATP are not fully understood but it seems to be due to 
intrinsic changes in various urothelial signalling pathways.
Various animal models have been utilized to investigate the release of ATP and its role 
in disease states of the bladder. IC/PBS is a chronic symptom condition characterised 
by urinary urgency, frequency, nocturia and bladder pain (Sun and Chai 2010). Up- 
regulation of purinergic signalling in the bladder urothelium has been suggested as the 
underlying aetiology for IC/PBS symptoms. Studies of bladder outlet obstruction (BOO) 
and overactive bladder (OAB) using a rabbit model showed that in response to electric 
field stimulation (EFS), there was an increased purinergic component in rabbits with 
early stage BOO and this was predominant in comparison to the cholinergic component 
(Calvert et al., 2001).
Birder et al. (2003), using a feline interstitial cystitis (FIC), model investigated the 
mechanisms involved in ATP release evoked by applying a hypotonic stimulus to 
urothelial cells from normal versus FIC cells. The results showed enhanced ATP 
release in FIC cells compared to the normal cells. Experiments performed on rats with 
bladder inflammation due to cyclophosphamide-induced bladder injury also exhibited 
similar increased ATP release (Dang et al., 2008). Urothelial cells from patients with 
benign prostatic hyperplasia (BPH) have been shown to release significantly more ATP 
than urothelial cells from control patients (Sun et al., 2002). Kumar et al. (2004) 
compared ATP release in bladders from pig and normal human tissue. This study 
found increased ATP release due to mechanical and electrical stimulation in both 
species. The mean ATP release from the pig bladder was comparable to ATP 
measured in the human samples, and in both, the main source of ATP was the 
urothelium and not the detrusor (Kumar et al., 2004). The ATP released was not 
sensitive to tetrodotoxin suggesting its source is non-neuronal. Subsequent studies 
investigating ATP release from the urothelium of patients with idiopathic and 
neurogenic detrusor overactivity similarly showed that mechanical stretch and electric
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field stimulation resulted in increased ATP release in both NDO and IDO. The 
increased ATP release was more significant in IDO than in NDO tissue strips (Kumar et 
al, 2010)
The heteromeric P2X3/P2X2 receptor is classed as a nociceptive receptor and thus 
increased expression in the bladder could mediate IC/PBS symptoms. The increased 
ATP levels due to cyclophosphamide-induced bladder injury were attributed to 
alterations in purinergic signalling in bladder afferent pathways whereby there was 
increased P2X receptor expression in pelvic and lumbar neural pathways contributing 
to bladder hypersensitivity associated with the inflammation (Dang et a l, 2008). 
Another study by Kim et a l also investigated purinergic signalling in the urothelium 
from rat bladders with BOO and concluded that there was increased P2X3 expression 
in the urothelium of BOO group in comparison to the control (Kim et a l, 2008). With 
regards to ageing, structural and functional changes inevitable with an increase in age 
are accountable for the high prevalence of voiding dysfunction in older people. Studies 
performed on detrusor strips from three different age groups - group 1 <50 years, 
group 2 51-70 years and group 3 >70 years - indicated a positive association between 
age and purinergic neurotransmission and a negative correlation between age and 
cholinergic neurotransmission (Yoshida et a l, 2001). With increasing age, there is a 
decreased cholinergic component in neurogenic contraction, whereas the reverse is 
true for the purinergic component (Yoshida et al, 2001).
All of the above studies highlight that changes in purinergic signalling may be important 
in bladder dysfunction and therefore there is a need for further understanding of 
purinergic signalling in the bladder, which may open new avenues for novel 
pharmacological therapies to treat LUTS. It is with this in mind that the experiments in 
this chapter were performed using pig bladders to investigate ATP release in the dome, 
body and trigone in response to stretch.
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5.3 Chapter A ims
The aims of this chapter were:-
>  To measure ATP released in response to stretch in isolated strips of pig bladder 
dome, body and trigone
>  To compare the amount of ATP released by tissue strips from the different 
bladder regions.
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5.4 Materials and methods
5.4.1 ATP MEASUREMENT AND DETERMINATION
A bioluminescent assay kit for ATP measurement can be used to determine levels of 
ATP in various samples ranging from 2 x 10'12 to 8 x 10'5moles/L. The reaction 
involves consumption of ATP resulting in emission of light due to the oxidation of D- 
luciferin by the firefly luciferase enzyme as shown below.
F i r e f ly  L u c ife ra s e
A T P  +  L u c i f e r  in <-> A d e n y l l u c i f e r i n  +  P P t (1 )
Mer++
A d e n y l  — l u c i f e r i n 02 —» O x y l u c i f e r i n  +  A M P  +  C02 4 -  (2 )
The amount of light emitted is proportional to the amount of ATP present in the sample 
(Strehler 1974; Leach 1981). The ATP assay kit used in the present study was 
obtained from Sigma Aldrich (U.K.). Each vial of ATP lyophilized assay mix (containing 
luciferase, luciferin, MgS04, DTT, EDTA, BSA and tricine buffer salts) was dissolved in 
5ml of sterile water and allowed to stand on ice for 1 hour to ensure complete 
dissolution. The assay was performed by adding 0.1ml of the ATP assay mix to each 
well of a 96-well plate and this was allowed to stand for approximately 3 minutes to 
ensure any endogenous ATP was hydrolysed. The samples were then rapidly added 
to the assay mix in the wells, swirled briskly and the amount of luminescence produced 
was measured using a luminometer (Victor™ X4 2030, Perkin Elmer, U.K).
For each assay performed a standard curve was prepared, against which the amount 
of ATP in the samples was determined. An ATP standard stock solution of 1x1 O'6 
moles/ml was prepared using sterile H20 . Using serial dilution, ATP standards ranging 
from 1x1 O'7 - 1x10'14moles/ml and 3x1 O'7 to 3x10'14moles/ml were prepared in order to 
create a calibration curve as shown in Figure 3.1. The amount of ATP in the samples 
was determined using the equation obtained from the standard curve as shown. 
Samples were measured in triplicate.
5.4.2 Optimisation of parameters for ATP determination
In order to ascertain the optimal settings for recording luminescence and to optimize 
the sensitivity of the ATP assay, a number of parameters were investigated. These 
included the effect of microplate type, height of the sensor, the size of aperture and the 
stability of the reaction.
1 7 3
5.4.2.1 Effect of plate type
Several different microfluor 96-well plates are available for use in luminometry based 
on their reflective properties. For plate type optimisation, three different plate types - 
clear, black and white (Thermo Scientific, U.K.) were investigated to determine the 
most suitable plate type for the luminometer used. Effects of height, aperture and 
reaction stability in the three plates were measured.
5.4.2.2 Effect of height
The luminometer height controls the distance between the sample and the instrument 
sensor. If the sensor is too close to the sample, it will not be able obtain accurate 
readings of dispersed light and conversely if it is too far from the sample it may 
inaccurately incorporate overspill light from neighbouring wells. It is therefore 
imperative to adjust the sensor height to a suitable distance that would maximize 
luminescent light detection and minimize light contamination from neighbouring wells. 
The effect of sensor height on luminescence readings was determined using ATP 
standards and three different distances between the sensor and sample, being 3mm, 
5mm and 7mm. The samples were measured for 1 second using 4mm aperture width.
5.4.2.3 Effect of aperture
Sensor aperture determines the amount of light reaching the sample by varying the 
sensor diameter. The effect of the aperture size on luminescence readings was 
investigated by varying the sensor diameter - 1mm (small), 4mm (normal) and 5mm 
(large) - with measurements taken for 1 second at 7mm luminometer height setting.
5.4.2.4 Stability of light emission
Finally, determination of the stability of the ATP-luciferin-luciferase reaction was 
performed on all three plate types using the optimised parameter settings for 
luminometer height and aperture size. Readings of the ATP standards were taken at 0, 
20, 50 and 90 minutes.
5 .4 .3  O p t im is a t io n  o f  s a m p l e  c o l l e c t io n
To determine the optimum method for collecting samples from bladder strips for ATP 
determination, a number of sample collection methods were trialled.
5.4.3.1 Microdialysis method for collection of samples
Microdialysis is a technique that allows for sampling from within an extracellular space 
of the tissue of interest. It was mainly developed for brain research but in recent years 
has been adapted to be utilised in various tissues including bladder for measurement of
1 7 4
ACh and ATP release (Inadome et al., 1998; Yoshida et al., 2004; Yoshida et al., 2006). 
This technique involves inserting a probe into a region of interest within the tissue and 
slowly perfusing buffer or medium through the probe. Analytes cross the probe 
membrane from the extracellular space with the perfusate and are collected over time 
for analysis (Figure 5.2).
The 0.22mm x 10mm dialysis probe used in the present study (OP-100-10, Eicom 
Corp., Dublin U.K.) has a regenerated cellulose membrane that is sustained by a 
0.04mm platinum wire. The probe was inserted through intact pig bladder strips into 
the sub-urothelial space using a microscope with the probe membrane maintained 
within the tissue. The inlet cannula of the probe was connected to a microdialysis 
syringe pump (ESP-64, Eicom, Dublin U.K.). Krebs' buffer was continuously perfused 
at a rate of 4pl/min. The tissue strips were suspended in a 10ml tissue bath as 
described in Chapter 2 and shown in Figure 5.2. Tissues were allowed to equilibrate 
for 60 minutes with the Krebs' buffer replaced every 15 minutes. Each strip was then 
stretched to 50% of its length and the microdialysis pump started to pump the Krebs' 
buffer through the tissue. The dialysate was collected on ice and frozen at -20°C prior 
to measurement of ATP.
5.4.3.2 Determination of optimal sample collection for measurement of basal 
ATP release and stretch-evoked ATP release
Isolated strips of bladder were mounted in tissue baths (as described in chapter 2 
section 2.3.4) and allowed to equilibrate under a load of 1g for 60 minutes with tissue 
bath content replaced with fresh Krebs' buffer every 15 minutes. After the equilibration 
period, the contents of the tissue bath were collected every 60 seconds for a period of 
10 minutes to determine whether basal ATP changed over time. As described above, 
tissue was allowed 15 minutes and another wash performed. The tissue was then 
stretched to 50% or 100% of its length and left for 60 second before the tissue bath 
content was collected to measure ATP release due to stretch.
5.4.3.2 Tissue bath collection of samples
These experiments utilized the tissue bath set up described in chapter 2 section 2.3.4. 
Pig bladder tissue taken from the different bladder regions was dissected into strips of 
approximately 1cm length, with the mucosa intact. The strips were mounted in 5ml 
tissue baths as described in chapter 2 section 2.3.4. The strips were allowed to 
equilibrate for 60 minutes under a load of 1g with tissue bath content replaced every 15 
minutes. After the final wash of the equilibration period, the tissue was left for 30 
seconds and the organ bath content was collected for basal ATP measurement.
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Tissue was then allowed 15 minutes and another wash performed. The tissue was 
subsequently stretched to 50% of its length, left for 60 seconds and the tissue bath 
content collected. 1ml of the tissue bath content was immediately frozen at -20°C 
awaiting ATP measurement.
176
Q.E3Q.
OU)c'u
(/>o
cf
1
Q>
£
PQ)<0
*fco>a
aS
a
Q>o>c
IsO
Q)
£
cQ>5
2!3<0TO
<D
s
6
£
co3o■SJ
oo .*1 TO PS i.5 SP io
V.O *» 
o '2g-pI?TO g
2 1  c °Q> Q)
■§ « C TO<D ^
5* to 
Uj P
, pCNI C id *8 
<D ■ £I I
i E ^
17
7
5.5 Da ta  and  S tatistical  A nalysis
The light luminescence measured as counts per second (CPS) from the analysed 
samples was converted into log luminescence values for both the ATP standards and 
the samples. An ATP standard curve was prepared with each assay of samples. ATP 
concentration in the sample was determined from the standard curve. Data was 
normalised for tissue weight and expressed at Mols/mg of tissue. All data are 
presented as mean ± SEM.
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5.6  R es u lts
5.6.1 ATP STANDARD CURVE
An example of the ATP standard curve used for the calculation of the amount of ATP in 
collected samples is shown in figure 5.3.
ATP Standard Curve
R square | 0.9905 
y=0.7076x + 12.27
r 10
-10 8 6-12-14
Log Moles of ATP
Figure 5.3 - Representative standard curve used to determine the amount 
of ATP in experimental samples. ATP standards were used and a linear 
curve fit performed to produce the equation y=0.7076x + 12.27 in this case, 
which is rearranged to determine the value of x which corresponds to the 
amount of ATP in the sample.
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5.6.2 O p t i m i s a t i o n  o f  p a r a m e t e r s
5.6.2.1 Effect of plate type
Figure 5.4 shows the results obtained for ATP standard curves measured on the 3 
different plate types. The black plate (Figure 5.4a) provided the best linear relationship 
and sensitivity over the range of ATP standards in comparison to the white and clear 
plates (Figure 5.4b & c). The white plates produced a higher luminescence reading but 
this seemed to plateau resulting in the loss of sensitivity and linearity. This was also 
the case for the clear plates.
5.6.2.1 Height optimisation
Comparison of sensor height across the 3 plate types did not reveal any great 
differences within each plate type. The graphs shown on Figure 5.5 reveal that at 3, 5 
and 7mm sensor height, no significant differences were observed. However, 
comparing the plate types against each other, the black plates maintained a better 
linear response (Figure 5.5a) over the range of standards in comparison to the white 
(Figure 5.5b) and clear plates (Figure 5.5c).
5.6.2.3 Aperture optimisation
Analysis of the effect of aperture size on luminescence readings across the 3 types of 
plates revealed that the 1mm aperture resulted in lower luminescence in comparison to 
the 4 and 5 mm aperture sizes as shown in Figure 5.6. The white and clear plates 
(Figure 5.6b & c) showed a trend whereby a linear response was observed with 
decreasing concentration of ATP standards and this plateaued off, whereas for the 
black plates (Figure 5.6a), the linear response was maintained over a larger range of 
ATP standards.
5.6.2.4 Stability of reaction
All 3 plate types showed a gradual decrease in luminescence measured with 
increasing time interval between the assay and the plate being read. This is shown in 
Figure 5.7. The white plates showed the highest luminescence reading (Figure 5.7b) in 
comparison to the black (Figure 5.7c) and clear plates (Figure 5.7b). Linearity of 
luminescence in the black plates was maintained over a larger range than in the clear 
and white plates.
Each optimisation parameter experiment was performed 3 times to ensure the 
consistent results for each plate type. These optimisation experiments resulted in the
180
decision to use black plates measured at 7mm height using normal (4mm) aperture 
size for 1 second for determining ATP amounts in collected samples.
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5 .6 .3  O p t im is a t io n  o f  s a m p le  c o l l e c t i o n  f o r  b a s a l  A T P  r e le a s e
Sample collection using the microdialysis method was not very successful. The 
amount of sample collected, the time it took to collect the sample and the low levels of 
ATP measured led to the investigation of alternative sample collection method. 
Collection of whole tissue bath content was tried and this method provided consistent 
results hence, subsequent experimental sample collection was performed this way.
Following 60 minutes equilibration of bladder strips, basal ATP release was determined 
over an 8 minute period with samples collected every 60 seconds. In strips of both 
dome and body (Figure 5.8) from the pig bladder, performing these multiple washes 
reduced basal ATP levels but the amount of basal ATP released was not significantly 
reduced over 8 minutes (p = 0.2998 and p = 0.6767 for dome and body respectively). 
In light of these results, sample collection for basal ATP was performed immediately 
after equilibration following 3 consecutive washes of the tissue.
5 .6 .4  E f f e c t  o f  S t r e t c h  o n  A T P  R e le a s e d
5.6.4.1 ATP Release evoked by 50% stretch
Isolated strips of pig bladder dome (n=8) stretched to 50% of the tissue length showed 
no significant increase in ATP levels following stretch (Figure 5.9A). Strips from the 
bladder body (n=8) showed increased levels of ATP release upon stretch but this 
increase was not statistically significant (Figure 5.10A). The same results presented as 
scatter plots showing the median and range of data for ATP release from the dome and 
body (Figure 5.9B and Figure 5.10B) mirrored the previous results.
5.6.4.2 ATP Release evoked by 100% stretch
Intact strips of dome (n=12) stretched to 100% of the tissue length showed increased 
ATP release vs. basal release, which was statistically significant (**p<0.01), as shown 
in Figure 5.11 A, and this is further supported by the scatter plot (Figure 5.11B) which 
shows increased levels of ATP release at 100% stretch compared to basal levels. 
Intact strips of body (n=12) showed increased levels of ATP release following 100% 
stretch (Figure 5.12A & B) when expressed as mean data, though not significantly so.
Upon expressing stretch-evoked ATP release data as % increase relative to basal ATP 
release (taken as 100%), analysis revealed that when the tissue was stretched by 50% 
of its length, ATP release was significantly greater than, basal ATP release in the body 
(p<0.05) but not in the dome region -  Figure 5.13A. On the other hand, the % increase 
of ATP release following 100% stretch was significantly greater than basal ATP release
186
in both the dome and the body regions (p<0.01 and p<0.05 respectively) as shown in 
Figure 5.13B. Figure 5.14A & B compare stretch-evoked % increase in ATP release in 
the dome and body regions respectively. The increase in ATP release was not 
statistically significant vs. basal ATP release in both regions when the tissue was 
stretched by 50% and 100%.
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Figure 5.13 - Stretch-evoked ATP release shown as a % increase vs. basal 
ATP levels. A) 50% stretch (n=8 ) and B) 100% stretch (n=12) in the dome 
and body regions. Data are presented as mean ± SEM, *p<0.05, **p<0.01 
vs. basal ATP.
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Figure 5.14 - Stretch-evoked ATP release - comparison of 50% (n=8) vs. 
100% (n=12) stretch shown as a % increase against basal ATP levels in A) 
dome and B) body regions. Data are presented as mean ± SEM.
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5.7 D iscussion
ATP release is thought to play an important role in bladder signalling by acting on sub- 
urothelial afferent nerves and the activation of purinergic receptors located in the 
bladder wall (Ferguson et al., 1997). ATP is released in response to various stimuli in 
the bladder. In this chapter, the effect of stretch of bladder tissues on ATP release was 
studies in the different bladder regions. The results confirm that stretch is an effective 
stimulus for ATP release in pig bladder tissue especially when tissues were stretched 
to 100% of original tissue length.
5.7.1 Optim isation o f  sam ple c o lle c t io n
Sample collection using the microdialysis method was not ideal for various reasons. 
The amount of time it took to collect a sample sufficient enough for the measurement of 
ATP was too long. It took 25 minutes to collect 100pl of sample perfusate at a rate of 
4pl/min. ATP extraction efficiency is dependent on the flow rate. At a high flow rate, 
ATP diffusing from sampling site into dialysate per unit time is smaller than at a lower 
rate (Lonnroth et al., 1987), hence the slower flow rate that was used for optimisation 
experiments. Measurement of the perfusate showed variable low levels of ATP in the 
samples, and this was not consistent. This could be due to the process of implantation 
of the probe as it has been reported this can alter the morphology resulting in disturbed 
microcirculation, rate of metabolism and the integrity of physiological barriers 
(Ungerstedt 2009). It is also possible that the ATP was rapidly broken down by 
enzymes and not representative of what was being released due to the stretch.
Initial preliminary experiments showed elevated levels of basal ATP in comparison to 
ATP release in response to stretch, but this was not consistent across all tissues. It 
was therefore important to determine the optimum method to obtain samples for 
measurement of basal ATP. In order to do this, the contents of the organ bath were 
analysed for ATP content at 60 second intervals following the 60 minute equilibration 
period - in an attempt to reduce any ATP that had accumulated over the equilibration 
period. However, in strips of both dome and body, there were no significant differences 
in the amount of basal ATP measured in the samples over the different time points. It 
was therefore decided to perform just a single basal ATP measurement immediately 
following the equilibration period.
5.7.2  Optim isation o f  ATP assay
Determination of the optimum parameters for the measurement of ATP release using 
the ATP bioluminescence assay was the first vital step in performing the ATP
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experiments. Three different plates - black, white and clear - were tested. In addition 
to this, height, aperture size and stability of the ATP reaction required optimisation. 
The distance between the plate reader sensor and the sample describes the sensor 
height and the diameter of the sensor refers to the aperture. The black plates absorb 
light and therefore decrease the amount of background light from the reaction. The 
white plates on the other hand reflect the light and produce higher background 
readings, whereas the clear plates disburse the light and thus may not give accurate 
readings of luminescence in each well. The combination of the sensor aperture size 
and its height is therefore important in giving an accurate reading. It is known that light 
travels in a straight line and if the aperture is too small and too close, the readings 
obtained may not be accurate as some of the reflected light may not be registered by 
the sensor. On the other hand, if the sensor is too high with a small aperture, then 
overspill of light over the top of the plate is not captured and hence inaccurate 
luminescence readings. The balance of the right size aperture and height is therefore 
crucial in the measurement of accurate ATP measurement from the samples. With 
regards to the height, the optimum was found to be 5-7mm with the black plates giving 
the best linearity for the standard curve. The ideal aperture size was found to be 4 or 
5mm diameter and again the black plate gave higher sensitivity and stability of the 
reaction in comparison to the clear or white plates.
Assessing the stability of the assay reaction was important as it informs us on how 
quickly the luciferase reaction occurs and the decline in light intensity over time. The 
optimisation experiments showed the reaction to be quite stable, with a gradual decline 
in luminescence over time in all 3 plate types. The highest luminescence readings 
were those taken at time zero - immediately upon addition of the sample - and this 
declined over the 90 minute time frame.
From these optimisation experiments, the optimal settings for the assay measurement 
were the use of black plates measured at a sensor height of 7mm, with an aperture 
size of 4mm, measured at time zero immediately upon addition of the sample into the 
assay mix.
5.7.3 ATP RELEASE IN PIG BLADDER STRIPS
It is well known that ATP plays an important role in bladder function. It is co-released 
with ACh from parasympathetic nerves and is essential for the initiation of the normal 
micturition reflex (Cockayne et al., 2000). It has been shown to be released non- 
neuronally and act on P2X3 receptors subsequently increasing afferent activity 
(Burnstock 2007) and eliciting sensations of bladder fullness via low threshold nerves
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and pain via high threshold nerves (Ferguson et al., 1997). However, our 
understanding of the role of non-neuronaily released ATP is still not complete, and it is 
possible that it acts on the underlying ICC and detrusor muscle, and may have a role in 
the modulation of PCs in the bladder, especially in pathological conditions where there 
is increased expression of ICC and ATP release (Birder et al., 2003; Birder et al., 2004; 
Kumar et al., 2010).
Previous studies on the release of ATP have been performed on cells in culture 
(Ferguson et al., 1997; Birder et al., 2003), animal models (Birder et al., 2004; Lu et al., 
2007), whole bladder strips and mucosal strips (Sadananda et al., 2009). Birder et al. 
used urothelial cells cultured from cat bladders to demonstrate release of ATP in 
response to hypotonic stimulation and this response was enhanced in cells taken from 
animals with feline interstitial cystitis. Urothelially released ATP, due to changes in 
hydrostatic pressure, has been shown to act on afferent nerves in the sub-urothelium to 
initiate afferent signalling mechanisms in the rabbit bladder (Ferguson et al., 1997). 
Recently, Kumar et al. demonstrated increased ATP release from human bladder strips 
taken from patients with idiopathic detrusor overactivity (IDO) and neurogenic detrusor 
overactivity (NDO). In that study, stretch was used as a stimulus for ATP release 
(Kumar et al., 2010). Previously, O'Reilly et al. (2002) had shown increased 
expression of P2X2 receptors in patients with IDO and this highlighted the importance 
of urothelial purinergic signalling function in pathological bladder conditions (O’reilly et 
al., 2002).
Limited studies have investigated ATP release from the pig bladder, in spite of it being 
shown to be a good model for human bladder (Hashitani and Brading 2003; 
Templeman et al., 2003; Kumar et al., 2004; Akino et al., 2008; Sadananda et al., 2008; 
Hernandez et al., 2009). Of those that have, all have shown increased ATP release 
due to various stimuli. Kumar et al. (2004) showed ATP release due to mechanical and 
electrical stimuli in the pig and human bladder to be relatively similar. Using cell 
cultures of the different cell types present in the bladder - urothelial, myofibroblast and 
detrusor muscle cells - Cheng et al. (2011) showed consistent increase in ATP release 
in the respective cell cultures in response to exposure to hypotonic Krebs' buffer 
solution. Mucosal strip studies by Sadananda et al. (2009) also showed increased ATP 
release in response to 50% stretch of the tissue and these strips contained a mixed 
population of cells. In the present study, intact pig bladder strips were used to 
investigate stretch-evoked ATP release. These intact strips contained all the bladder 
cell types and thus it was not possible to attribute ATP release to a specific cell type, as 
can be performed on isolated cells, and as previously performed by Cheng et al. (2011).
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However, given the evidence available it is highly likely that a significant amount of 
ATP was released from the urothelium.
The exact mechanism by which ATP is released from the urothelium is not entirely 
clear and several hypotheses have been postulated to explain this. Electron 
microscopy ultra-structural studies were first to provide preliminary evidence of vesicle 
involvement in the release of neurotransmitter release (Bodin and Burnstock 2001). 
Analysis of pure populations of synaptic vesicles via sub-cellular fractionation 
techniques conclusively identified neurotransmitter localization in these vesicles 
(Dowdall et al., 1974) and it now widely accepted that exocytosis is a possible release 
mechanism of neurotransmitters (Bodin and Burnstock 2001). The trigger for the 
fusion of these vesicles and release of their contents is mainly the presence of Ca2+. 
The arrival of an action potential causes membrane depolarization producing increased 
permeability of Ca2+ which causes an increase in the influx of Ca2+ via voltage gated 
channels and this subsequently triggers vesicle exocytosis (Bodin and Burnstock 2001). 
The ATP from these vesicles can ultimately stimulate the purinergic receptors in the 
urothelium, sub-urothelium and possibly some unmyelinated C-fibres and these in turn 
activate the afferent arm of the micturition reflex (Kumar et al., 2010). Increased ATP 
release may therefore contribute to the detrusor overactivity in both IDO and NDO.
In this chapter, ATP release due to stretch was measured in the dome and body 
regions only. Protocol optimisation for these experiments took significantly longer than 
anticipated and preliminary results showed variability between the tissues from the 
different regions, hence the decision to just optimise experiments on the dome and the 
body regions. The amount of basal ATP released in the dome and body regions 
showed great variability (note differences in scales). Cheng et al. (2011), using 
cultured urothelial, myofibroblast and detrusor cells, and Sadananda et al. (2009), 
using rat bladder mucosal strips also both showed variability of ATP release due to 
stretch. The amounts of ATP release presented in the aforementioned studies were 
significantly higher in comparison to that measured in the present study using pig 
bladder. This may be attributed to the fact that the size of organ/tissue baths used was 
very different -  0.2ml for the rat bladder mucosal strips vs. 5ml for the pig bladder strips. 
It is possible that the volume of the tissue bath greatly diluted the amount of ATP, 
hence the lower measurements of fMols of ATP compared to nMols in the smaller 
baths. In addition, in the present study the data was obtained using whole bladder 
thickness strips from dome and body regions, and this may account for the differences 
observed in the amounts of ATP levels measured - i.e. ATP produced in the whole 
tissue strips may not adequately diffuse into the Krebs' buffer and may remain in the
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tissue, therefore it may be that there is not an accurate representative measure of ATP 
release in the samples. In addition, although all of the tissue used was obtained fresh 
from the abattoir and handled in a consistent manner, it is possible that the variability of 
the data in the present study may be due to the inherent variation in the different 
animals sacrificed. These animals were not kept in controlled environments, where 
routine and uniformity in the care and handling can be kept constant.
The increase in ATP release in pig bladder strips from the body and dome regions was 
stretch dependent i.e. there were increased ATP levels with an increase in stretch, 
although this was not significant versus basal ATP release. This data is similar to 
several published works that show significant increased levels of ATP in response to 
stretch (Ferguson et al., 1997; Birder et al., 2003; Birder et al., 2004; Smith et al., 2005; 
Sadananda et al., 2009; Kumar et al., 2010; Sadananda et al., 2012). Even though no 
significance was noted in the levels of ATP release, it is possible that due to the varied 
nature of the tissue, an increase in the number of experiments performed may reveal a 
significant difference. The variability may be due to various experimental factors, as 
mentioned above, and may also include rapid ATP breakdown by endogenous 
ectonucleotidase enzymes. Experiments by Ferguson et al. (1997) using isolated 
rabbit bladder strips to investigate the effect of calcium on EFS-evoked ATP release 
showed that absence of calcium significantly potentiated the release of ATP in 
comparison to data collected in the presence of calcium. This is supported by a study 
that established that there is increased breakdown of ATP by ectonucleotidases in the 
presence of calcium (Seguchi et al., 1982) in rabbit transitional bladder epithelium. The 
Krebs' buffer used for the experiments contains physiological levels of Ca2+ and 
therefore could possibly be a reason for the variability observed in the data presented 
in this chapter. ATP breakdown could have been prevented by freezing the collected 
samples immediately in liquid nitrogen prior to measurement.
Another possible explanation for the differences observed in the present study in 
comparison to published data maybe the use of different stimuli to evoke stretch. The 
use of a hypotonic solution to induce stretch results in an osmotic effect whereby there 
is an uptake of fluid into the cell thereby simulating stretch. This may actually cause a 
more profound effect than physically stretching the tissue.
When examining mean data and comparing stretch-evoked ATP release at 50%, no 
significant differences were observed in both dome and body regions. When the 
stretch was increased to 100% of the tissue length, ATP release due to stretch was 
significantly increased in the dome but not in the body region. Calculation of
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percentage change in response to stretch versus basal release values altered the 
findings. At 50% stretch, there was an increase in ATP release in both the dome and 
body regions vs. basal ATP, but this was only significant in the body region. On the 
other hand, at 100% stretch ATP release was significantly increased in both dome and 
body regions in comparison to the basal levels. This is in line with published data. 
Performing the % change calculation removes the effect of comparing mean values for 
all tissue strips as a representative for basal and stretch respectively. Single 
calculations of the percentage change, taking into account individual basal values and 
ATP due to stretch, provide a more accurate depiction of the ATP levels. Intra-regional 
comparisons of 50% vs. 100% stretch for both dome and body revealed no significant 
differences of increasing the amount of stretch performed on the tissue. Moro et al. 
(2011) recently suggested a more physiological approach to stretch is to gradually 
stretch the tissue over time rather than subjecting the tissue to sudden stretch for short 
periods of time. Using the phased stretch approach of a few mm every 30 seconds 
over a few minutes may be more physiological (Moro et al., 2011a) and might account 
for the lack of significance in the data obtained in the present study.
The physiological relevance of stretching to 50% or 100% of tissue strip length is 
difficult to determine, and different protocols have been used in previous studies 
examining ATP release from bladder cells and tissues. In light of this, a more 
physiological approach may be to measure ATP release in response to filling, by 
distending whole bladders and collecting the bladder luminal content afterwards to 
measure ATP release. In this way particular consideration can be paid to pressure and 
volume. This is something that could be pursued in the future in light of the recent 
published finding validating a functional isolated pig whole bladder model for 
physiological experimentation (Parsons et al., 2012). This study confirmed that large 
animal bladders are viable in vitro and can provide valuable insight into the physiology 
of large animal bladders, as they have the potential of being more informative in 
comparison to cell culture studies, tissue strip studies and rodent animal models 
(Parsons etal., 2012).
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5.8 Co nclusion
The present study has shown ATP release in response to stretch in isolated whole 
bladder thickness strips of pig bladder dome and body. However, there was a level of 
variability in the tissues and the response to stretch was not consistent across the 
experiments.
>  The source of ATP release is not clear, and urothelial, myofibroblast and 
detrusor smooth muscle are all a possibility, although given the evidence for 
the literature urothelial cells may be the dominant source
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C h a p te r  6 
G en er a l  D is c u s s io n
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Overactive bladder is a common and distressing condition of the LUT which affects 
millions of people worldwide. Our understanding of OAB and its underlying causes is 
limited, and although there have been many advances in our knowledge of normal 
bladder function in recent years, particularly in the role of the urothelium, much still 
remains unclear. Thus, a greater understanding of bladder function, both normal and 
pathological, is needed in order to lead to more effective treatments. The aim of this 
thesis was therefore to investigate and better understand bladder function, with 
particular focus on the inherent phasic activity of the bladder and components of the 
bladder wall thought to be involved in mechanosensation. In addition, a secondary aim 
was to study these aspects in the pig bladder, which has been used widely as a good 
model for human bladder with respect to pharmacology and physiology, but used less 
for studies characterising mechanosensation.
OAB is characterised by involuntary contractions of the bladder during the filling phase, 
the cause of which is not understood. It has been suggested that these involuntary 
contractions may be linked with increased phasic activity, and a mechanosensory basis 
for OAB has emerged, which suggests changes in transmitter release from the bladder 
urothelium, the functioning of ICC, increased afferent nerve activity and altered 
detrusor excitability.
In chapter 1 it was demonstrated that in vitro, in the absence of electrical or chemical 
stimulation, isolated bladder strips develop rhythmic phasic contractions, and that this 
occurs in both intact strips and denuded strips. The time for development of these PCs 
was however significantly increased in the denuded strips, in which the mucosa 
(urothelium and sub-urothelium) had been removed. The absence of the mucosa 
therefore resulted in a delay in the time for PCs to develop. This implies a clear role for 
the urothelium/sub-urothelium in regulation/modulation of PCs, but that these layers 
are not responsible for generating these PCs, since they are still able to develop in 
denuded strips. Within these layers are a number of cell types that may play a role in 
this regulation of PCs. The release of neurotransmitters from the urothelium, such as 
ATP, ACh, PGs and NO, may be important as they may act on the underlying ICC, 
afferent nerves and/or the detrusor. The hypothesis that the mediators released from 
the urothelium underlie the increase in PCs seen in various LUT conditions was 
investigated by Fry et al. (2012). These authors proposed that there is a syncytium 
within the sub-urothelial space where PCs are generated and went on to provide 
evidence of this using a rat spinal cord transected rodent model, showing calcium and 
membrane potential (Em) waves that originated in the sub-urothelial space and 
propagated to the detrusor and urothelium (Fry et al., 2012). Addition of various
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purines increased the conduction velocities of the Ca2+/Em waves. These findings 
support the idea of the presence of a syncytium whereby neurotransmitters are 
released from the urothelium and act on ICC and afferent nerves to initiate PCs in the 
bladder. The findings presented in this study suggest a similar mechanism may be at 
play in the pig bladder, but it appears the activity does not initiate in the mucosa. It 
may originate in the detrusor or from ICC around the detrusor, and the cells in the 
mucosa may play a role in modulating the PCs via transmitter release. Non-neuronal 
tetrodotoxin resistant bladder contractions have been named autonomous activity, 
micromotions, intrinsic activity, non-micturition contractions, rhythmic and phasic 
activity. Whether these phenomena are one and the same activity is not yet clear, and 
the origin of these PCs has been debated upon and several theories have been 
proposed. It has been established that this 'autonomous activity' is not generated by 
post-ganglionic parasympathetic nerves, or by the activation of the neuromuscular 
junction, and that the underlying mechanism is different to that of detrusor activation 
during micturition (Drake et al., 2003; Gillespie 2004). Instead it seems that there 
exists a complex system capable of generating coordinated contractions. Bladder PCs 
have therefore been suggested to be due to ICC or myofibroblasts in the sub- 
urothelium, and indeed reports suggest that this layer can contract in response to 
mediators such as ATP, NO and ACh (Sadananda et al., 2008; Moro et al., 2011a). 
Sub-urothelial myofibroblasts have been shown to possess muscarinic M3 receptors 
whereupon mediators may act to induce PCs. In addition, a novel muscularis mucosae 
layer of cells, located between the urothelium and the detrusor has been described, 
and although its properties and role in bladder function is unclear, guinea pig mucosal 
tissue strips have been shown to exhibit spontaneous phasic contractions that appear 
to originate in the muscularis mucosae (Heppner et al., 2011). Thus this layer of SM 
that is physiologically and pharmacologically different to the detrusor, may contribute to 
the phasic contractions of the bladder
An interesting finding in the present study was that PCs in the bladder trigone region 
were not affected by removal of the urothelium, indicating a functional heterogeneity. 
This supports the suggestion from previous immunohistochemical studies that showed 
morphological differences in the bladder regions (Gillespie et al., 2004; Gillespie et al., 
2005). In addition differences exist in the receptor density and distribution in these 
regions (Sanchez et al., 2011). This is most likely associated with the different 
physiological roles of the regions - a contractile function for the dome and body versus, 
a funnelling function for the trigone. During bladder filling, the trigone is fixed in shape 
and helps to anchor the ureteric orifices to prevent backward flow of urine into the
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ureters and, more importantly, contributes to bladder neck closure, for which it is vital 
that the trigone generates its own muscle tone (Akino et al., 2008). In subsequent 
chapters these PCs were investigated further and some of these ideas.
Firstly, was a study to determine whether PCs in the pig bladder could be modulated 
cholinergically by low concentrations of carbachol, since there have been suggestions 
that an increased release of ACh might underlie increased phasic activity seen in OAB 
(Kanai et al., 2007). Also, anticholinergics are now thought to act at sites other than 
just the detrusor muscle, and therefore block actions of ACh at multiple cell types in the 
bladder wall (Chappie 2000; Andersson et al., 2009). Indeed in the present study, PCs 
were increased by low concentrations of carbachol, and thus it appears that a 
muscarinic receptor mediated system is important in PCs, as well as the characterised 
role for muscarinic receptor pathways in detrusor contraction that leads to micturition. 
The target of the carbachol could have been multi-site, since muscarinic receptors are 
widespread in the bladder wall and are found on nerves (Matsumoto et al., 2010; 
Nandigama et al., 2010; Sellers and Chess-Williams 2012), detrusor muscle (Hegde et 
al., 1997; Sellers et al., 2000; Chess-Williams 2002; Mansfield et al., 2005; Creed et al., 
2010; Sellers and Chess-Williams 2012), urothelium (Chess-Williams 2002; Bschleipfer 
et al., 2007; Kim et al., 2008; Moro et al., 2011b; Moro et al., 2011b; Yoshida et al., 
2011; Sellers and Chess-Williams 2012) and ICC (Grol et al., 2009). However, it was 
not possible to determine the precise target in the present study. Relatively selective 
antagonists for the muscarinic receptor subtypes were used to determine which 
receptor subtype(s) may be involved. Muscarinic receptor antagonists are the first line 
of therapy for OAB symptoms and urinary incontinence and the study of muscarinic 
receptors using the available agonists and antagonists has been important in 
establishing treatment for OAB. Although there is much information with regards to 
muscarinic receptors in the bladder, studies have been hampered significantly due to 
the lack of receptor subtype selective agents. In the present study, it was not possible 
to obtain conclusive results as to the muscarinic receptor subtype responsible for the 
cholinergic modulation of the PCs. The lack of muscarinic antagonist selectivity for a 
single receptor subtype compounded the complexity of determining the particular 
subtype responsible for the PCs in pig bladder. The fact that the bladder wall co­
expresses more than one receptor subtype makes the determination of the function a 
single subtype more difficult. The presence of a heterogeneous population of cells 
within the bladder wall expressing various receptors and lack of selective antagonists 
contributed to the inability of identification of the responsible receptor subtype. From
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these studies there remains the potential that non-neuronal acetylcholine released from 
the urothelium in the pig bladder may act on underlying cells to modulate bladder PCs.
Since it is possible that this ACh acts on ICC in the pig bladder wall, as this class of 
cells has been implicated in PCs, this led into the next study, which investigated 
whether ICCs were involved in PCs in the pig bladder, as has been shown in other 
species (Hashitani et al., 2004; Hashitani et al., 2008; Vahabi et al., 2011c). The 
bladder wall appears to have a heterogeneous population of ICC, expressing different 
markers and found in different locations (Smet et al., 1996; Davidson and McCloskey 
2005; Lagou et al., 2006; Lavoie et al., 2007; Johnston et al., 2010; McCloskey 2010). 
Since c-Kit is expressed only in ICC and not SMCs, an inhibitor of this tyrosine kinase 
receptor - imatinib - was used to investigate the role of ICC, with particular emphasis 
specifically on c-Kit positive cells in PCs of the pig bladder. The results showed that 
imatinib did not affect PCs in the pig bladder, and indeed using an antibody directed 
against c-kit, it was not possible to detect c-Kit positive cells in the pig bladder. Thus, it 
might be concluded that c-Kit positive cells are not functionally involved in PCs in the 
pig bladder. However, due to the lack of specificity of the available antibodies for pig 
tissues, it was difficult to draw definite conclusions as to whether these cells are 
present. It is possible that they may be present, but that they are not involved 
functionally in the PCs. These studies also did not rule out the possibility that PCs of 
the pig bladder are mediated by other ICC, since not all ICC express c-Kit, and 
potentially PCs may be mediated by other types of ICC, myofibroblasts or muscularis 
mucosae and detrusor. In response to the questions raised in chapters 2 and 3, it is 
possible that more elaborate technical approaches are required, such as 
electrophysiological recording from whole bladder tissues or cells and molecular 
studies to investigate c-Kit expression of the various cell types and receptors in the pig 
bladder in the different regions.
Given the emerging role of transmitter release from the urothelium in bladder function 
and PCs, the next stage was to study ATP release from the pig bladder. The rationale 
for this was the evidence that ATP is important in normal bladder function and has 
been shown to have an increased role in bladder pathology (Birder et al., 2003; Khera 
et al., 2004; Smith et al., 2005; Salas et al., 2007). One of the most successful, yet 
little understood treatments for OAB is injection of botulinum toxin into the bladder, 
which has been suggested to act via alteration of ATP signalling in the bladder wall. It 
was with this in mind that these experiments were undertaken. The original aims of the 
study were to optimise the measurement of ATP release from bladder tissues and then
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progress to study the effects of botulinum toxin on this and investigate these 
mechanisms in a pathological model of bladder dysfunction.
A significant amount of time was spent on optimisation of the protocol for measuring 
ATP release in the pig bladder. To begin with, microdialysis probes were used in the 
collection of perfusate to measure ATP release. This method produced inconsistent 
and variable results, which may be attributed to the fact that the method of collection 
was not efficient (4pl/min) and the delay in collecting enough perfusate ample enough 
for the assay may have resulted in ATP breakdown by ectonucleotidase enzymes 
hence the inconsistent results. There is also the possibility that the process of inserting 
the microdialysis needle and probe may have caused substantial tissue damage that 
could have altered ATP release. Collection of whole tissue bath content was more 
successful and provided consistent measurement of ATP release. The outcome from 
the optimisation process meant that it was only able to investigate ATP release from 
the dome and body regions of the pig bladder. The results presented in this study 
showed ATP release from whole bladder strips and this increased upon stretching of 
the tissue. The amount of ATP measured in comparison to other published data was 
relatively low, and this may be due to the experimental protocol used. The size of the 
tissue baths (5ml vs. 0.2ml) may have significantly altered the concentration of ATP 
hence the lower values measured, and in hindsight a better approach may have been 
to freeze the samples immediately upon collection on dry ice or liquid nitrogen, to 
minimize ATP breakdown. Preliminary data obtained on the effect of botulinum toxin 
on ATP release showed no effect on ATP release (n=3, data not included) thereby 
suggesting that botulinum toxin did not affect ATP release from the three bladder 
regions, regardless of whether it had been injected into the tissue or incubated with the 
bladder tissue overnight.
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S ummary and conclusions
The study highlights a need for further investigation and understanding of not only 
pathways that mediate normal bladder function but also the complex interaction of the 
various emerging mechanosensory components of the bladder including the urothelium, 
the ICCs, muscularis mucosae, the mediators they release and how they interact with 
underlying afferent nerves and muscle to enable bladder function.
The physiological investigation of pig bladder tissue showed that in vitro, isolated strips 
from the three bladder regions - dome, body and trigone - could develop PCs and that 
the urothelium plays a role in the time it took for these PCs to develop. Further 
analysis of these PCs revealed significant functional heterogeneity between the 
different bladder regions. These PCs could be modulated cholinergically, although it 
was not possible to identify the exact receptor subtype(s) responsible for this. 
Identification of ICCs in bladders of other species naturally led to the question of 
whether they were present in the pig bladder and if so, did they have a role in the PCs 
that developed in the pig tissue? Functional experiments using imatinib, a tyrosine 
kinase inhibitor, showed that the c-Kit ICC population, if present in the pig bladder, did 
not have an effect on the PCs. This led to the investigation of these cells using 
antibodies to try and identify if and where they are located. Immunohistochemical 
results showed a group of cells staining positive for vimentin in similar areas of the 
bladder as shown in other species, but the lack of specific antibodies could not 
definitively identify-Kit positive cells.
Data investigating transmitter release showed that ATP was released from the pig 
bladder in response to stretch. This ATP may exert its effects by acting on the 
receptors present in the underlying nerves, muscle and ICC.
The results presented in this thesis using pig bladder tissues have provided some 
important information with regards to bladder function that can be applied to future 
experiments on human bladder samples. The burden of OAB and the lack of 
compliance with the available pharmacological tools highlights a need for new drug 
therapies to tackle this condition that grossly affects quality of life for millions of people, 
and this will only be achieved with further understanding of the normal and pathological 
function of the bladder.
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F u tu r e  w o r k
Although the bulk of data presented in this study was obtained using tissue bath 
techniques, it seems that more elaborate approaches are needed in order to fully 
answer some of the questions raised. Molecular biology techniques such as PCR 
could be used to identify the expression of the muscarinic subtypes in the different 
regions of the bladder. This could also be used to confirm the presence of ICC in the 
bladder. Further investigation of ICC using antibodies specific to the pig could also be 
performed to firmly establish the localization of these cells in the different regions. The 
lack of an effect with imatinib suggests that c-Kit positive ICCs are not involved in PCs. 
Confirmation of their location and their expression with PCR would lay to rest whether 
the pig bladder expressed c-Kit or not..
The recent validation of a method to use large animal whole bladders could be 
exploited to investigate further ATP and ACh release, and maybe even other 
transmitters, from whole organs rather than using tissue strips. ATP experiments may 
need to include an ectoATPase inhibitor to ensure accurate measurement of ATP 
levels. Future research areas of interest would be completion of studies investigating 
the mechanisms underlying botulinum toxin and investigating potential changes in 
these mechanosensory pathways in pathological models/human tissue samples.
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